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Abstract 
 
Protein motions, which occur on a multitude of timescales, are known to be central to 
enzyme catalysis. However, between enzyme variants there exists diversity in the 
influence such motions have. Understanding why apparently similar enzymes that have 
similar primary sequences, tertiary structures and rate constants utilize different motions 
is therefore of great interest. Dihydrofolate reductase (DHFR) has been used extensively 
as a model to study such relationships between protein motions and catalysis. Firstly, 
we have probed conformational behaviour exhibited by different DHFR variants by a 
simplified, cost-effective NMR based approach utilizing selective 13C labelling of 
methionine and tryptophan sidechains. Before this work, DHFR from Escherichia coli 
(EcDHFR) was the only known DHFR to adopt an occluded conformation following the 
chemical step. 13C labelling of methionine and tryptophan sidechains is shown to be 
sufficient to probe such conformational behaviour in EcDHFR, with clear chemical shift 
perturbations observed between the two conformational states. No such chemical shift 
perturbations are observed in spectra relating to DHFR from Thermotoga maritima 
(TmDHFR) or DHFR from Moritella profunda (MpDHFR), where an occluded 
conformation is not adopted following the chemical step. Through amino acid sequence 
analysis DHFR from Salmonella enterica (SeDHFR) was identified as conserving a key 
hydrogen bonding interaction known to stabilise an occluded conformation in EcDHFR. 
By analysing chemical shift perturbations of 13C labelled methionine and tryptophan 
sidechains, it has been confirmed SeDHFR exhibits similar conformational behaviour to 
EcDHFR. The second part of this work aimed to further explore the contribution of 
femtosecond dynamics acting upon the chemical step of catalysis in SeDHFR. The role 
of such motions coupling to the chemical step is hugely controversial. Our work, with 
SeDHFR, aligns with previous reports that the influence of dynamic coupling to the 
chemical step is minimised in catalysis by DHFR. To further explore the role of 
dynamic coupling to the chemical step in other enzyme families, L-lactate 
dehydrogenase-1 from Staphylococcus aureus (SaLDH) was studied. Initial findings 
align with work done with DHFR variants and reports the dynamic coupling to the 
chemical step is minimised at close to physiological conditions. 
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Introduction. 
 
1.1 Enzymes as catalysts. 	
Spoiled wine is not often a problem in the modern world but in 1860 it became a 
national crisis for France.1 Contrary to the popular beliefs of the time, Louis Pasteur 
identified that yeast was responsible for converting sugars to alcohol and that bacterial 
growth resulted in spoiled wine.1,2 Following this, Eduard Buchner showed that extracts 
from yeast were still able to convert sugar into alcohol. This discovery won Buchner the 
1907 Nobel Prize in chemistry for cell-free fermentation and proved that living cells 
were not necessary to catalyse chemical reactions.3  
 
Over the last 150 years, enzymology has identified a huge variety of enzymes that 
catalyse a wide range of chemical reactions.4 Compared to manmade catalysts enzymes 
exhibit a number of interesting properties. Firstly, enzymes have enormous catalytic 
power and are able to increase reaction rates up to 1017 fold compared to uncatalysed 
reactions (Table 1.1).4 In the case of hydrogen peroxide decomposition the enzyme 
catalase is able to outperform an iron chloride catalyst by 106 fold, protecting the host 
organism from oxidative damage.5,6 Secondly, enzymes are both specific to the reaction 
they catalyse and to the substrate they bind, being able to select specific substrates from 
a pool of structurally similar compounds. The origin of such specificity arises from the 
three-dimensional structure of the enzymes active site, which also facilitates the 
production of stereospecific products.7 Thirdly, enzymes can be tightly regulated by 
small ions or molecules, which bind non-covalently resulting in competitive inhibition, 
or allosteric effects at a distinct binding site that either perturb the three-dimensional 
structure of the active site or restrict conformational behaviour resulting in stimulation 
or inhibition of activity. Enzymes can also be regulated through changes to their 
covalent structure, such as is the case with reversible phosphorylation that can switch an 
enzymes activity on or off.8 Moreover, some enzymes are susceptible to product 
inhibition allowing the system to self-regulate, preventing over production of products 
which may be toxic to the cell.4,9 Finally, enzymes are increasingly being used in 
industrial applications such as laundry detergents and food processing due to their 
ability to fulfil their function under moderate temperatures and aqueous 
environments.10,11 
 
Introduction 
 3 
Table 1.1: Enzymatic rate enhancements taken by comparing catalysed and uncatalysed 
reactions under aqueous conditions, data taken from reference.9 
Enzyme Rate enhancement 
Cyclophilin 105 
Carbonic anhydrase 107 
Triose phosphate isomerase 109 
Carboxypeptidase A 1011 
Phosphoglucomutase 1012 
Succinyl-CoA transferase 1013 
Urease 1014 
Orotine monophosphate decarboxylase 1017 
   
To explain the mechanism of enzyme catalysis, Emil Fisher in 1894 proposed that 
enzymes only bind substrates which match the geometry of the enzymes active site, 
defined as the ‘lock and key’ model.12 Shortly after, Brown in 1902 provided evidence 
for an enzyme-substrate complex by showing the enzyme invertase had increased 
thermal stability in the presence of sugar. Brown also noted that formation of such a 
complex likely impacted on the overall rate constant for the catalysed reaction.13 
Observations such as these laid the foundations for Victor Henri in 1903 to release the 
first realistic mathematical model for the kinetic analysis of enzyme catalysed 
reactions.14,15 A decade later, Leonor Michaelis and Maud Menten built on the work of 
Henri, adding detail to the mathematical model through better defining of the constants 
involved.16 
 
These models, however, did not explain the chemical mechanism or how enzymes were 
able to achieve such large rate enhancements. Transition state theory (TST), first 
developed in 1935, by Eyring, Evans and Polanyi, proposed that it is possible to 
increase reaction rates by reducing the energy of the transition state.17–19 Koshland 
added to this theory in 1958 with his theory of ‘induced fit’ wherein enzymes undergo 
conformational changes upon substrate binding, allowing for residues within the 
enzyme active site to form intermolecular interactions with the substrate, effectively 
enhancing the activity of the enzyme.20 Contrary to this it was noted that enzymes could 
also be inhibited by molecules other than the designated substrate and to address this 
Introduction 
 4 
Changeux, Monod and Wyman developed the ‘allosteric model’ in 1965, which allows 
such molecules to bind into allosteric sites, inducing conformational changes which can 
de-activate or even activate the protein.21 However, no single model is yet able to fully 
explain how enzymes achieve their catalytic power. In particular, the role of 
conformational behaviour and protein dynamics are still not fully understood. As a 
result, this Thesis will further investigate the role of such motions and how they impact 
on catalysis in enzymatic systems. 
 
1.2 Steady state kinetics and Michaelis-Menten. 	
In order to explain how enzymes convert substrates into product steady state kinetic 
explanations can be used. One of the most famous is the Michaelis-Menten equation 
proposed in 1913. In this model the enzyme rapidly and reversibly binds substrate to 
form an enzyme substrate complex [ES]. In the second step this slowly breaks down 
into free enzyme [E] and product [P] as described in Equation 1.1. The rate of catalysis 
(Vo) increases with substrate concentration [S] until saturation conditions are reached; at 
this point the system has reached Vmax (Figure 1.1). In Michaelis-Menten kinetics a 
number of assumptions are adopted; 
1. Almost zero [P] reverts back to starting material [ES]. 
2. The concentration of intermediates remains constant. 
3. The enzyme concentration [E] is much lower than substrate concentration 
[S]. 
4. The formation of [P] is much slower than formation of [ES]. 
Through derivation of Equation 1.1, Equation 1.2 is yielded.16,22 
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Figure 1.1: Initially the rate of reaction is first order and linearly dependent on substrate concentration. 
As the enzyme becomes saturated it becomes independent of substrate concentration.  
 𝐸 + 𝑆 𝑘!⇌𝑘!!𝐸𝑆 𝑘!⟶ 𝐸 + 𝑃 
 
Equation 1.1: A simple equation that accounts for a two-step model of enzyme catalysis. 
 𝑉! = 𝑉!"# 𝑆𝐾! + [𝑆] 
 
Equation 1.2: Michaelis-Menten equation.16 
 
From Equation 1.2 we get the Michaelis constant, KM which has units of concentration 
and can be described as the concentration of substrate required to achieve half the 
maximal velocity (Vmax) of the reaction. Although the value of KM is affected by pH, 
temperature and ionic strength of the buffer it is independent of enzyme concentration. 
Although Equation 1.1 characterises the formation of product from the enzyme 
substrate complex as a single step it often involves multiple intermediates. The turnover 
number, or kcat encompasses all intermediates and describes the total complete 
conversions an enzyme is capable of in a given timescale. The ratio of kcat/ KM is also 
known as the specificity constant and reports on the efficiency of an enzyme, the higher 
the value, the more able the enzyme is to convert substrate to product. The specificity 
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constant is often used as a measure of enzyme efficiency and is utilised in the 
identification of the enzymes natural substrate and varies greatly between different 
enzymes. For example, Hexokinase, phosphorylates a number of hexoses and 
comparison of the specificity constants allows for the identification of its preferred 
substrate, glucose.4,22,23  
 
1.3 Transition state theory and KIE. 
 
From a thermodynamic perspective, chemical reactions proceed from reactants to 
products over a transition state barrier (Figure 1.2). The transition state has the highest 
Gibbs free energy and as such is the lowest populated point along the reaction pathway. 
Enzymes effectively lower the activation energy barrier without altering the Gibbs free 
energy of reactants/products, thus not changing the equilibrium constant.4  
 
Figure 1.2: Graphical representation of how enzymes lower the ΔG‡ of the reaction, (red) with enzyme, 
(blue) without enzyme. ES, ES‡, and EP represent the enzyme-substrate complex, the transition state 
complex and the enzyme-product complex respectfully.4,22  
 
Transition state theory (TST) is based upon assumptions that molecules in the transition 
state are in quasi-equilibrium with reactants and that the reaction rate is governed by 
breakdown of the transition state complex. The development of TST is attributed to 
Eyring, Evans and Polanyi in 1935 and builds upon work done by Arrhenius nearly 50 
years earlier.17,18,24 The Arrhenius equation (Equation 1.3) developed in 1889 was 
originally used to study reactions in the gas phase and describes the relationship 
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between the activation energy (Ea), the rate of reaction and the temperature of chemical 
reactions. Two important observations can be made: firstly, as the activation energy 
increases, the rate of reaction decreases exponentially, and secondly, with every 10 °C 
rise in temperature the rate is expected to roughly double.24 
 𝑘 = 𝐴𝑒!!!/(!") 
 
Equation 1.3: The Arrhenius equation. k is the rate constant, Ea is the activation energy, R is the 
universal gas constant, T is the temperature in Kelvin and A is the pre-exponential factor which is 
dependent on temperature and describes the number of successful collisions in the correct orientation 
between molecules and is different for every chemical reaction.24  
 
The Eyring equation (Equation 1.4) further developed the Arrhenius equation, which it 
is notably similar too, except it is derived mathematically from model systems and not 
from experimental observations. The Eyring equation expands the pre-exponential 
factor (A) to include the transmission coefficient (𝜅), which includes a number of 
correcting factors including solvent friction events and re-crossing of the transition state 
barrier, which leads to unsuccessful reaction trajectories. Subsequently, the transmission 
coefficient can deviate greatly from unity in enzyme-catalysed reactions.17,22  
 𝑘 = 𝜅𝑘!𝑇ℎ 𝑒∆‡!! 𝑒!∆‡!!"  
 
Equation 1.4: The Eyring equation. Highlighted in green is the enthalpy of activation (Δ‡H) and this 
corresponds to the activation energy in the Arrhenius equation. Highlighted in red is the section which 
corresponds to the pre-exponential factor, A. kB is the Boltzmann constant, h the plancks constant, Δ‡S 
the entropy of activation and 𝜅 is the transmission coefficient.17,22  
 
The use of kinetic isotope effects (KIE) in the study of reaction mechanisms has 
become an important tool in understanding mechanisms and is empirically defined by 
Equation 1.5. A KIE is a ratio of the rate constants for reactions involving a light (kL) 
and heavy (kH) isotopes. A primary KIE involves isotopic substitution of the atom that 
is directly connected the bond being broken/formed.25 
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𝐾𝐼𝐸 =  𝑘!𝑘! 
 
Equation 1.5: The KIE is the ratio of the rate constant for the reaction with the light isotope (kL) and the 
heavy isotope (kH).26 
 
If we consider a potential energy well from a quantum mechanical perspective we 
observe discrete energy levels. The lowest energy level is slightly higher than the trough 
of the potential energy well; this is defined as the zero point energy (ZPE).26 In TST the 
KIE is primarily thought to derive from a lower zero point energy of the heavier isotope 
as a result of the greater reduced mass, resulting in a smaller stretching frequency 
(Equations 1.6a, b & c). This effectively increases the free energy needed to overcome 
the activation energy (Figure 1.3).26,27  
 𝐸! = 12ℏ𝜔                              𝜔 = (𝑘!𝜇 )!!                              𝜇 = 𝑚!×𝑚!𝑚! +𝑚!  
 
Equations 1.6a, b & c (left to right): Eo equates to the Z.P.E, ℏ is reduced plancks constant, ω is 
described by equation 1.6b. where kf is the force constant  and µ the reduced mass described by equation 
1.6c. m1 is the mass of the lighter isotope, m2 the mass of the heavier isotope.26  
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Figure 1.3: Difference in Z.P.E. in a reaction involving breaking of a carbon-hydrogen bond compared to 
a carbon-deuterium bond.  
  
The difference in Z.P.E. between a C-H and C-D bond is ~4.8 kJ mol-1, with stretching 
frequencies of ~3000 cm-1 and ~2200 cm-1 respectively.28 When these values are 
substituted into the Eyring equation (Equation 1.7) semi-classical models predict a 
primary KIE of ~6.9 at 298 K, which tends to zero at infinite temperatures as the ratio 
of pre-exponential factors (AH/AD) nears unity. Semi classical models propose the 
difference in rates arises from these differences in Z.P.E. and does not take into account 
effects from tunnelling or dynamics. Semi-classical models therefore fail to account for 
experimentally observed temperature independent KIEs, larger than expected KIEs or 
even KIEs that are smaller than expected but strongly dependant on temperature.22  
 
𝐾𝐼𝐸 = 𝑘!𝑘! =
𝜅𝐾!𝑇ℎ 𝑒∆!‡!"𝜅𝐾!𝑇ℎ 𝑒∆!‡!!"##!" = 𝑒
!"##!" = 6.9 
 
Equation 1.7: Using the Eyring equation to calculate the maximum primary KIE between a C-H and C-D 
bond. 
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1.4 Tunnelling in enzymatic reactions. 
 
Semi-classical models do not account for tunnelling contributions in enzymatic 
reactions. As such semi-classical models fail to explain KIE for a number of enzyme 
systems including, lipoxygenase-1 from soybean,29 alcohol dehydrogenase from 
Bacillus stearothermophilus,30 flavoprotein pentaerythritol tetranitrate reductase,31 and 
dihydrofolate reductase from Escherichia coli.32 In the semi-classical model, KIE are 
said to arise from differences in Z.P.E of the isotopolouges involved, directly altering 
the activation energies (Ea) classically required for the reaction to occur. Tunnelling 
allows for a particle to cross a transition state barrier when it classically it does not have 
enough energy to do so, thereby breaking down the semi-classical models (Figure 
1.4).33,34 Bells modification to the semi-classical model adds a correction factor (Qt) to 
the Eyring equation (Equation 1.8a) in order to account for effects from tunnelling. 
The correction factor (Qt), mathematically calculates the likelihood of a particle 
tunnelling in a given reaction (Equation 1.8b). The variable, G depends strongly on the 
mass of the particle and as such explains the large difference observed in KIE between 
reactions involving hydrogen and deuterium. Tunnelling also depends on both the width 
and height of the potential energy barrier.33,34 The addition of Bells tunnelling 
correction factor to semi-classical models can mathematically explain KIEs that exceed 
the semi-classical limit of 6.9.34 
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Figure 1.4: Graphical representation of Bells correction for tunnelling, note how quantum tunnelling has 
a larger effect on the lighter molecule.  
 𝑘!"# = 𝑄!𝐴𝑒!!!!"                     𝑄! = 1𝑘𝑇 𝑒!!!!!! 𝐺(𝑊)𝑘𝑇 𝑒!(!!!!)!!! 𝑑𝑊 
 
Equations 1.8a & b: Where Qt is the tunnelling correction factor, G is the probability of barrier crossing 
and is heavily dependant on the mass of the tunnelling particle, W is the energy of the particle and kb is 
the Boltzmann constant  
 
Semi-classical models also fail to effectively model the temperature dependence of the 
KIE. The semi-classical Arrhenius equation (Equation 1.3) shows that the relationship 
between rate and the activation barrier is exponential; with the KIE simply a ratio of the 
light and heavy rate constants (Equation 1.8).27 At high temperatures the barrier to the 
reaction becomes negligible, as there is enough thermal energy to overcome it and 
consequently the contribution from different isotopes also becomes negligible and the 
ratio between the pre-exponential factors (AH/AD) tends to unity. Under these conditions 
the contribution from tunnelling is also mitigated (figure 1.5). At low temperatures the 
opposite is true, the lack of thermal energy means most molecules do not have the 
energy required to overcome the potential energy barrier for the reaction. Contributions 
from tunnelling therefore have a large effect on the rate of reaction, the KIE will be 
large and the ratio between the pre-exponential factors large (AH/AD >1) in respect to 
measurements at higher temperatures. Between the two temperature extremes the 
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contribution from tunnelling will be greatest from the lighter isotopologue producing 
strongly temperature dependant KIE. Therefore if an enzymatic system has a 
relationship between the ratio of the pre-exponential factors and temperature as 
described above tunnelling is likely taking place. 27,35 
 𝐾!𝐾! = 𝐴!𝐴! 𝑒∆!!(!!!)!"  
 
Equation 1.8: Calculation of KIE via the Arrhenius equation.  
 
 
Figure 1.5: Graphical representation of an Arrhenius plot for a H transfer reaction with Bells tunnelling 
correction, adapted from ref.27  
 
One of the major pit-falls of Bells tunnelling correction and TST theory in general is 
that it considers the reaction coordinate as rigid and one dimensional and considers only 
the hydrogen atom being transferred, failing to effectively model contributions from the 
heavier atoms from which the particle is being transferred too or from. Dihydrofolate 
reductase, thymidylate synthase and soybean lipoxygenase-1 all represent enzymatic 
systems that cannot be effectively modelled by semi-classical TST with Bells tunnelling 
correction due to either larger than expected KIEs, pre-exponential factors (AH/AD) that 
exceed unity and discrepancies in whether temperature independent or dependant KIEs 
are observed.27,29,32,36–38 
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To this end Marcus theory was developed as a way to account for discrepancies in TST 
theory.27 Marcus theory was originally developed to model rates of electron transfer 
from a donor to acceptor molecule.39 Modified versions of his theory are known as 
Marcus-like models and replace electron transfer with proton transfer and include 
parameters to include heavy atom re-organisation and fluctuations in the donor-acceptor 
distance (DAD).27,33 From this model the theory of ‘protein promoting motions’ has its 
foundations.40 Marcus-like models have two main selection rules for efficient 
tunnelling, a narrow activation barrier and the reactant and product energy levels must 
be degenerate (Equation 1.9 describes Marcus like models and graphical representation 
is shown in figure 1.6).41,42  
  
𝑘 = 𝐶𝑒!(∆!!!!)!/(!!"#) 𝑒!(!)𝑒!!! ! /!!!𝑑𝐷𝐴𝐷!!!!  
 
Equation 1.9: Equation describing Marcus like models, where k is the rate constant. The equation can be 
considered in parts; C is a constant, the first exponential is the Marcus term, the second exponential 
(F(m)) is the Frank-Condon term and the third exponential is the gating term (Ef(m)).   
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Figure 1.6: Graphical representation of the Marcus-like model. In this model there are two orthogonal 
co-ordinates. The gating term describes fluctuations in the donor-acceptor distance (DAD) and the 
Marcus term has the energy wells for both the reactant and product as well as the energy of the transition 
state.  
  
The equation (Equation 1.9) before the integral represents the Marcus term and 
describes the re-organisation of the wave functions leading to a state where tunnelling is 
permitted. The term C includes factors relating to reorganisation energy (λ), electronic 
coupling, reaction driving force (ΔGO) and the temperature (T) in degrees Kelvin. The 
C term is also independent with respect to isotope mass.  Terms after the integral 
calculate tunnelling probability once the system has reached a tunnelling ready state and 
is dependant on both temperature and isotopic mass.27,33 Marcus-like models are able to 
address some of the pitfalls in TST: the formation of the tunnelling ready conformation 
is independent of temperature and as such is able to account for temperature 
independent KIEs. Secondly, the equation addresses contributions from the heavier 
isotopes in the second exponential term and better models donor-acceptor distances.27,33  
 
The most recent debate with respect to the catalytic power of enzymes is how or if 
protein dynamics influence the rate of reaction by altering the potential energy 
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landscape.43 Trular and co-workers also developed a variational TST model (VTST) to 
account for the shortcomings of TST, which is described in section 1.13 of this thesis.44 
The role of dynamics will be further investigated in this thesis.   
 
1.5 Pre-steady state kinetics. 	
Steady-state kinetic studies offer limited information regarding the rates of individual 
steps present in the catalytic cycle. Typically steady-state kinetics using Michaelis 
Menten provide kcat and KM. This gives a measure of catalytic efficiency with average 
values of kcat for enzyme catalysis being on the order of 10 s-1, although this varies 
greatly with the enzyme catalase able to achieve a kcat of 107 s-1.5,9,22,45 The value of kcat 
predominantly reports on the slowest step in a catalytic cycle, which often involves a 
conformational change or ligand binding/release. In order to determine individual rate 
constants within the reaction coordinate it is necessary to study the enzyme in the 
transient phase of the enzymatic reaction, before establishment of steady state 
conditions where the concentration of [ES] reaches equilibrium (Figure 1.7). For this 
purpose it is necessary to study the enzyme under single-turnover conditions and unlike 
steady state methods the concentration of enzyme [E] is usually greater than 
concentration of substrate [S].22,46  
 
Introduction 
 16 
 
Figure 1.7: Curve showing transient phase of enzymatic reaction (red) as well as when the system has 
reached steady state conditions (blue), continuation of the steady state slope to the y axis (hashed line) 
gives an approximate concentration of enzyme in the experiment as at this point the system each single 
enzyme has completed one reaction. 
 
1.5.1 Study of fast dynamics by stopped-flow. 
 
In order to study KIEs involving the chemical step a method of rapid analysis is 
necessary. The stopped-flow technique allows for the rapid mixing of solutions for the 
study of reactions on a timescale of up to a few milli-seconds. This allows for the 
examination of pre-steady state kinetics in enzymes (Figure 1.8).22 In order to study a 
primary KIE in enzymatic reactions, isotopically labelled substrates need to be 
prepared. 
 
Recently groups have also been measuring enzyme KIE to gain information on how fast 
dynamics influence the chemical step of catalysis. Enzymes are produced recombinantly 
in minimal media containing ‘heavy’ feedstocks such as 13C-glucose. Rates of reaction 
catalysed by heavy enzymes (labelled with 1H &/or 13C &/or 15N) can then be compared 
with the light isotopologue (natural abundance).47 Heavy labelling is thought to effect 
vibrational and rotational motions without altering the electrostatic properties or 
potential energy surface.48,49  
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Figure 1.8: Simplified diagram of a stopped-flow spectrometer. Small amounts of solution are rapidly 
mixed via the application of force to the drive syringes. A sensor on the stopping syringe triggers the 
system to observe the reaction-taking place in the observation cell.  
 
1.6 Dihydrofolate reductase (DHFR). 
 
Dihydrofolate reductase (DHFR) catalyses the transfer of a hydride from the C4 
position of NADPH to the C6, Re face of DHF, and protonation from water of the N5 
position to form THF (Figure 1.9).50,51 Interestingly, a few DHFR variants are also able 
to reduce folate to DHF.52 DHFR has been used as a model enzyme to study the 
contribution of protein dynamics and conformational behaviour on catalysis.53 
 
 
 
Figure 1.9: Reaction catalysed by DHFR, DHF is reduced to THF in the presence of NADPH. The 
structural parts of DHF are highlighted; pterin ring (blue), P-aminobenzoate (green) and glutamate (red).   
 
THF partakes in a number of vital metabolic reactions as a carrier of activated one 
carbon units. THF is able to bond one-carbon units in various oxidation states to either 
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its N5 or N10 position (Figure. 1.10).9 Serine hydroxymethyltransferase catalyses the 
reversible transfer of a single carbon unit to THF, forming N5,N10-Methylene-
tetrahydrofolate. Easy inter-conversion between the resulting one-carbon derivatives 
allows for a stable supply and demand relationship in which THF partakes in over 20 
reactions including the systematic synthesis of deoxythymidine monophosphate (dTMP) 
and deoxyuridine monophosphate (dUMP), used in the synthesis of DNA and hence 
critical for cell replication.9 Consequently, over the last half century a number of drugs 
targeting DHFR in pathogens have been developed to block replication. These include 
Methotrexate (Anti-neoplastic), Trimethoprim (Anti-bacterial), Trimetrexate (Anti-
fungal) and Proguanil (Anti-malarial).54 A lack of dietary folate or Vitamin B9 can 
cause a range of health problems: neural tube defects in developing foetuses, reduced 
fertility, depression, anaemia and poor growth to list a few. As a consequence many 
countries now fortify particular foods with folic acid.55–57 
 
Introduction 
 19 
 
 
Figure 1.10: Redox transitions between various forms of tetrahydrofolate. The reaction catalysed by 
DHFR is highlighted in red, figure adapted from reference.9 
 
1.7 The physical structure of DHFR with a focus on EcDHFR. 
 
Over 340 structures have been published for various DHFRs with a diverse range of 
bound ligands (inhibitors, substrates and products) in the protein data bank.58,59 DHFRs 
can be considered as having three main sub-domains: the adenosine binding domain, the 
loop domain and the substrate-binding domain (Figure 1.11a). Dihydrofolate reductase 
from Escherichia coli (EcDHFR) has a core structure of the enzyme consists of an 
eight-stranded β-sheet; strands βA-βG run in parallel and strand βH is antiparallel and 
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encompasses the C-terminus. DHFR also contains 4 α-helices (labelled B, C, E and F) 
and four mobile loops: M20 loop (residues 10-24 with EcDHFR numbering), FG loop 
(residues 117-131) and the GH loop (residues 146-148) (Figure 1.11b).60,61 The 
nicotinamide ring of NADPH sits in a hydrophobic cleft between the βA and βE sheets. 
Folate and its derivatives bind between the αB and αC helices, the pterin ring is bent 
perpendicular to its benzoic acid moiety and is coplanar to the nicotinamide ring of 
NADPH.60,62  
 
 
Figure 1.11: Two cartoon representations of EcDHFR (1RX2),61 both in complex with folate (pink) and 
NADP+ (yellow). A. The Three main domains are highlighted: Substrate binding domain (green), 
Adenosine binding domain (red) and the loop domain (blue). B. Highlighted are the important secondary 
structural elements: β-sheet (green), α-helices (red) and loops (blue).  
 
1.8 The chemical step in EcDHFR. 
 
All known DHFR variants have a single ionisable residue in their active site which is 
implicated in the protonation of the N5 position of DHF: aspartic acid in bacteria and 
glutamic acid in vertebrates.63,64 Asp27 is the only ionisable residue present in the active 
site of EcDHFR and as such it was deemed probable that it acts as the proton source in 
the protonation of the N5 position of DHF. Crystallographic structures however show 
that Asp27 forms a hydrogen-bonding network to the C2 and N3 position of the pterin 
ring of DHF, which is over 5 Å away from the N5 position. In order to explain how 
Asp27 is involved in protonation of the N5 position a number of papers have proposed a 
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keto-enol tautomerization mechanism. In this theory Asp27 stabilises an enol form of 
DHF, which in turn allows water held within in the active site to act as a proton source 
for the N5 position (Figure 1.12).65–69  
 
  
Figure 1.12: Proposed Keto-enol tautomerisation mechanism for protonation of the DHF N5 position, 
Asp27 indirectly protonates the N5 position. 
 
However, no water molecule was previously observed adjacent to the N5 position of 
DHF in any crystal structures of the ternary complex (Site B), although a water 
molecule was observed between Asp27 and Try22 (Figure 1.13). A computational 
study by Shrimpton and Allemann in 2002 proposed that the mechanism involving keto-
enol tautomerisation was not viable due to the bond angles and lengths being 
unfavourable for the protonation of the N5 position. Instead it was proposed rapid, 
subtle structural rearrangements allowed water trapped within the active site to move 
closer to the N5 position (site B).70,71 
 
 
Figure 1.13: The two possible positions of water molecules inside the active site of DHFR respective to 
DHF. Site A is highlighted in red and site B highlighted in blue.  
 
A high-resolution X-ray structure of EcDHFR in the Michaelis complex was solved by 
Wan et al. in 2014, which revealed the substrate, exists in the keto form with Asp27 
carrying a negative charge. Moreover, it was found minor fluctuations in the M20 loop 
allowed water into site B, allowing for direct protonation of the N5 position of DHF, the 
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produced hydroxide stabilised by residues in the active site. This direct protonation 
mechanism means that formation of the enol form is not required.72 It is considered 
EcDHFR facilitates protonation at this position through elevation of the N5 pKa from 
2.6 to 6.5.67 Recent work has provided evidence that protonation of the N5 position and 
hydride transfer from the C4 position of NADPH to the C6 position of DHF proceed 
independently of one another.73  
 
1.9 The catalytic cycle of EcDHFR. 	
Using ‘stopped flow’ spectroscopy, Benkovic and co-workers published the kinetic 
scheme of the catalytic cycle for EcDHFR, which was shown to have five major kinetic 
intermediates (Figure 1.14).51 The holoenzyme, E:NADPH first binds DHF to form the 
Michaelis complex E:NADPH:DHF. Following hydride transfer, the product ternary 
complex, E:NADP+:THF, is formed. The maximum measured rate for the chemical step 
is 950 s-1 at pH 5.0, dropping to 220 s-1 at pH 7.0. Above pH 9 it becomes rate limiting. 
The enzyme then releases NADP+ to form the product binary complex, E:THF. 
Rebinding of NADPH forms the product release complex, E:NADPH:THF, and 
precedes the release of THF to reform the holoenzyme E:NADPH. Under close to 
physiological conditions (pH 7) release of THF is the rate-limiting step (12 s-1). At no 
point in the catalytic cycle is there any significant quantity of apo-EcDHFR.51  
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Figure 1.14: Kinetic scheme of catalysis by EcDHFR as determined by Benkovic et al.51 
 
1.10 Motions involved in enzyme catalysis. 
 
Enzymes are found to exhibit motions on massively different timescales. Motions that 
occur on a second to millisecond (ms) timescale are often considered slow in 
comparison to the rate of catalysis and largely consist of either large domain movements 
or loop motion (Figure 1.15). Motions, which occur on a nanosecond or lower 
timescale, are considered fast in comparison to the rate of catalysis and include such 
things as side-chain rotations. Bond-vibrations, which occur on a femto second 
timescale (10-15 s-1), are dramatically faster than any other observed protein motion. In 
this thesis the term ‘dynamics’ will refer to motions occurring on a fast, femtosecond 
timescale.74,75 
 
 
 
Figure 1.15: Timescale of protein motions. 
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1.11 Conformational behaviour and catalysis in DHFR. 
 
EcDHFR as has three mobile loops: the FG loop (residues 116-132), the GH loop (142-
149) and the M20 loop (9-24).61 During catalysis EcDHFR cycles predominantly 
through two main structural conformations, as defined by positions of the M20 loop 
(Figure 1.16).61 In the E:NADPH and Michaelis complex the enzyme adopts a closed 
conformation, with the M20 loop closed over the nicotinamide group of NADPH in the 
active site. Following the chemical step the enzyme switches to an occluded 
conformation, where residues in the M20 loop protrude into the active site, lowering the 
binding affinity of the product, NADP+.61,76 Although free EcDHFR is not observed 
during catalysis, crystallographic evidence shows the apo form to adopt an 
open/disordered conformation.51,61 Computational simulations propose that relatively 
small energy barriers separate the different conformational states of EcDHFR, and that 
binding of different ligands alters their relative stability resulting in conformational 
changes occurring concurrently with the catalytic cycle. Different conformational states 
being more or less thermodynamically favourable depending on bound ligands.77 In the 
closed conformation residues in the M20 loop form a hairpin turn and an anti-parallel 
sheet, stabilised by a hydrogen-bonding network between Asn18 in the M20 loop and 
His45 in the αC helix. In this conformation Met16 and Glu17 are arranged in such a 
manner to allow nicotinamide binding.61,78 In the occluded conformation these residues 
move into the active site forcing the nicotinamide group out into solution.61,78 In 
EcDHFR residues Ser148 in the GH loop and Asn23 in the M20 loop stabilise an 
occluded conformation via hydrogen bonding interactions.61 Only in the closed 
conformation are the co-factor and substrate close enough to allow hydride transfer.79,80 
The ability of EcDHFR to adopt an occluded conformation has been shown important 
for product release and, as such, efficient progress through the catalytic cycle.61,81  
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Figures 1.16 & 1.17: (1.16) Cartoon representation of EcDHFR with the M20 loop highlighted in 
different structural conformations (Green = open/disordered, Blue = closed, Red = Occluded) (1.17) 
catalytic cycle of EcDHFR with each of the five kinetic intermediates highlighted with respect to the 
structural conformation adopted by EcDHFR (Green = open/disordered, Blue = closed, Red = Occluded). 
 
Using NMR relaxation dispersion experiments Boehr et al. proposed an altered catalytic 
cycle to that shown in Figure 1.17. The new model proposed that the major kinetic 
intermediates, whose structures have all been observed via x-ray crystallography sample 
higher energy intermediates that effectively mimic the conformational structure of the 
following or past intermediate.81 Arguably, one of the most interesting findings of the 
work was that the Michaelis complex closed structure samples the ground state 
occluded structure of the product complex at a rate of ~1200 s-1. This is comparable to 
the rate of hydride transfer (~950 s-1) and it was postulated that kH and kcat may be 
governed by physical structural changes.51,81 Following on from this, again using Carr-
Purcell-Meiboom-Gill (CPMG) NMR relaxation experiments, it was postulated that 
release of THF from the active site is facilitated by the enzyme in the E:NADPH:THF 
complex rapidly probing an excited state that mimics the structural conformation of the 
E:NADPH complex. In this complex the pterin ring of THF is forced out of the active 
site to avoid steric clash with NADPH in the closed like structure. This in turn lowers 
the binding affinity facilitating product release (Figure 1.18).82  
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Figure 1.18: Cartoon representation of EcDHFR in the occluded (red), E:NADPH:THF complex rapidly 
probing a structural conformation similar to that of the closed (blue), E:NADPH complex to facilitate 
release of THF. NADPH is highlighted in green and folate derivatives in orange. The middle complex 
highlights how steric clash between substrates may lower binding affinities. The original rate measured 
by Benkovic et al is shown on top. 
 
Conformational behaviour varies greatly between DHFR variants; previously EcDHFR 
was the only known DHFR variant to adopt an occluded conformation following the 
chemical step.83 DHFR from Moritella profunda (MpDHFR) shares 55% sequence 
identity to EcDHFR and in terms of tertiary structure is near superimposable (R.M.S.D. 
of the atomic position of the Cα is calculated to be 0.878 Å).61,84 Like EcDHFR, the 
release of THF from the E:NADPH:THF complex is rate limiting at pH 7.0.76 
Crystallographic and NMR studies have shown that MpDHFR does not adopt an 
occluded conformation following the chemical step. The Ser148-Asn23 interaction, 
which stabilises the occluded conformation in EcDHFR, is knocked out in MpDHFR 
due to the equivalent Ser148 position being replaced with a proline residue.76,84 The 
lack of an occluded conformation is also true for DHFRs from Lactobacillus casei and 
Bacillus anthracis that respectively have an alanine and proline reside in place of 
Ser148.85–87 The mutant, EcDHFR-S148P showed no significant change to koff for THF, 
however the binding affinity for NADP+ dramatically increased.76 This resulted in the 
realise of THF from the E:NADP+:THF complex rather than the E:NADPH:THF 
complex becoming the rate limiting step. The mutant, MpDHFR-P150S appeared to 
show evidence of adopting a second conformation and had a much lower binding 
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affinity for NADP+ than wild type MpDHFR (Table 1.2).76 It was concluded an ability 
to adopt an occluded conformation following the chemical step of catalysis lowered the 
binding affinity for NADP+, allowing for efficient progress through the catalytic cycle 
in the reaction catalysed by EcDHFR.76 However, MpDHFR and EcDHFR exhibit 
similar KM values for NADPH and koff values for THF, suggesting MpDHFR does not 
circumvent the problem of not adopting an occluded conformation by lowering overall 
binding affinities for substrates. Instead, it is likely additional features in MpDHFR help 
facilitate release of NADP+, this likely explains why the IC50 value for NADP+ for 
MpDHFR is much larger than for EcDHFR-S148P. Furthermore, EcDHFR and 
MpDHFR have similar single turnover rates at pH 7, showing that the inability to adopt 
an occluded does not have a deleterious effect on the overall rate of catalysis.76 
 
Table 1.2: IC50 Values for NADP+ (µM) at 20 °C, taken from reference.76 
Enzyme IC50 value for NADP+ at  pH 7  
EcDHFR 820 +/- 59 
EcDHFR-S148P 40 +/- 1 
MpDHFR 170 +/- 11 
MpDHFR-P150S 321 +/-12 
 
DHFR from the hyperthermophile Thermotoga maritima (TmDHFR) is the only known 
homodimeric DHFR to exist. The equivalent residues of the FG loop in EcDHFR are 
locked into the dimer interface in TmDHFR, and as such it was thought TmDHFR 
remains in a fixed open conformation throughout its catalytic cycle.88,89 Restriction of 
flexibility in the M20 and FG loops in EcDHFR has shown to affect catalysis, and it is 
theorised that the much lower catalytic activity of TmDHFR can be attributed to its 
rigidity.90 The fixed, open nature of the active site in TmDHFR prevents both 
modulation of the substrate pka by the residues in the M20 loop and expulsion of solvent 
from the active site during catalysis.89,91,92 As such, it is thought that the N5 position of 
THF is protonated directly from bulk solvent.92,93 The addition of CHAPS to the mutant 
TmDHFR-V11D resulted in formation of monomeric enzyme. Although no significant 
decrease in kH was observed between TmDHFR-V11D and the native dimer, a decrease 
in kcat was observed. It was concluded that the lower rates observed for TmDHFR in 
comparison to monomeric DHFRs, are not simply a result of increased rigidity but 
evolutionary pressure to select for modifications to the protein structure, which allow 
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for greater thermostability.94 In order to further study the effects of dimerization, 
residues from the dimeric interface in TmDHFR were inserted into the equivalent 
positions in EcDHFR to create the dimeric mutant, Xet-3. Like TmDHFR, Xet-3 had 
increased thermostability compared to native EcDHFR, and reduced kH and kcat rate 
constants. However, unlike TmDHFR, it was concluded that the reduction in rate 
constants observed for Xet-3 were a consequence of reduced flexibility which facilitates 
efficient progression through the catalytic cycle in EcDHFR.94,95  
 
Bacterial DHFRs are usually poor in their ability to reduce folate.96 Like mammalian 
variants, TmDHFR is able to reduce folate with a similar catalytic efficiency as DHF, 
reducing folate to THF without the release of DHF from the active site. It is likely the 
open nature of TmDHFR facilitates protonated folate.52 The specificity for folate can be 
increased in EcDHFR via the addition of avian loop regions, which is believed to 
restrict loop motion.97 
 
Mammalian DHFRs have also been found not to adopt an occluded conformation. Most 
have a proline rich region at the end of their equivalent M20 loops, decreasing the 
mobility of the M20 loop in comparison to the bacterial counterparts.98–100 DHFR from 
Homo sapiens (HsDHFR) exhibits no significant structural changes between the 
Michaelis and product complexes, in evidence gained from either crystallographic or 
NMR experiments.99 It has previously been noted that mutants which hinder loop 
motions in EcDHFR drastically affects the efficiency of the enzyme.76 NMR CPMG 
relaxation experiments also yielded no evidence of conformational behaviour on a 
millisecond timescale, unlike in EcDHFR where the enzyme rapidly probes structural 
conformations similar to the next or previous kinetic step.81,99 However, motions on the 
microsecond timescale were revealed and it is thought HsDHFR utilises such motions 
for ligand binding/release.99 Ligand binding is therefore not facilitated by loop motion. 
Crystallographic evidence suggests movement of the adenosine binding domain closes 
the active site upon substrate binding. Further evidence of this movement has been 
found through NMR experiments.99 Such hinge movements have also been observed in 
EcDHFR but accounts for only ~20 % of the movement observed in HsDHFR.61,99 
 
The double mutant EcDHFR-N23PP/S148A was designed to incorporate the proline 
rich region found in mammalian DHFR and knock out the stabilising effects of the 
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Ser148-Asn23 interaction.98 The mutant reported a significant reduction in kcat as well a 
change in the rate limiting step from dissociation of THF to dissociation of NADP+.98 
The single mutant, EcDHFR-S148A reported a similar rate for kH but release of THF 
from the E:NADP+:THF product complex became rate limiting rather than release from 
the E:NADPH:THF mixed ternary complex.76 However, further work has shown that 
the insertion of a single alanine residue into this part of the protein sequence in 
EcDHFR prevents formation of an occluded conformation and a reduction of motions 
on an associated timescale. It has been theorised that the extra residues in this region 
influences millisecond motions more than proline content. In contrast, the extra residues 
in this position are thought to improve flexibility on a microsecond timescale.99 
 
It has been found that the ratio of NADP+:NADPH concentrations in mammalian and 
bacterial cells are significantly different (1:100 and 1:1 respectively).99 Furthermore 
IC50 values for inhibition by NADP+ are much lower in HsDHFR (620 µM) than in 
EcDHFR (5 mM).99 It has, therefore, been postulated that the occluded conformation in 
EcDHFR may be a mechanism for the enzyme to modulate co-factor binding affinities, 
allowing for efficient progress through the catalytic cycle by mitigating possible product 
inhibition effects.76,98 
 
1.12 Role of fast dynamics in catalysis. 	
Enzymes where the rate-limiting step is substrate diffusion are often regarded as 
‘perfect’ enzymes.45,101 ‘Perfect’ enzymes such as carbonic anhydrase or catalase have 
turnover rates as high as 106 s-1.45 Using unbiased transition path sampling methods the 
length of transition states has been calculated for DHFR (10-15 s), lactate dehydrogenase 
(LDH) (10-15 s) and purine nucleoside phosphorylase (PNP) (10-14 s), this is on the same 
timescale as bond vibrations which occur on a femtosecond timescale.102 As transition 
states occur for only small periods of time, direct characterisation of them through 
experimental observations is essentially impossible, instead computational methods are 
used to model the transition state structures.103,104 It is widely accepted that physical 
events such as ligand binding/release may in part be controlled by loop or domain 
motion.47,76,81,105,106 However, whether motions on fs-ps timescale couple to the 
chemical step is still a contentious issue. There have been a number conflicting reports 
on how or if such motions influence the chemical step of catalysis.47 
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It has been proposed that a network of residues in EcDHFR influence catalysis by 
forming a network of protein promoting motions (Figure 1.19).107 Mutation of Gly121 
in EcDHFR, located ~19 Å away from the active site, results in a drastically diminished 
rate of hydride transfer (400 fold).65,108 MD simulations postulated a disruption in the 
coupling of backbone dynamics to the rate of hydride transfer, which in turn was 
claimed to promote barrier crossing.109 To identify the residues in this proposed 
network, sequence analysis was performed amongst 36 DHFR variants, which yielded a 
number of residues that were highly conserved. It was explicit that these residues may 
be important for catalysis and possibly participate in this proposed network of coupled 
motions.109 Mutation of distal residues, Met42 and Gly121 negatively impacted the rate 
of hydride transfer and, alongside computational analysis, a theory was put forward of 
promoting protein motions that increase, the rate of hydride transfer by promoting 
barrier crossing.107,109,110  
 
Stopped-flow experiments have been used extensively to study dynamics in DHFR 
variants as they are believed to mainly report on hydride transfer. At pH 7.0, however, 
results can be complicated by small contributions from physical events.111 At elevated 
pH values the rate of hydride transfer becomes rate limiting and as such the small 
contributions from physical events become lessened.51 It needs to be considered 
however, that at elevated pH values the conformational behaviour and protonation states 
of residues in the protein may be altered.111,112 At pH 9.0 the double mutant EcDHFR-
G121V/M42W showed a much greater temperature dependence of the KIE than both 
the single mutants combined. It was proposed this was a synergistic effect that 
confirmed the theory of promoting motions.36 Through bioinformatics, Phe125 and 
Trp133 were proposed to also be part of this promoting network.113 Mutation of Phe125 
showed increased temperature dependence with respect to KIE at pH 9.0 and as such it 
was proposed this residue part of the network that facilitates promoting motions. The 
EcDHFR-Trp133 mutant on the other hand showed characteristics similar to wild type 
enzyme so was eliminated.113  
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Figure 1.19: The network of promoting motions proposed in EcDHFR, highlighted in red are the 
partaking residues, ASP122, GLY15, LLE14, TYR100 and PHE31 and NADPH (green) and DHF 
(orange) as proposed by Agarwal et.al.107 
 
Computational studies of the G121V mutant indeed showed an increase in the energy 
barrier.114 However, no crystal structure of the G121V mutant existed so the isopropyl 
side chain was modelled onto the backbone of the original glycine residue.114 Further 
MD simulations revealed a decrease in stability and folding properties of the enzyme.115 
The study implied the massive decrease in the single turnover rate could be explained 
by diminished stability of the tertiary structure and not by an interruption of long-range 
coupling.115 This is likely due to the valine side-chain causing steric clash, destabilising 
the closed conformation as it points into the active site.61,115,116 
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1.13 Enzyme KIE. 
 
A lot of evidence regarding dynamics in EcDHFR is based upon hydride transfer KIE in 
either WT or mutant enzymes. Recent work has utilised isotope labelling to create 
isotopolouges of enzymes, which have then been studied via stopped flow 
methodologies to gain insights into enzyme dynamics.48,49,53,79,117 By producing 
enzymes in labelled media (2H2O, 13C,2H-glucose & 15N ammonium chloride), it is 
possible to increase the weight of the enzyme by around 10 % and achieve 
incorporation rates of up to 98 %. It is generally considered that heavy labelling of 
enzymes slows the vibrational behaviour of the bond without impairing the 
electrostatics of the enzyme.48,118 Enzyme KIEs are calculated using Equation 1.10. 
 𝐸𝑛𝑧𝑦𝑚𝑒 𝐾𝐼𝐸 = 𝑘!"𝑘!" 
 
Equation 1.10: where kLE and kHE are the rate constants for the light and heavy enzymes respectfully.  
 
In order to effectively quantify effects observed in the study of enzyme KIE, analysis of 
dynamic contributions to the chemical step were calculated using a modified from of 
variational TST (VTST) developed by Truhlar et al., Equation 1.11. The correction 
factor Γ(T) accounts for dynamic and tunnelling effects and can be expressed as in 
Equation 1.12.44 
 𝑘 = Γ(𝑇) 𝑘!𝑇ℎ 𝑒∆!!"#!"!"  
 
Equation 1.11: kb is Boltzmann’s constant, T is temperature in kelvins, R is the gas constant, h is 
Planck’s constant, Γ(T) is the correcting factor which accounts for both dynamics and tunnelling effects 
and is temperature dependant. ∆𝐺!"#!"  is the quasiclassical free energy.  
 Γ 𝑇 = 𝛾 𝑇 ×𝜅(𝑇) 
 
Equation 1.12: Description of the correcting factor Γ(T). γ(T) is the dynamic recrossing coefficient and 
accounts for unsuccessful reaction trajectories. κ(T) is the contribution from tunnelling.  
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Initial studies with heavy-EcDHFR reported a slightly inverse kH/D KIE which increased 
over the measured temperature range to a value of 1.15 near physiological 
temperatures.79 Analysis of this result using models based on VTST developed by 
Truhlar et al. and backed up by computational simulations showed no significant 
differences in either activation energies or tunnelling contributions between the light 
and heavy enzymes.44,79 This initial study proved controversial as it gave evidence that 
promoting protein motions may not be significant in driving catalysis at a chemical 
level.79 The mutant EcDHFR-N23PP/S148A has previously been shown to have 
reduced conformational behaviour in comparison to WT-EcDHFR, resulting in a 
decrease in the steady state rate constant, kcat. However it was further reported to also 
lower the rate of kH and it consequently was claimed as evidence of coupling of large-
scale motions to the chemical step.98 At pH 7.0 at 25 °C the N23PP/S148A mutant 
exhibited an enzyme KIE of ~1.33 compared to ~1.13 of the WT enzyme. Although the 
mutant is known to have diminished flexibility on a millisecond timescale, QM/MM 
simulations showed residues located in the active site were more mobile in the mutant 
on a femtosecond timescale. This was the first report which suggested increased 
coupling of dynamics to the chemical step could be detrimental to the chemical 
step.79,119 
 
Enzyme KIE was also measured over a temperature range of 5-45 °C for the 
thermophilic enzyme, Bacillus stearothermophilus DHFR (BsDHFR). Interestingly, at 
near physiological temperatures the KIE was ~1, where at 5°C the KIE had increased to 
~1.70. Similarly, variational TST suggested BsDHFR has increased flexibility on 
timescales associated with the chemical step in comparison to EcDHFR. As in the case 
of the EcDHFR-N23PP/S148A mutant this lead to increased non-viable reaction 
trajectories, the heavier isotopologue being more susceptible to dynamic re-crossing 
events.120 Heavy KIE for MpDHFR has also been reported, at 5 °C the KIE is 1.07. As 
the temperature increases and the enzyme moves away from physiological temperature 
the KIE increases up to ~1.5.47 MpDHFR, EcDHFR and BsDHFR all follow a similar 
trend with respect to temperature dependence of the enzyme KIE, which approaches 
unity at near physiological temperatures. It has been suggested that as an enzyme nears 
physiological temperatures dynamic coupling to the reaction coordinate becomes 
minimised (Figure 1.20).53,79,119  
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Figure 1.20: Graph showing the enzyme KIE of various DHFR variants over a temperature range. 
EcDHFR = Blue, MpDHFR = green, BsDHFR = red and TmDHFR = black. Values taken from 
references.47,79,121 
 
TmDHFR reported a different trend to other DHFR variants with respect to enzyme 
KIE. No significant KIE was observed between light and heavy TmDHFR with respect 
to single turnover rate constants across the measured temperature range (5-65 °C). This 
suggests motions occurring on the timescale of bond-vibrations do not influence the 
chemical step. Evidence from the EcDHFR-N23PP/S148A mutant suggested dynamics 
might negatively influence catalysis.  Evidence from TmDHFR further suggests 
evolutionary pressure has minimized active site dynamics in DHFR enzymes to help 
lower the chances of non-viable reaction trajectories.117 
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2.1 Materials 
 
13C glucose, 15N ammonium chloride, D2O and indole (2-13C) were purchased from 
Cambridge Isotope laboratories. L-methionine-(methyl-13C) along with all other 
reagents were purchased from Sigma-Aldrich. 
 
2.2 Media and buffers 
 
2.2.1 Lysogeny broth (LB) 
 
LB liquid medium was prepared by dissolving tryptone (10 g), yeast extract (5 g) and 
sodium chloride (10 g) in 1000 ml ddH2O. The media was sterilised by autoclaving at 
121 °C for a period of 20 minutes. 
 
LB solid plates were prepared in the same way as LB liquid except for the addition of 
agar (15 g L-1) prior to autoclaving. Antibiotics, if required, were added to the molten 
agar solution once it had cooled to approximately 50 °C. The agar solution was then 
aseptically poured into 100 mm Petri dishes. 
 
2.2.2 M9 minimal media 
 
M9 media was prepared by dissolving Na2HPO4 (6.78 g), KH2PO4 (3 g) and NaCl 
(0.84 g) in 800 ml of ddH2O. The pH was adjusted to 7.5 and sterilised by autoclaving 
at 121 °C for a period of 20 minutes. NH4Cl (1 g), D-glucose (4 g), 1M MgSO4 
solution (2 ml) (section 2.2.2.1), 1M CaCl2 solution (100 µL) (section 2.2.2.2) and 
trace elements solution (section 2.2.2.3) was then added and the final volume made up 
to 1000 ml with ddH2O.  
 
2.2.2.1 Preparation of 1M MgSO4 solution 
 
Magnesium sulphate (12.04 g) was dissolved into 100 mL of ddH2O and sterilised by 
autoclaving at 121 °C for a period of 20 minutes. 
 
2.2.2.2 Preparation of 1M CaCl2 solution 
 
Calcium chloride (11.10 g) was dissolved into 100 mL of ddH2O and sterilised by 
autoclaving at 121 °C for a period of 20 minutes. 
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2.2.2.3 Preparation of (100x) trace elements solution 
 
EDTA (5 g) was dissolved into 800 mL of ddH2O and the pH adjusted to 7.5 with 
NaOH. FeCl3-6H2O (0.83 g), ZnCl2 (84 mg), CuCl2-H2O (13 mg), CoCl2-2H2O (10 
mg), H3BO3 (10 mg) and MnCl2-4H2O (1.6 mg) were then added and the final volume 
made up to 1000 mL. The solution was then passed through a 0.2 µm filter to sterilise.  
 
2.2.3 Use of Ampicillin (Antibiotic) 	
Ampicillin (1 g) was dissolved into 10 mL of sterile ddH2O. 1 mL of this solution was 
used per 1 L of culture where required. 
 
2.2.4 Preparation of sterile solutions 	
Buffers/solutions were largely sterilised via autoclave (121 °C for 15 minutes). Where 
this was not suitable solutions were passed through a disposable, sterile bottle top 
filter (0.2 µM). 
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2.2.5 Buffers used 	
Table 2.1: Preparations of buffers used in this work. 
Code 
Name 
Purpose Buffering Agents Salt(s) Reducing agents 
/other 
A (SDS-PAGE) 
(Resolving) 
1.5 M Tris-HCl, 
pH 8.8 
- - 
B (SDS-PAGE) 
(Stacking) 
0.5 M Tris-HCl, 
pH 6.8 
- - 
C Purification 
(BSD75) 
50 mM Trizma, pH 
7.0 
1 mM NaCl 10 mM βME 
D Purification  
(BSD75/QSEPH) 
50 mM potassium 
phosphate, pH7.0 
- 15 mM βME 
E Purification 
(QSEPH) 
50 mM potassium 
phosphate, pH7.0 
1 M NaCl 15 mM βME 
F Purification 
(BSD75/QSEPH) 
50 mM potassium 
phosphate, pH 8.0 
- 15 mM βME 
G Purification 
(QSEPH) 
50 mM potassium 
phosphate, pH 8.0 
1 M NaCl 15 mM βME 
H Purification/ 
Kinetics/ 
Exchange buffer 
50 mM potassium 
phosphate, pH 7.0 
100 mM NaCl 15 mM βME 
I Nickel column  50 mM Tris, pH 
7.5 
- 15 mM βME, 20 
mM Imidazole 
J Nickel column  50 mM Tris, pH 
7.5 
- 15 mM βME, 20 
mM Imidazole 
K Nickel column 50 mM Tris, pH 
7.5 
- 15 mM βME, 20 
mM Imidazole 
L Exchange buffer 
(HIS-TEV) 
50 mM Tris, pH 
8.0 
- 2 mM TCEP 
M Purification 
(NADH/NADPH) 
20 mM Tris, pH 
9.0 
- - 
N Purification 
(NADH/NADPH) 
20 mM Tris, pH 
9.0 
1 M NaCl - 
O (SDS-PAGE) 
running buffer 
25 mM Tris - 200 mM glycine, 3.5 
mM SDS 
P 50x TAE buffer 2 M Tris 50 mM 
Disodium 
EDTA 
1M glacial acetic 
acid 
Q MTEN buffer 25 mM Mes, 
50 mM Tris, 
25 mM 
ethanolamine 
100 mM NaCl 10 mM βME 
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2.2.5.1 P1 re-suspension buffer  
 
606 mg of Trizma® base (50 mM) and 292 mg of EDTA (10 mM) was dissolved in 
100 mL of ddH20 and the pH adjusted to 8.0 with HCl. 10 mg RNase A was added 
and the solution stored at 4 °C until needed.  
 
2.2.5.2 P2 lysis buffer  
 
800 mg NaOH (200 mM) and 2.88 g of SDS (100 mM) was dissolved in 100 mL of 
ddH20. 
 
2.2.5.3 N3 neutralisation buffer   
 
40.12 g of guanidine chloride (4.2 M) and 8.83 g of potassium acetate (0.9 M) was 
dissolved in 100 mL of ddH20 and the pH adjusted to 4.8. 
 
2.2.5.4 PE wash buffer  
 
121 mg of Trizma® base was dissolved in 20 mL 100 mL of ddH20 and the pH 
adjusted to 4.8 before the final volume was made up to 100 mL with ethanol.  
 
2.3 Methods 
 
2.3.1 E.coli strains used 	
 
2.3.1.1 Preparation of calcium competent cells 	
Cells from a frozen glycerol stock were streaked out, aseptically, onto an antibiotic 
free LB agar plate (section 2.2.1) and incubated overnight at 37 °C. A starter culture 
was prepared from a single colony and grown in 10 mL LB media overnight at 37 °C. 
LB media (1 L) was then inoculated with starter culture and grown in a shaker at 37 
°C until an O.D.600 of 0.5 was achieved. The cells were centrifuged (3400 g for 15 
minutes at 4 °C). The supernatant was discarded and the cell pellet re-suspended in 
100 mL 100mM MgCl2. The cells were harvested by centrifugation (3400 g for 15 
minutes at 4 °C), the supernatant discarded and the cell pellet re-suspended in 200 mL 
of ice-cold 100 mM CaCL2. The suspension was incubated on ice for 20 minutes. The 
cells were harvested by centrifugation (3400 g for 15 minutes at 4 °C) and re-
suspended in 2 mL ice-cold 100 mM CaCL2 and 15% glycerol. The suspension was 
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then aliquoted (50 µL) into sterile 1.5 mL micro-centrifuge tubes, flash frozen with N2 
and stored at -80 °C for future use.  
 
2.3.1.2 Expression strains 
 
For large-scale protein expression BL21 Star™ (DE3) chemically competent cells 
were used (as prepared in section 2.3.1.1) 
  
2.3.1.3 Cloning strains 
 
For expression of plasmid DNA chemically competent XL1-Blue or DH5α cells (as 
prepared in section 2.3.1.1) 
 
2.3.2 Transformation protocol for chemically competent cells 
 
A 50 µL aliquot of chemically competent cells (section 2.3.1) was defrosted on ice. 
Approximately 50 ng/µL plasmid DNA was added (2 µL) and the cells kept on ice for 
30 minutes. The cells were heat shocked (42 °C for 45 seconds) and returned to ice 
for 30 minutes. Pre-heated LB media (1 mL) was added and the cells incubated for a 
period of 60 minutes at 37 °C. The cells were spun down (3400g for 10 minutes) and 
the majority of the supernatant removed. The resulting pellet was then re-suspended 
in approximately 50 µL supernatant and plated onto LB-Agar plates containing the 
appropriate antibiotic. 
 
Table 2.2: Plasmids used in this study. 
Name Vector Selective marker Source 
WT EcDHFR pET-28a Ampicillin 
Allemann group 
plasmid Library 
WT MpDHFR pET-28a Ampicillin 
WT TmDHFR pET-28a Ampicillin 
WT SeDHFR pET-11b Ampicillin 
Produced for this 
study 
S150A-SeDHFR pET-11b Ampicillin 
WT SaLDH pET-11b Ampicillin 
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2.3.3 Plasmid purification 	
Plasmid purification was carried out following the methodology detailed by 
QIAGEN®. A single colony from a selective plate was added to 5 mL LB media in a 
30 mL Sterilin™ universal container, and incubated overnight at 37 °C with shaking. 
The culture was pelleted (3400 g for 10 minutes), and re-suspended in 250 µL P1 
buffer. P2 buffer (250 µL) was added and the suspension inverted 6 times to ensure 
proper mixing. After 3 minutes, 350 µL N3 buffer was added, and the solution again 
inverted 6 times before being centrifuged (24300 g for 10 minutes). The supernatant 
was applied to an Econospin® all in one mini spin column. The solution was 
centrifuged (24300 g for 5 minutes), and the flow through was discarded. PE buffer 
(500 µL) was added and again centrifuged (24300 g for 1 minute), the flow through 
again discarded. Plasmid DNA was eluted by the addition of 50 µL ddH2O and again 
centrifuging (24300 g for 1 minute), collecting the solubilised DNA in a sterile 1.5 
mL micro-centrifuge tube.   
 
2.3.4 PCR protocol 	
PCR reactions were performed using Primestar® HS (premix) from Takara BIO INC. 
25 µL of Primestar® HS (premix) was combined with 0.5 µL of forward and reverse 
primers (diluted to 10 µM), approximately 50 ng template DNA and 23.5 µL ddH20 in 
a PCR tube. PCR reaction conditions are detailed in Table 2.3. The reactions were 
carried out in a Techne touch gene gradient thermal cycler.  
 
Table 2.3: PCR conditions used 
Step Temperature (°C) Time 
Initial denaturation 98 2 minutes 
 98 10 seconds 
30 Cycles 55 15 seconds 
 72 1 minute/Kb 
Final extension 72 5 minutes 
End 4 Hold 
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PCR products were incubated with 1 µL FastDigest Dpn1 for 20 minutes at 37°C and  
directly transformed into suitable cloning strains.  
 
2.3.4.1 Primer design 
 
Below are detailed the primers used, underlined are changes respective to original 
base pair.  
 
SeDHFR_S150A; 
5’-GCGGACGATAAGAACGCGTATGCGTGCGAGTTTG-3’ 
5’-CAAACTCGCACGCATACGCGTTCTTATCGTCCGC-3’ 
 
2.3.5 DNA sequencing   	
The concentration of purified DNA from an appropriate cloning strain was measured 
by NanoDrop 1000 and sent for sequencing to Eurofins genomics. 
 
2.3.6 Protein production 
 
A single colony from a selective plate was used to inoculate 10 mL LB media with 
the appropriate antibiotic and incubated overnight in a shaker at 37 °C. This was used 
to inoculate 1000 mL of LB media with antibiotics and incubated in a shaker at 200 
rpm at 37 °C until O.D.600. Gene expression was induced with IPTG (1 mM) and the 
culture left at 16 °C overnight with shaking at 200 rpm. Cells were harvested via 
centrifugation (3400 g for 15 minutes at 4 °C). Pelleted cells were either used 
immediately or stored at -80 °C for future use.   
 
Heavy enzyme (13C & 15N) for use in kinetic experiments was over-produced in the 
same way except LB was substituted for minimal media (M9). The recipe is described 
in section 2.2.2 but 13C-glucose and 15N ammonium chloride were substituted in place 
of natural abundance feedstock.  
 
2.3.7 Protein purification 
 
Pelleted cells were re-suspended in lysis buffer and sonicated for a total of 15 minutes 
(5 seconds on, 10 seconds off cycle). Cell debris was removed via centrifuge (24300 g 
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for 30 minutes), the supernatant passed through a 0.2 µM filter and purified by one of 
the methods below: 
 
2.3.7.1 Purification via Ni-NTA agarose affinity column 
 
LDH was synthesised with 6x histidine tag and a TEV cleavage site on the N-
terminus. TEV protease was also synthesised with a 6x histidine tag on the C-
terminus. As such they were purified via a Ni-NTA affinity column. Protein was 
prepared as above (section 2.3.2, in buffer I) and loaded onto a pre-charged, 5 mL Ni-
NTA agarose column. Protein was eluted using a step-wise gradient as described in 
(Table 2.4). Various concentrations of imidazole in elution buffers were prepared by 
mixing of buffers I,J and K. TEV protease was used without further purification.  The 
6x histidine tag on LDH was removed by incubating with TEV protease overnight at 
4 °C. LDH was then purified again by Ni-NTA agarose column. Protein purity was 
confirmed by SDS-PAGE.  
 
Table 2.4: Concentrations of Imidazole used in the 
purification of LDH and TEV protease. 
Fraction Conc. Imidazole (mM) Fraction size (mL) 
1 20 100 
2 50 10 
3 50 10 
4 100 10 
5 150 10 
6 200 10 
7 250 10 
8 250 10 
9 500 10 
10 500 100 
 
2.3.7.2 Purification via Q-sepharose anion exchange  
 
Proteins were prepared as in section 2.3.2. The clarified lysate was loaded onto a 70 
mL Q-sepharose column. The column was washed with 3 column volumes of low salt 
buffer (buffer D or E). Protein was eluted with a salt gradient from 0 % NaCl to 100 
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% NaCl (buffer E or G) over 3 column volumes. Exact buffer conditions for various 
proteins can be found in (Table 2.5). Purity of proteins was determined by SDS-
PAGE. 
 
Table 2.5: Buffer conditions used in the purification of enzymes. 
Protein Lysis buffer Low salt buffer High salt buffer 
EcDHFR D D E 
MpDHFR D D E 
SeDHFR WT and S150A F F G 
 
2.3.7.3 Purification via BSD75 size exclusion  
 
Proteins were concentrated in a 50 mL Amicon® stirred cell protein concentrator 
fitted with a 10 MWCO membrane to an approximate volume of 5 mL. The 
concentrate was loaded onto the column and eluted with an isocratic gradient. The 
exact buffer conditions are recorded in (Table 2.6). 
 
Table 2.6: Exact buffer conditions used in the 
purification of enzymes (BSD-75). 
Protein Buffer 
EcDHFR, MpDHFR and SeDHFR D 
TmDHFR C 
 
2.3.8 Enzyme concentration 
 
Enzyme concentration was measured by one of two ways; 
 
2.3.8.1 Concentration from Bradford assay 
 
Bradford reagent was prepared by dissolving 50 mg coomassie brilliant blue G-250 in 
50 mL methanol. 100 mL 85 % (w/v) phosphoric acid was added and the total volume 
made up to 1000 mL with ddH2O. To remove precipitants, the solution was passed 
through Whatman #1 filter paper. The solution was stored at 4 °C in actinic glass. 
Known concentrations of BSA solution were incubated with Bradford reagent to 
create a calibration curve, from which protein of unknown concentrations could be 
measured.  
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2.3.8.2 Concentration from UV 
 
20 µL of enzyme solution was added to a 1mL, 1 cm-1 path length quartz cuvette and 
the absorbance measured at 210 nm, 215 nm and 220 nm on a Shimadzu UV-2600 
UV-Vis spectrophotometer. Protein concentration was determined using Equations 
2.1 & 2.2. 
 
𝐶𝑜𝑛𝑐 𝑚𝑔 𝑚𝐿 = 𝐴!"#ℇ!"# + 𝐴!"#ℇ!"# + 𝐴!!"ℇ!"!#3  × 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
 
Equation 2.1: Equation used to calculate protein concentration from absorption values. 
 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑒𝑛𝑧𝑦𝑚𝑒 𝑚𝑀 =  𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑚𝑔/𝑚𝐿 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 × 1000  
 
Equation 2.2: the equation used to convert protein concentrations into molar quantities. 
 
2.3.9 Preparation of 12% SDS-Page gel 
 
Reagents were combined as in (Table 2.7). APS 10 % solution and TEMED were 
added immediately before pouring into casting plates. The resolving gel was first 
poured into 0.75 mm glass plates (BIO-RAD) leaving a 2 cm gap from the top. This 
was then overlaid with isopropanol and allowed to set. The isopropanol was then 
decanted, the stacking gel poured on and a 15 well comb added.  
 
Table 2.7: Quantities of reagents used in the making of SDS plates. 
Reagent Resolving Gel Stacking Gel 
ddH2O 3.4 mL 2.9 mL 
40 % Acrylamide/ Bis solution 19:1 2.4 mL 0.75 mL 
Buffer 2.0 mL 1.25 mL 
10 % SDS solution 80 µL 50 µL 
10 % APS solution 80 µL 50 µL 
TEMED 8 µL 5 µL 
 
Materials & Methods 
 46 
 
2.3.10 1 % agarose gel 	
1 g of agarose in 100 mL 1x TAE buffer was microwaved until boiling and all 
agarose had dissolved. Once cooled, GelRed™ stain was mixed in before being 
poured and then allowed to set in a casting block. Gels were run at 80 V for 50 
minutes in 1x TAE buffer and visualised using a Syngene gene-flash transilluminator. 
 
2.3.11 Synthesis of dihydrofolate 	
Folic acid (400 mg) was dissolved in 10 % (w/v) ascorbic acid solution, the pH 
adjusted to 6.0 and stirred on ice for a period of 5 minutes under a N2 atmosphere. 
Sodium dithionite (4.4 g) was added followed by the drop wise addition of 1M HCl to 
pH 2.8. The suspension was centrifuged (24300 g for 5 minutes) and the pellet re-
suspended in 10 % (w/v) ascorbic acid solution. The pH was returned to pH 2.8 via 
the drop wise addition of 1M HCl. Again the suspension was centrifuged (24300 g for 
5 minutes). The pellet was washed by sequential re-suspension and centrifuge cycles 
(2x acetone followed by 1x Diethyl ether). The product was dried under a stream of 
N2.122   	
2.3.12 Synthesis of NADPD 	
NADPD was synthesised enzymatically from commercially available reagents. 20 mg 
NAD+ was dissolved into 4.8 mL of buffer M along with approximately 2 mg of 
TbADH (Thermoanaerobacter brockii) and 200 µL deuterated d8-2-propanol. 
Reaction progress was monitored by an increase of UV absorbance at 340 nM.111  
 
2.3.13 Synthesis of NADD 	
NADD was synthesised enzymatically from commercially available reagents. 20 mg 
NAD+ was dissolved into 4.8 mL of buffer M along with approximately 2 mg of 
ScADH (Saccharomyces cerevisiae) and 200 µL deuterated d8-2-propanol. Reaction 
progress was monitored by an increase of UV absorbance at 340 nM.123  
 
2.3.14 Purification of NADPD and NADD 
 
Both NADPD and NADD were purified by HPLC using an anion exchange column, 
ProPac™ SAX-10 LC. A gradient from no NaCl (buffer M) to high NaCl (buffer N) 
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was run over a period of 60 minutes with a flow rate of 5 ml/min. Wavelengths at 260 
nM and 340 nM was monitored in order to distinguish between reduced (product) and 
oxidised (starting material) forms.111  
 
2.3.15 Kinetic Assays 	
2.3.15.1 Pre-steady state kinetics 
 
All stopped flow measurements were carried out on an applied photophysics stopped-
flow spectrometer. SeDHFR was pre-incubated with NADPH and rapidly mixed with 
an excess of DHF to give final concentrations of 20 µM, 10 µM and 200 µM 
respectively. The enzyme was pre-incubated with NADPH for at least 10 minutes to 
avoid hysteresis. To study the primary kinetic isotope effect, NADPD was prepared as 
described in section 2.3.12 and used in the same concentration as NADPH. The 
reaction was excited at 292 nm and emission measured with a cut-off of 400 nm, 
which allowed the monitoring of fluorescence energy transfer from residue Trp22 in 
the active site to NADPH.  
 
2.3.15.2 Kinetics involving heavy enzymes 
 
Heavy enzyme kinetics where performed in an identical manor to section 2.3.15.1 and 
section 2.3.15.3 with the exception of using 13C & 15N labelled enzymes. Heavy 
enzymes (labelled 13C & 15N) were prepared as described in section 2.3.6. 
 
2.3.15.3 Steady state kinetics 
 
All measurements were carried out on a JASCO V-660. Rates were monitored under 
saturating conditions: for SeDHFR (100 µM DHF and NADPH), for LDH (300 µM 
NADH and 2000 µM pyruvate). Rates were monitored by following the decrease in 
absorbance at 340 nM. Measurements involving temperature dependence were 
measured in buffer H and the temperature in the cuvette was monitored immediately 
before the experiment using a Fisherbrand™ Traceable™ RTD platinum 
thermometer. Measurements were carried out in triplicate.  
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2.3.15.4 Measurements involving pH dependency 
 
Steady state measurements involving pH dependency were carried out in MTEN 
buffer (buffer Q). Measurements involving pH dependency were all carried out at 
20°C, the buffer being adjusted at this temperature before every experiment.  
 
2.3.15.5 Measuring KM (Michaelis constant) 
 
For SeDHFR, the concentration of either NADPH (0.1 µM -200 µM) or DHF (0.1 µM 
-200 µM) was varied whilst the other substrate remained fixed with respect to 
concentration. For LDH, the concentration of NADH was again varied (1 µM -3000 
µM), as well as pyruvate (0.1 µM -5000 µM). For both enzymes, at least seven points 
were recorded in triplicate. Points were fitted to sigmoidal curve using SigmaPlot 10. 
 
2.3.15.6 Calculation of activation energies (Ea) and Arrhenius pre-exponential 
factors (A) 
 
Activation energies and Arrhenius pre-exponential factors were calculated by plotting 
the natural log of the measured rate constants vs. the reciprocal temperature on 
Microsoft® Excel®, from which a linear trend line could be fitted. The Arrhenius 
equation was rearranged into Equation 2.2, which is in the same form as a typical 
equation for a straight line, Equation 2.3. In this form the Arrhenius pre-exponential 
factor equates to the y-intercept (highlighted in orange) and the activation energy 
equates to the slope (highlighted in red). 
 𝑙𝑛 𝑘 =  −𝐸!𝑅  ×  1𝑇 + ln𝐴 
 
Equation 2.2: Rearranged Arrhenius equation where k is the measured rate constant, R the gas 
constant, T the temperature in kelvins, Ea the activation energy and A the Arrhenius pre factor. 
 𝑦 = 𝑚𝑥 + 𝑏 
 
Equation 2.3: Equation of straight line, m equates to the slope and b the y-intercept. 
 
2.3.16 Sidechain NMR experiments 
  
All NMR experiments were carried out on a Bruker AVANCE III 600 MHz (1H) 
spectrometer with a QCI-P cryoprobe. Proteins were purified and worked with at 
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approximate concentrations of 250 µM. MpDHFR, EcDHFR and SeDHFR were 
recorded in 50 mM potassium phosphate buffer with 1 mM NaCl and 10 mM βME. 
TmDHFR was recorded in 50 mM Tris with 1 mM NaCl and 10 mM βME. Ligands, 
if required, were used in a ten-fold excess from pre-prepared stocks (Section 
2.3.15.1). For spectra requiring NADP+ and THF, equimolar concentrations of 
NADPH and DHF were directly reacted with enzyme in the NMR tube for 
approximately 30 minutes. The reaction progress was monitored by 1H NMR. 10 % 
D2O was added to each NMR sample and the spectra recorded at 7, 25, 25 and 40 °C 
for MpDHFR, EcDHFR, SeDHFR and TmDHFR respectively. NMR spectra were 
processed with NMRpipe and analysed with CcpNMR Analysis 2.4.1.124,125 
 
2.3.16.1 Preparation of Ligand stocks 
 
Ligand stocks were prepared at concentrations of 100mM in the same buffer as the 
enzyme for each respective NMR experiment. Concentrations were calculated by 
reference to molar extinction coefficients (Table 2.8). 
 
Table 2.8: Molar coefficients of ligands used. 
Ligand Molar extinction coefficient (cm-1 M-1) 
NADPH 6200 at 339 nM126 
NADP+ 18700 at 260 nM127 
DHF 28000 at 282 nM128 
Folate 28000 at 297 nM129 
 
 
2.3.16.2 Calculation of weighted chemical shifts 
 
In order to obtain weighted chemical shift perturbations Equation 2.4 was used.130  
 
∆𝛿 = 12 𝛿!! + 𝛿!!4  
 
Equation 2.4: where δH and δC is the change in ppm between the two states in the proton and carbon 
dimension respectfully. 
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2.3.17 Circular Dichroism spectroscopy 
 
All measurements were performed on a Chirascan™ circular dichroism spectrometer. 
Measurements were performed in 5 mM potassium phosphate buffer (pH 7) with no 
salt or reducing agents, using 10 µM of protein. Measurements were taken between 
190-400 nm with a 1 nm bandwidth. The mean residue ellipticity (MRE) was 
calculated using Equation 2.5.  
 ⊝!"#= ⊝10. 𝑐.𝑛. 𝑙 
 
Equation 2.5: Where Θ is the CD signal in milli-degrees, c is the molar concentration, n is the number 
of peptide bonds and l is the path-length in cm of the cuvette used.  
 
2.3.17.1 Calculation of melting temperature (Tm)  
 
A series of CD spectra were recorded over a temperature range of 5 to 85 °C with a 
temperature gradient of 0.5 °C/min. The CD signal at 208 nm was monitored and the 
fraction of unfolded protein (Fu) at various temperatures calculated using Equation 
2.6.  
 𝐹! =  𝐹!  −  𝐹𝑈!  −  𝐹 
 
Equation 2.6: Where Fu is the fraction of unfolded (denatured) protein, F and Uf are extrapolated 
values of the points where the protein is completely folded and unfolded respectfully, and Fo is the 
value of ellipticity at 208 nm.  
 
2.3.18 Calculation of errors and propagation of errors. 	
Variation or error in a particular data set were calculated using Equation 2.7 and 
expressed as a standard deviation of the mean (σ). 
 
𝜎 = (𝑥! −𝑀)!!!!!𝑁 − 1  
 
Materials & Methods 
 51 
Equation 2.7: where σ is the standard deviation in the sample, N is the number of data points in the 
sample, M is the mean value of the sample and xi is the measured values.  
 
Where the error could not be directly calculated, it became necessary to estimate the 
value of uncertainty via the propagation of errors using the equations shown below.  
 
Where Z = X*Y or Z = X/Y, Equation 2.8 was used.  
 
∆𝑍 = 𝑍 ∆𝑋𝑋 ! + ∆𝑌𝑌 ! 
 
Equation 2.8: Where ΔZ is the propagated error and Z the value of which the propagated error needs 
to be calculated for, X and Y are the experimentally measured values and ΔX and ΔY is their 
associated error.  
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3.1 Variations in conformational behaviour in DHFRs 	
Discovered off the coast of Italy inhabiting underwater volcanic vents, Thermotoga 
maritima is a hyperthermophilic bacteria with an optimal growth temperature of ~80 
°C.131 TmDHFR shares 27% sequence identity with EcDHFR,61,132 and with respect to 
tertiary structure is nearly superimposable.61,133 TmDHFR has an extra ninth β-strand, 
which runs antiparallel to the extended FG loop on the opposing monomer (Figure 
3.1).133 In contrast, TmDHFR is the only known DHFR to form a thermostable (Tm = 83 
°C) homo-dimer.90 It is believed a reduction in the number of thermo-labile amino 
acids, a shortening of solvent exposed loops and its dimeric nature all likely contribute 
to its thermo-stability.94,133,134 66% of the amino acids in the dimer interface of 
TmDHFR are either aliphatic or aromatic forming a hydrophobic core; in EcDHFR 
many of these residues are either ionic or polar.94,133 Lys129 forms an intermolecular 
ion-pair with Glu136 and Glu138 in the adjacent monomer.133 Further stabilization 
comes from hydrogen bonding interactions between the two monomers, with an average 
of 1.22 interactions per 100 Å2 of interface area.133  
 
 
 
Figure 3.1: Crystal structure of TmDHFR (PDB entry 1D1G)133. NADPH (yellow) and methotrexate 
(pink) are depicted as sticks. Secondary structural elements are depicted as a cartoon: β-sheet (green), α-
helices (red) and loops (blue).  One monomer is coloured orange for clarity.89  
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EcDHFR undergoes a catalytic cycle adopting closed and occluded conformations in 
order to enable efficient catalysis.61 It has been proposed that the occluded 
conformation, which is adopted after the chemical step is needed to allow for efficient 
release of NADP+ under intracellular concentrations where NADP+ is increased 
compared to other organisms.76 Other DHFR variants have been shown to only adopt a 
single major conformation throughout the catalytic cycle, equivalent to the closed 
conformation, even though the tertiary structures and primary sequences are similar to 
EcDHFR.76,85–87 The occluded conformation in EcDHFR is stabilised by a hydrogen 
bonding interaction between Asn23 in the flexible M20 loop and Ser150 in the GH 
loop.61 In MpDHFR the equivalent Ser150 residue is replaced with a proline residue and 
as such destabilises formation of an occluded conformation.76 TmDHFR has a much 
lower catalytic turnover than EcDHFR (approx. 8-fold) even at their respective 
physiological temperatures.90,135 Mobile loops in EcDHFR, which are critical for 
efficient progress through the catalytic cycle, are locked into the dimer interface in 
TmDHFR, greatly reducing protein flexibility and it has been suggested TmDHFR 
remains in a fixed, open conformation through its catalytic cycle.88,90,133  
 
Although the catalytic cycle of EcDHFR has been well studied, other DHFR variants 
have been less well characterised. To better understand the role of the occluded 
conformation, the key amino acid determinants for its formation and how common it is, 
a more widespread investigation of DHFR variants is needed. TmDHFR represents an 
interesting variant as the equivalent mobile loops present in EcDHFR are locked within 
the rigid dimer interface. TmDHFR has been suggested to remain in a single, open 
conformation throughout the catalytic cycle but no direct evidence has yet been 
established.89,121 Here we investigate the conformational landscape of TmDHFR. 
 
3.2 NMR assignment of TmDHFR 
  
In order to study enzymes by NMR, isotopic enrichment must be employed to improve 
sensitivity to the experiment.136 Protein preparation involves recombinant 
overproduction in M9 minimal media, which allows natural abundance feedstock to be 
replaced with 2H, 13C and 15N enriched water, glucose and ammonium chloride 
respectively. Following overproduction, isotopically enriched protein is purified in 
buffers that contain natural abundance levels of protium, resulting in nearly all 
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exchangeable 2H being replaced with 1H, which is important for the NMR experiment to 
work.136,137  
 
In order to characterise TmDHFR further a backbone resonance assignment was 
needed. 2H, 13C and 15N isotopically enriched TmDHFR was recombinantly 
overproduced, purified and concentrated to 400 µL, and placed into a 5 mm borosilicate 
glass NMR tube. 100 µL of D2O was added to the sample to act as a lock frequency for 
the NMR experiment.136 In order to align with previous work with EcDHFR and 
MpDHFR, NADP+ and folate, which mimic the Michaelis complex, were added so the 
final concentration of both ligands in the sample was 6 mM and the pH adjusted to 
7.0.76,138–140 The final concentration of TmDHFR in the NMR sample was calculated to 
be ~600 µM. Isotopic enrichment was confirmed via mass spectrometry (Figure 3.2).  
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Figure 3.2: (Top) mass spectrum of natural abundance TmDHFR, Mw = 19235.5 +/- 0.5. (Middle) mass 
spectrum of triply labelled TmDHFR (2H, 13C & 15N), Mw = 21289.0 +/- 12.0, corresponding to 99.4% 
enrichment of non-exchangeable atoms. (Bottom) mass spectrum of triply labelled TmDHFR (2H, 13C & 
15N) grown in 70 % D2O, Mw = 21053.7 +/- 7.9, corresponding to ~59 % deuteration. 
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A proton spectrum was acquired but as TmDHFR has ~2750 atoms, the 1D proton 
spectra exhibits hundreds of overlapping resonances, which are impossible to assign 
(Figure 3.3).88,133 The distribution of resonances at high and low field indicates that the 
protein is folded under these conditions, due to the range of chemical environments 
found in folded proteins as opposed to an unfolded peptide polymer. A 2D 1H-15N 
HSQC spectra was also acquired and is the primary method of studying proteins by 
NMR (Figure 3.4). This provides a single resonance for each backbone amide. The 1H-
15N spectrum displayed a large number of resonances with minimal signal diffusion. 
From this spectrum we assessed it would be feasible to attempt to assign backbone 
resonances through a multidimensional NMR approach.  
 
 
Figure 3.3: 1D 1H spectra of TmDHFR complexed with NADP+ and folate, a reasonable signal to noise 
ratio was achieved after 16 scans and the dispersion of chemical shifts at low and high fields is indicative 
of the protein being folded. 
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Figure 3.4: 1H-15N HSQC of TmDHFR complexed with NADP+ and folate, spectra was acquired at 800 
MHz. 
 
Although 2D 1H-15N spectroscopy provides a method to investigate TmDHFR, the 
information is limited without an assignment of each resonance to the protein sequence. 
A series of 3D experiments were acquired to assign the backbone resonances in 
TmDHFR (amide 1H and 15N, 13Cα and 13Cβ and the carbonyl 13C) (Table 3.1). Each of 
these experiments is based upon the core 1H-15N HSQC and provides specific 13C 
resonances in a third dimension. The 13C resonances recorded are selected depending on 
the pulse programme used and experiments are often acquired in pairs such that the 
resonance can be linked sequentially and the sequence deduced. Using facilities at the 
National Institute for Medical Research (NIMR) at Mill hill (now the Crick Institute) 
NMR spectra were recorded at high field strengths (700, 800 MHz). Nearly all NMR 
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experiments acquired for TmDHFR utilised Transverse Relaxation-Optimised 
Spectroscopy (TROSY). Large protein molecules have faster transverse relaxation times 
(T2) resulting in rapid signal decay and low-resolution spectra. The TROSY pulse 
sequence was designed for large proteins and mitigates effects from multiple relaxation 
events resulting in narrower linewidths without adverse effects on sensitivity.141 Some 
experiments were performed with samples that had only 70 % perdeuteration, this was 
in an attempt to further improve relaxation issues, details of which will be discussed 
later on in this chapter. 
 
Table 3.1: List of recorded spectra recorded for TmDHFR complexed with NADP+ 
and folate at pH 7.0. 
Experiment Field Strength (MHz) Deuteration  
1H-15N HSQC 800 100 % 
1H-15N HSQC-TROSY 800 100 % 
HNCA-TROSY 800 100 % 
HN(CO)CA-TROSY 800 100 % 
HNCACB-TROSY 800 100 % 
HN(CO)CACB-TROSY 800 100 % 
1H-15N HSQC 800 70 % 
HNCO-TROSY 800 70 % 
HN(CO)CA-TROSY 800 70 % 
HN(CO)CACB-TROSY 800 70 % 
HCCH-TOCSY 700 70 % 
hCCH-TOCSY 700 70 % 
hC(CO)NH-TOCSY 700 70 % 
H(CC)(CO)NH 700 70 % 
 
Multidimensional NMR experiments are designed to take advantage of the repeating 
polypeptide backbone unit and allow assignment of the backbone resonances (amide 1H 
and 15N, 13Cα and 13Cβ and the carbonyl 13C). 3D NMR experiments used to assign 
protein resonances are often based of the 2D 1H-15N HSQC experiment by extending it 
into the 13C dimension. The third dimension further decreases signal overlap and yields 
extra information crucial for assignment. 3D experiments are often used in pairs to 
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assign protein resonances such as the HNCA and HN(CO)CA or HNCO and 
HN(CA)CO experiments (Figure 3.5). Using experiments such as these allows for 
sequential assignment of the protein backbone. During assignment each amino acid 
residue is considered as its own spin system, experiments such as HNCA and 
HN(CO)CA allow assignment of the 13Cα in the next (NHi) and previous (NHi-1) spin 
system, thus facilitating sequential assignment of spin systems. Amino acids such as 
serine, threonine, alanine and glycine have distinctive 13Cα and 13Cβ chemical shifts, 
which allows for identification of specific amino acids in the spin system chain and 
comparison with the amino acid sequence allows for assignment. When ambiguity or 
further conformation for the correct identification of amino acids is required, side-chain 
specific experiments such as HCCH-TOCSY and H(CCO)NH can be employed.136,137 
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Figure 3.5: Top: HNCA, magnetization is evolved on the amide proton before being passed to 15N and 
then onto the alpha carbon via J coupling, before being returned by the same pathway for detection. 
Chemical shifts are gained for all three isotopes involved (1H, 13C & 15N) producing 3D spectra. Bottom: 
HN(CO)CA, is very similar to HNCA experiment except magnetisation is passed onto the immediate 
carbonyl 13C before the alpha carbon. Again chemical shifts are evolved for the amide 1H and 15N and the 
alpha carbon but not for the carbonyl 13C.  As the HN(CO)CA experiment only selects for the previous 
alpha carbon sequential assignment becomes possible.  
 
Spectra were processed using NMRPipe and resonances picked using CcpNmr 
analysis.124,125 Once a significant number of resonances were picked and spin systems 
formed it was possible to form linkages and assign resonances to the atoms of the 
protein sequence. During this process it became apparent that the quality of the spectra 
for TmDHFR was poorer than expected and that observed for other DHFR orthologues.  
 
A number of factors, which could be negatively impacting the quality of the obtained 
spectra, were considered. Firstly, increased protein size of TmDHFR leads to slow 
tumbling in solution, quicker T2 relaxation and thus poor quality NMR spectra.136 
TmDHFR is a homodimeric DHFR with a molecular mass of 38472 and an elongated 
shape, which further impacts tumbling properties, and results in diminished NMR 
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spectra.88,89 However, proteins with a molecular mass of up to 50 kDa should be 
accessible to the described methodologies with the application of specialised pulse 
sequences and partial deuteration.137 1H-13C dipolar interactions dramatically accelerates 
relaxation rates of 13C atoms with attached protons, through deuteration these 
interactions can be minimized, both increasing peak resolution and resonance 
intensity.142–144 Deuteration of the protein therefore often improves relaxation 
properties.   
 
Secondly, it was noted spin systems located within the core of the protein structure 
yielded particularly poor, or no signal at all. TmDHFR has a melting temperature of 83 
°C and it is thought its structural rigidity facilitates stability at such high physiological 
temperatures.88–90 This rigidity however is believed to prevent efficient back-exchange 
of protons in positions that are not solvent exposed, which is necessary for the 
experiment to work. 
 
In order to assess whether the thermostability of TmDHFR was preventing efficient 
back exchange of the amide protons, a 15N sample of TmDHFR was expressed and 
purified. To assess whether the amide backbone exchanged completely the sample was 
dialysed into 99% D2O. The sample was incubated for 4 days at 60 °C, spectra being 
recorded every 24 hours. The aim of this experiment was to increase the flexibility of 
the protein through increased thermal energy, thus increasing the chance of proton back-
exchange in non-solvent exposed residues. If residues in TmDHFR were not accessible 
to proton back exchange this would result in a persistence of signal in the recorded 
spectra. A number of cross peaks remained in the 1H-15N HSQC spectra after a period 
of 4 days and incubation at 60 °C (Figure 3.6). Also, a number of cross peaks appeared 
to exhibit no significant decrease with respect to signal intensity.  
 
This result confirmed that a number of residues present in TmDHFR were not 
accessible to proton back exchange from the bulk solvent, complicating efforts to 
improve relaxation issues through deuteration. It was suggested that unfolding the 
protein would expose the non-solvent exposed regions allowing for proton back-
exchange. However, previous unfolding and re-folding experiments with TmDHFR in 
our group suggested proper re-folding of the protein was difficult due in part to the 
added complexity of the dimer interface.145  
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Figure 3.6: 1H-15N spectra of 15N labelled TmDHFR recorded after 4 days at 60 °C incubation in buffer 
containing 99 % D2O. 
 
Through these methods it was possible to only assign just over ~30% of the protein 
backbone (Figure 3.7 and 3.8), most of the assigned residues residing in solvent 
exposed regions of the protein structure. As the assigned spin systems do not represent 
an effective cross section of the different environments in the protein structure it was 
deemed necessary to attempt a different approach to probe conformational behaviour in 
TmDHFR.  
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Figure 3.7: Cartoon representation of TmDHFR, Spin systems that have been assigned have been 
highlighted in red, approximately 30 %. 
 
AKVIFVLAMDVSGKIASSVESWSSFEDRKNFRKITTEIGNVVMGRITFEEIGRPLPERL
NVVLTRRPKTSNNPSLVFFNGSPADVVKFLEGKGYERVAVIGGKTVFTEFLREKLVDEL
FVTVEPYVFGKGIPFFDEFEGYFPLKLLEMRRLNERGTLFLKYSVEKSHR 
 
Figure 3.8: Primary sequence of TmDHFR, highlighted in yellow are residues we found possible to 
assign. 
 	
3.3 Introduction to chemical shift mapping  	
The backbone assignment of TmDHFR could not be completed due to the adverse 
properties of the protein; high thermal stability preventing back-exchange after 
perdeuteration; dimerization giving unsuitable relaxation properties. This prevented the 
use of conventional NMR methods that rely on the 1H-15N HSQC as the fingerprint on 
which other experiments are based. In order to investigate protein conformational 
changes for TmDHFR an alternative NMR approach involving sidechain labelling was 
undertaken. Sidechain labelling provides defined probes within the protein but with low 
enough populations to enable characterisation without a backbone assignment. 
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Importantly methyl labelling affords good relaxation properties without the requirement 
of perdeuteration. 
 
Importantly, using conventional 1H-15N approaches for widespread analysis of protein 
variants from different organisms is impossible due to both the length of time required 
and simply the number of resonances that provide a complex picture without 
assignment. Yet it is important to investigate many orthologues to get a picture of the 
importance of conformational changes to catalysis and to identify key amino acid 
networks that conserve the mechanism. Therefore we wished to find an alternative 
method that made analysis of multiple enzymes straightforward.  
 
In order to simplify NMR spectra and optimise we wished to have probes within 
defined locations of the protein at a low population and with suitable properties. 
Sidechain labelling affords this.  
 
A search on the protein data bank returns >400 structures relating to DHFR and 
multiple studies have been conducted with respect to conformational behaviour in 
DHFR variants.58,63 Most of these determined structures are however of the apo enzyme 
or with DHFR inhibitors such as trimethoprim or methotrexate and as such do not 
effectively model conformational changes that could occur before and after the 
chemical step of catalysis. DHFRs from Lactobacillus casei and Bacillius anthracis 
have been postulated not to adopt an occluded conformation, however the absence of 
structural evidence suggesting for an occluded conformation does not imply they cannot 
adopt such a conformation.85–87  
 
3.4 Sidechain labelling to probe conformational behaviour  
 
The method used in this thesis involves labelling of the enzyme with [methyl-13C]-
methionine and [indole-δ1-13C] tryptophan.146,147 By adding various ligand combinations 
the different structural conformations such as the Michaelis and product complexes 
could be probed. This method significantly reduces spectral complexity compared to a 
1H-15N HSQC and as such allows for the rapid and intuitive probing of conformational 
behaviour. Further more [methyl-13C]-methionine labelling is very sensitive due to the 
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three equivalent protons on the 13C labelled methyl group, and will subsequently help to 
overcome issues caused by relaxation effects in TmDHFR.136  
 
As stated in the introduction, evidence of a DHFR enzyme adopting an occluded like 
conformation following the chemical step has only been found in EcDHFR.53,61,76,83 
Mutants, which reduce flexibility of the M20 loop, have a diminishing effect on the 
value of kcat and it is postulated EcDHFR adopts an occluded conformation to reduce 
product inhibitory effects.53,76,98–100 MpDHFR on the other hand, has been shown not to 
adopt such a conformational change following the chemical step, even though the 
tertiary structures of EcDHFR and MpDHFR appear to be superimposable.61,76,84 To 
validate side-chain labelling as a method of tracking conformational behaviour in 
DHFR variants data from EcDHFR and MpDHFR was compared. This identified 
whether formation of an occluded like conformation could be identified through a 
simplified chemical shift mapping approach utilizing a limited number of resonances 
dispersed throughout the protein structure. 
 
Classically chemical shift perturbations have been quantified using Equation 3.1.148 
Quantification of chemical shift perturbations allows for a simplified way of identifying 
significant chemical shift changes, which in this case is likely a result of conformational 
change. In order to acknowledge the difference in magnetogyric ratios between the 
proton and carbon atom (γC/ γH) a scaling factor of 0.25 is used to allow chemical shifts 
of different isotopes to be more comparable.148  
 
 ∆𝛿 = 1 2 𝛿!   ! + 𝛿!   !4 !.! 
 
Equation 3.1: Equation used to calculate weighted chemical shifts (Δδ), wherein δH and δC is the 
difference in chemical shifts for each respective atom measured in parts per million (ppm).  
 
Methionine comprises 3.1% of total amino acids in EcDHFR and MpDHFR  and 2.4 % 
in TmDHFR. Similarly tryptophan comprises 3.1% of total amino acids in EcDHFR, 
1.9 % in MpDHFR and 0.6 % in TmDHFR (Figure 3.9).84,88,133,149 Methionine and 
tryptophan residues are also well dispersed throughout a number of other DHFR 
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variants (Figure 3.10), a number of these residues being highly conserved, allowing for 
a simplified comparison between data sets from different DHFRs. Trp22, located in the 
M20 loop has been shown to be important for catalysis in EcDHFR and is highly 
conserved amongst DHFR variants.150 Trp133 is also highly conserved and is present in 
EcDHFR and MpDHFR; all other tryptophan residues are located throughout the 
enzyme structure. Met42, although distal to the active site is also highly conserved, 
mutation of this residue in EcDHFR results in diminished kcat and km values.151 Met92 
and Met42 are also conserved in MpDHFR. Only Met44 is conserved in TmDHFR, the 
two remaining methionine residues located within the dimer interface. From mass 
spectrometry we know Met1 usually remains intact on the protein structure, in 
TmDHFR however aminopeptidase only partially removes this residue (Figure 3.11).152  
 
Figure 3.9: Cartoon representation of three DHFR variants discussed in this work; EcDHFR (PDB entry 
1RX261, light blue), TmDHFR (PDB entry 1D1G89, green) and MpDHFR (PDB entry 3IA5153, red. The 
M20 loop in the closed position in EcDHFR and MpDHFR and open position in TmDHFR is highlighted 
in yellow. The M20 loop in the occluded position is highlighted in black in EcDHFR. The positions of 
methionine (blue) and tryptophan (purple) residues are also highlighted.  
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              1                  20                          40    
EcDHFR      --MISLIAALAVDRVIGMENAMPWN-LPADLAWFKRNTLD-------KPVIMGRHTWESI 
TmDHFR      MAKVIFVLAMDVSGKIAS-SVESWS-SFEDRKNFRKITTE------IGNVVMGRITFEEI  
MpDHFR      -MIVSMIAALANNRVIGLDNKMPWH-LPAELQLFKRATLG-------KPIVMGRNTFESI 
SeDHFR      -MLISLIAALAHNNLIGKDNLIPWH-LPADLRHFKAVTLG-------KPVVMGRRTFESI  
hDHFR       VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSI 
mmDHFR      VRPLNCIVAVSQNMGIGKNGDLPWPPLRNEFKYFQRMTTTSSVEGKQNLVIMGRKTWFSI 
LcDHFR      ---TAFLWAQNRNGLIGKDGHLPWH-LPDDLHYFRAQTVG-------KIMVVGRRTYESF 
MtDHFR      --MVGLIWAQATSGVIGRGGDIPWR-LPEDQAHFREITMG-------HTIVMGRRTWDSL 
MyDHFR      -----MIAALANNRVIGLDNKMPWH-LPAELQLFKRATLG-------KPIVMGRNTFESI 
SaDHFR      -MTLSILVAHDLQRVIGFENQLPWH-LPNDLKHVKKLSTG-------HTLVMGRKTFESI 
BsDHFR      --MISHIVAMDENRVIGKDNRLPWH-LPADLAYFKRVTMG-------HAIVMGRKTFEAI 
BaDHFR      -MIVSFMVAMDENRVIGKDNNLPWR-LPSELQYVKKTTMG-------HPLIMGRKNYEAI 
 
                           60                     80        
EcDHFR      ---GRPLPGRKNIILSSQPGTD-DRV-TWV-KSVDEAIAA-C----GD-VPEIMVIGGGR 
TmDHFR      ---GRPLPERLNVVLTRRPKTSNNPSLVFFNGSPADVVKFLE----GKGYERVAVIGGKT 
MpDHFR      ---GRPLPGRLNIVLSRQTDYQPEGV-TVV-ATLEDAVVA-A----GD-VEELMIIGGAT 
SeDHFR      ---GRPLPGRRNVVVSRNPQWQAEGV-EVA-PSLDAALAL-L----TD-CEEAMIIGGGQ  
hDHFR       PEKNRPLKGRINLVLSRELKEPPQGA-HFLSRSLDDALKLTEQPELANKVDMVWIVGGSS 
mmDHFR      PEKNRPLKDRINIVLSRELKEPPRGA-HFLAKSLDDALRLIEQPELASKVDMVWIVGGSS 
LcDHFR      P--KRPLPERTNVVLTHQEDYQAQGA-VVV-HDVAAVFAYAK----QHLDQELVIAGGAQ 
MtDHFR      PAKVRPLPGRRNVVLSRQADFMASGA-EVV-GSLEEALTS----------PETWVIGGGQ 
MyDHFR      ---GRPLPGRLNIVLSRQTDYQPEGV-TVV-ATLEDAVVA-A----GD-VEELMIIGGAT 
SaDHFR      ---GKPLPNRRNVVLTSDTSFNVEGV-DVI-HSIEDIYQL---------PGHVFIFGGQT 
BsDHFR      ---GRPLPGRDNVVVTGNRSFRPEGC-LVL-HSLEEVKQWIA----SR-ADEVFIIGGAE 
BaDHFR      ---GRPLPGRRNIIVTRNEGYHVEGC-EVA-HSVEEVFEL-C----KN-EEEIFIFGGAQ 
 
             100                   120                   140 
EcDHFR      VYEQFLP--KAQKLYLTHIDAEVEGD--THFPDYEPDDWESVFSEFHD---ADAQNSH-- 
MpDHFR      IYNQCLA--AADRLYLTHIELTTEGD--TWFPDYEQYNWQEIEHESYA---ADDKNPH-- 
TmDHFR      VFTEFLREKLVDELFVTVEPYVFGKG-IPFFDEFEGY-FPLKLLEMRR---LNERGTLFL 
SeDHFR      LYAEALP--RADRLYLTYIDAQLNGD--THFPDYLSLGWQELERSTHP---ADDKNSY— 
hDHFR       VYKEAMNHPGHLKLFVTRIMQDFESD--TFFPEIDLEKYKLLPEYPGVLSDVQEEKGI-- 
mmDHFR      VYQEAMNQPGHLRLFVTRIMQEFESD--TFFPEIDLGKYKLLPEYPGVLSEVQEEKGI-- 
LcDHFR      IFTAFKD--DVDTLLVTRLAGSFEGD--TKMIPLNWDDFTKVSSRT-V---EDTNPAL-- 
MtDHFR      VYALALP--YATRCEVTEVDIGLPREAGDALAPVLDETWRGETGEWRF---SR--SGL--  
MyDHFR      IYNQYLA--AADRLYLTHIELTIEGD--TWFPDYEQYHWQEIEHESYA---ADDKNPH-- 
SaDHFR      LFEEMID--KVDDMYITVIEGKFRGD--TFFPPYTFEDWEVASSVEGK---LDEKNTI-- 
BsDHFR      LFRATMP--IVDRLYVTKIFASFPGD--TFYPPISDDEWEIVSYTPGG---KDEKNPY-- 
BaDHFR      IYDLFLP--YVDKLYITKIHHAFEGD--TFFPEMDMTNWKEVFVEKGL---TDEKNPY-- 
 
               
EcDHFR      SYCFEILERR---  
MpDHFR      NYRFSLLERVK— 
TmDHFR      KYSVEKSHR----  
SeDHFR      ACEFVTLSRQR— 
hDHFR       KYKFEVYEKND— 
mmDHFR      KYKFEVYEKKD— 
LcDHFR      THTYEVWQKKA— 
MtDHFR      RYRLYSYHRS---  
MyDHFR      DYRFSLLERVK— 
SaDHFR      PHTFLHLIRKLE-  
BsDHFR      EHAFIIYERKKAK  
BaDHFR      TYYYHVYEKQQ— 
 
Figure 3.10: Alignment of the amino acid sequences of DHFR orthologues, showing methionine and 
tryptophan residues in DHFR variants. DHFR alignments comprise Thermotoga maritima (TmDHFR), 
Human (hDHFR), Mus musculus (mouse, MmDHFR), Lactobacillus casei (LcDHFR), Mycobacterium 
tuberculosis (MtDHFR), Escherichia coli (EcDHFR), Salmonella enterica (SeDHFR), Moritella 
profunda (MpDHFR), Moritella yayanosii (MyDHFR), Staphylococcus aureus (SaDHFR), Geobacillus 
stearothermophilus (BsDHFR) and Bacillus anthracis (BaDHFR). 
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Figure 3.11: Deconvoluted ESI mass spectrum of TmDHFR wherein the methyl group of each 
methionine residue has been systematically labelled with 13C. The calculated mass is 19,370.0 and 
following cleavage of Met1 by aminopeptidase is 19,239.0. As can be observed the majority of Met1 has 
been cleaved but a significant amount of TmDHFR with Met1 still remains. 
 
Sidechain labelling can be achieved by adding various starting materials to the media 
during recombinant expression. By adding indole, in E.coli, tryptophan synthase 
converts indole-3-glycerol phosphate and serine into tryptophan, passing through an 
indole intermediate. Indole-(2-13C) was used to systematically label the C2 position of 
the indole ring of tryptophan residues, utilizing the tryptophan biosynthetic pathway 
used by E.coli (Figure 3.12).4,147 Allowing for a cost-effective and simple approach to 
the labelling of tryptophan residues.147 For simplicity and reduced label scrambling L-
Rapid Analysis of Conformational Behaviour in DHFR variants 
 70 
methionine-(methyl-13C) was used to directly label the methyl groups of methionine 
residues.146 Successful labelling being confirmed by mass spectrometry.  
 
 
Figure 3.12: Reaction catalysed by Tryptophan synthase. Serine forms a Schiff base with pyridoxal 
phosphate (PLP) held within the active site which reacts with indole to form tryptophan.4,154  
 
3.5 Sidechain NMR experiments 
 
In order to confirm that sidechain labelling is able to identify the conformational 
changes that occur with DHFR catalysis, EcDHFR was investigated. 1H-13C HSQC 
spectra of EcDHFR labelled with [methyl-13C]-methionine or [indole-δ1-13C] tryptophan 
were acquired. Different samples were formed representing the different complexes 
present in the catalytic cycle. An apo sample was first recorded with no bound ligands 
in order to gain structural information about the open/disordered state. Direct addition 
of NADPH and DHF to form the Michaelis complex was not possible due to near 
immediate product formation. A Michaelis complex was therefore formed using NADP+ 
and folate to prevent turnover, work by Sawaya et.al. has shown this complex to adopt a 
closed conformation in EcDHFR.149 The ternary product complex was formed by 
adding equimolar concentrations of NADPH and DHF to DHFR directly in the NMR 
tube. A period of 20 minutes was allowed for the enzyme to completely turnover all 
substrates to NADP+ and THF, the reaction being monitored by 1H NMR. A 1H-13C 
HSQC spectrum of the Michaelis and product complexes yielded 5 well-defined cross-
peaks in spectra of both [methyl-13C]-methionine and [indole-δ1-13C] tryptophan 
labelled EcDHFR (Figure 3.13). Spectral quality is greatly diminished when studying 
the enzyme in the apo state, a consequence of conformational heterogeneity, where the 
enzyme is in slow equilibrium between multiple states.138,155 Addition of ligands 
reduces the number of additional cross peaks and increases resolution as exchange 
between conformational states is suppressed.139  
 
N
H
OP32-
OHHO
N
H N
H
COO-
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Due to previously published NMR assignments, residues in EcDHFR and MpDHFR 
were assigned by Stella Matthews and Dr E. Joel Loveridge. For MpDHFR all 
methionine methyl groups with the exception of Met94 had previously been published 
which was confirmed through re-evaluation of a previously recorded 13C-15N edited 
NOESY.138 Tryptophan indole groups were assigned by correlating indole-δ1 1H 
resonances recorded through [indole-δ1-13C] tryptophan labelling to previously recorded 
spectra. If not already assigned in spectra relating to EcDHFR, residues were assigned 
via a similar approach and re-evaluation of CCH-TOCSY, HCCH-TOCSY spectra, 
which was again previously acquired with reference to published material.139,140 
 
Significant differences with respect to chemical shift were observed between the apo, 
Michaelis and product complexes, indicative of the enzyme undergoing structural 
conformational changes. It is known that EcDHFR changes from a closed to occluded 
conformation following the chemical step and as such dramatic changes with respect to 
chemical shift were witnessed between EcDHFR:NADP+:folate and 
EcDHFR:NADP+:THF complexes (Figure 3.14). Met16, Met20 and Trp22 located in 
the flexible M20 loop of EcDHFR showed large chemical shift perturbations (Table 
3.2). Met42, Met92 and Trp133 although located distal to the active site also exhibited 
significant chemical shift perturbations (Table 3.3).  
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Figure 3.13: 1H-13C HSQC spectra of 13C-labelled EcDHFR complexes. (A) [methyl-13C]methionine-
labelled EcDHFR with no ligands. (B) [δ1-13C] tryptophan-labelled EcDHFR with no ligands. (C) 
[methyl-13C]methionine-labelled EcDHFR in the Michaelis complex. (D) [δ1-13C] tryptophan-labelled 
EcDHFR in the Michaelis complex. (E) [methyl-13C]methionine-labelled EcDHFR in the product 
complex. (F) [δ1-13C] tryptophan-labelled EcDHFR in the product complex. 
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Figure 3.14: 1H-13C HSQC spectra of 13C-labelled EcDHFR complexes, Apo (green), E:NADP+:folate 
(closed conformation in EcDHFR) (blue) and E:NADP+:THF (occluded conformation in EcDHFR) (red). 
(G and I) [methyl-13C]methionine-labelled EcDHFR (H and J) [δ1-13C] tryptophan-labelled EcDHFR.  
 
Table 3.2: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [methyl-
13C] methionine-labelled EcDHFR. 
Residue Apo to Michaelis complex Michaelis to product complex 
Met1 0.012 0.011 
Met16 0.062 0.122 
Met20 0.100 0.120 
Met42 0.032 0.036 
Met92 0.107 0.040 
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Table 3.3: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [δ1-13C] 
tryptophan-labelled EcDHFR. 
Residue Apo to Michaelis complex Michaelis to product complex 
Trp22 0.233 0.226 
Trp30 0.060 0.067 
Trp47 0.108 0.046 
Trp74 0.129 0.006 
Trp133 0.036 0.153 
 
To confirm that chemical shifts observed for EcDHFR are indeed representative of 
conformational changes and not due to other effects such as ligand binding, MpDHFR 
was investigated using the same methods. The catalytic cycle of MpDHFR has been 
previously investigated and shown to progress with a single conformation, alike to the 
EcDHFR closed conformation. This therefore provides a negative control for the 
methodology, allowing us to see if we can differentiate between chemical shift 
perturbations caused by changes in structural conformation or those that are simply an 
effect of ligand binding. 
 
The spectra for [methyl-13C]-methionine and [indole-δ1-13C] tryptophan labelled 
MpDHFR again showed poor spectral quality in the apo form, likely due to 
conformational heterogeneity (Figure 3.15). When in the Michaelis, 
MpDHFR:NADP+:folate complex, 5 and 3 well defined cross peaks were observed in 
the methionine and tryptophan labelled spectra respectively as expected. No significant 
chemical shift perturbations were observed between the MpDHFR:NADP+:folate and 
MpDHFR:NADP+:THF complexes (Figure 3.16 & Table 3.5). Although small 
chemical shift perturbations were observed for Met21 and Trp23 this is likely due to 
their location within the active site and these residues are therefore very susceptible to 
ligand binding effects. It is very important to be able to differentiate between chemical 
shift perturbations due to ligand binding effects and those as a result of large-scale 
conformational changes as observed in EcDHFR.  
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Figure 3.15: 1H-13C HSQC spectra of 13C-labelled MpDHFR complexes. (A) [methyl-13C]methionine-
labelled MpDHFR with no ligands. (B) [δ1-13C] tryptophan-labelled MpDHFR with no ligands. (C) 
[methyl-13C]methionine-labelled MpDHFR in the Michaelis complex. (D) [δ1-13C] tryptophan-labelled 
MpDHFR in the Michaelis complex. (E) [methyl-13C]methionine-labelled MpDHFR in the product 
complex. (F) [δ1-13C] tryptophan-labelled MpDHFR in the product complex. 
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Figure 3.16: 1H-13C HSQC spectra of 13C-labelled MpDHFR complexes, Apo (green), E:NADP+:folate 
(closed conformation in EcDHFR) (blue) and E:NADP+:THF (occluded conformation in EcDHFR) (red). 
(G and I) [methyl-13C]methionine-labelled MpDHFR (H and J) [δ1-13C] tryptophan-labelled MpDHFR. 
 
Table 3.4: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [methyl-
13C] methionine-labelled MpDHFR. 
Residue Apo to Michaelis complex Michaelis to product complex 
Met1 0.011 0.008 
Met5 0.184 0.011 
Met21 0.009 0.008 
Met43 0.003 0.011 
Met94 0.120 0.090 
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Table 3.5: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [δ1-13C] 
tryptophan-labelled MpDHFR. 
Residue Apo to Michaelis complex Michaelis to product complex 
Trp23 0.016 0.015 
Trp126 0.018 0.020 
Trp135 0.024 0.009 
 
Extensive chemical shift perturbations between the Michaelis and product complexes in 
EcDHFR have also previously been observed with 15N alanine labelled EcDHFR.156 
MpDHFR, which acted as a negative control for this methodology exhibited no 
significant chemical shift perturbations between the Michaelis and product complexes. 
These results provide evidence this method of tryptophan and methionine side chain 
labelling is sufficient for probing large-scale conformational behaviour in DHFR 
variants. Residues located in the flexible M20 (Met16, Met20 and Trp22) loop exhibit 
the largest chemical shift perturbations. From crystal structures Met16 points out into 
bulk solvent in the apo and EcDHFR:NADP+:folate complex, wherein the 
EcDHFR:NADP+:THF complex the site chain points directly into the active site, 
drastically altering the electronic environment around the 13C nucleus.61 The methyl 
group of Met20 faces the FG loop in the Michaelis product but becomes increasingly 
solvent exposed in the product complex, explaining the downfield shift observed.61 In 
EcDHFR the majority of methionine and tryptophan side-chains exhibit clear chemical 
shift perturbations. No such chemical shift perturbations are observed between the 
MpDHFR:NADP+:folate and MpDHFR:NADP+:THF complexes, aligning with earlier 
work which theorised MpDHFR failed to adopt an occluded conformation following the 
chemical step.76 These results further validate our method and allow us to probe other 
DHFRs for an ability to adopt an occluded conformation.   
 
As our methodology was now validated attention was returned to TmDHFR. Although 
it has previously been suggested TmDHFR remains in a fixed, open conformation 
during the catalytic cycle there existed no direct structural evidence for this claim.  
 
As stated earlier in this chapter the elongated shape, increased mass (38 K) and thermal 
stability of TmDHFR led to poor tumbling and thus fast T2 relaxation which meant no 
assigned triple resonance spectra could be achieved for TmDHFR.89 Methionine and 
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tryptophan side-chain labelling has superior sensitivity and relaxation properties 
compared to traditional NMR based approaches and thus could be applied to explore 
conformational behaviour in TmDHFR.136,148,157 TmDHFR has four methionine residues 
and a single tryptophan residue (Figure 3.17).88 Met1 was found to be present in ~10 % 
of protein, this is due to partial activity of aminopeptidase present in E.coli.152 Due to 
the decreased cross-peak intensity it was possible to assign Met1. No significant 
chemical shift perturbations were observed between [methyl-13C]-methionine labelled 
spectra in either the Michaelis or product complexes (Figure 3.18 and Table 3.7). A 
proton chemical shift of 0.07 ppm was observed for Trp23 between the Michaelis and 
product complexes, a similar shift is also observed in MpDHFR. Again this is more than 
likely due to ligand binding effects and not large scale conformational changes. The apo 
spectra for TmDHFR shows well resolved cross-peaks and no evidence of 
conformational heterogeneity (Figure 3.17). This evidence suggests TmDHFR remains 
in a fixed, open conformation during catalysis.  
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Figure 3.17: 1H-13C HSQC spectra of 13C-labelled TmDHFR complexes. (A) [methyl-13C]methionine-
labelled TmDHFR with no ligands. (B) [δ1-13C] tryptophan-labelled TmDHFR with no ligands. (C) 
[methyl-13C]methionine-labelled TmDHFR in the Michaelis complex. (D) [δ1-13C] tryptophan-labelled 
TmDHFR in the Michaelis complex. (E) [methyl-13C]methionine-labelled TmDHFR in the product 
complex. (F) [δ1-13C] tryptophan-labelled TmDHFR in the product complex. 
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Figure 3.18: 1H-13C HSQC spectra of 13C-labelled TmDHFR complexes, Apo (green), E:NADP+:folate 
(closed conformation in EcDHFR) (blue) and E:NADP+:THF (occluded conformation in EcDHFR) (red). 
(G and I) [methyl-13C]methionine-labelled TmDHFR (H and J) [δ1-13C] tryptophan-labelled TmDHFR. 
 
Table 3.6: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [methyl-
13C] methionine-labelled TmDHFR. 
Residue Apo to Michaelis complex Michaelis to product complex 
Met1 0.009 0.041 
Unassigned  0.009 0.001 
Unassigned 0.006 0.027 
Unassigned 0.016 0.013 
 
Table 3.7: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [δ1-13C] 
tryptophan-labelled TmDHFR. 
Residue Apo to Michaelis complex Michaelis to product complex 
Trp23 0.069 0.050 
 
Rapid Analysis of Conformational Behaviour in DHFR variants 
 81 
To demonstrate the utility of sidechain labelling to rapidly assess the conformational 
landscape of multiple enzyme variants we wanted to identify a DHFR variant that also 
formed the occluded conformation. Previously, formation of the occluded conformation 
following the chemical step had only been observed in EcDHFR.99 Although some 
evidence of conformational behaviour following hydride transfer step has been 
presented for other DHFRs. The Ser148-Asn23 interaction has previously been shown 
to be crucial for stabilisation of an occluded conformation.76 Amino acid sequence 
analysis identified DHFR from Salmonella enterica (SeDHFR) as having a Ser150 
residue in an equivalent position to Ser148 in EcDHFR. In place of Asn23, SeDHFR 
has His24 but as the hydrogen bonds form to the amide backbone this should not hinder 
stabilisation of an occluded conformation. No X-ray structures or triple resonance NMR 
assignment exists for SeDHFR. Details of the expression and purification of SeDHFR is 
described in chapter 4. 
 
Like in EcDHFR and MpDHFR, the apo spectra of methyl-13C spectra of methionine 
labelled SeDHFR was of low quality with multiple additional cross-peaks, indicating 
the enzyme is in conformational heterogeneity when unbound to ligands (Figure 3.19). 
SeDHFR has 3 methionine residues but unlike EcDHFR and MpDHFR exhibits 6 well 
defined, equally populated cross peaks in the product complex suggesting the enzyme is 
in slow equilibrium between two major conformational states (Figure 3.20). In the 
Michaelis complex only 3 cross peaks are observed which match cross peaks present in 
spectra relating to the product complex. This suggests that in the product complex 
SeDHFR is in equilibrium between the Michaelis conformation and a second, 
uncharacterised conformation.  
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Figure 3.19: 1H-13C HSQC spectra of 13C-labelled SeDHFR complexes. (A) [methyl-13C]methionine-
labelled SeDHFR with no ligands. (B) [δ1-13C] tryptophan-labelled SeDHFR with no ligands. (C) 
[methyl-13C]methionine-labelled SeDHFR in the Michaelis complex. (D) [δ1-13C] tryptophan-labelled 
SeDHFR in the Michaelis complex. (E) [methyl-13C]methionine-labelled SeDHFR in the product 
complex. (F) [δ1-13C] tryptophan-labelled SeDHFR in the product complex. 
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Figure 3.20: 1H-13C HSQC spectra of 13C-labelled SeDHFR complexes, Apo (green), E:NADP+:folate 
(closed conformation in EcDHFR) (blue) and E:NADP+:THF (occluded conformation in EcDHFR) (red). 
(G and I) [methyl-13C]methionine-labelled SeDHFR (H and J) [δ1-13C] tryptophan-labelled SeDHFR. 
 
Table 3.8: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [methyl-
13C] methionine-labelled SeDHFR. 
Residue Apo to Michaelis complex Michaelis to product complex 
Unassigned  0.082 0.076 
Unassigned 0.044 0.072 
Unassigned 0.770 0.183 
 
Table 3.9: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [δ1-13C] 
tryptophan-labelled SeDHFR. 
Residue Apo to Michaelis complex Michaelis to product complex 
Unassigned  0.105 0.062 
Unassigned 0.286 0.023 
Unassigned 0.244 0.000 
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The Ser148-Asn23 interaction is crucial for stabilisation of the occluded conformation 
in EcDHFR.53,76 To confirm whether the second conformation observed in methyl-13C 
spectra of methionine labelled SeDHFR is an occluded conformation the S150A-
SeDHFR mutant was designed. Again in the product complex the methyl-13C spectra of 
methionine labelled S150A-SeDHFR exhibited evidence of two conformational states 
(Figure 3.21). However the population of the second conformation was drastically 
reduced, the three major cross peaks again overlapping with those in the Michaelis 
complex (Figure 3.22). It was therefore theorised that the observed second 
conformation may be similar the conformational change observed in EcDHFR 
following the chemical step. Furthermore the importance of the Ser48-Asn23 interaction 
in the stabilisation of an occluded conformation was reinforced. With respect to the 
[indole-δ1-13C] tryptophan labelled spectra for SeDHFR and the S150A-SeDHFR 
spectra no significant chemical shift perturbations were observed between the Michaelis 
and product complexes, yielding no evidence of conformational change.  
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Figure 3.21: 1H-13C HSQC spectra of 13C-labelled S150A-SeDHFR complexes. (A) [methyl-
13C]methionine-labelled S150A-SeDHFR with no ligands. (B) [δ1-13C] tryptophan-labelled S150A-
SeDHFR with no ligands. (C) [methyl-13C]methionine-labelled S150A-SeDHFR in the Michaelis 
complex. (D) [δ1-13C] tryptophan-labelled S150A-SeDHFR in the Michaelis complex. (E) [methyl-
13C]methionine-labelled S150A-SeDHFR in the product complex. (F) [δ1-13C] tryptophan-labelled 
S150A-SeDHFR in the product complex. 
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Figure 3.22: 1H-13C HSQC spectra of 13C-labelled S150A-SeDHFR complexes, Apo (green), 
E:NADP+:folate (closed conformation in EcDHFR) (blue) and E:NADP+:THF (occluded conformation in 
EcDHFR) (red). (G and I) [methyl-13C]methionine-labelled S150A-SeDHFR (H and J) [δ1-13C] 
tryptophan-labelled S150A-SeDHFR. 
 
Table 3.10: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to 
[methyl-13C] methionine-labelled SeDHFR-S150A. 
Residue Apo to Michaelis complex Michaelis to product complex 
Unassigned  0.021 0.021 
Unassigned 0.044 0.002 
Unassigned 0.311 0.083 
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Table 3.11: Weighted chemical shift perturbations (ppm) between 1H-13C HSQC of spectra relating to [δ1-
13C] tryptophan-labelled SeDHFR-S150A. 
Residue Apo to Michaelis complex Michaelis to product complex 
Unassigned  0.240 0.021 
Unassigned 0.188 0.219 
Unassigned 0.168 0.029 
 
To further confirm our theory that SeDHFR adopts a second conformation following the 
chemical step, 15N labelled SeDHFR was expressed. 1H-15N HSQC spectra were 
recorded of the enzyme in both the Michaelis and product complexes (Figure 3.23). 
Like in the spectra of methyl-13C spectra of methionine labelled SeDHFR significant 
chemical shift perturbations was observed between complexes. This further suggests the 
second conformation observed in SeDHFR is most likely the formation of an occluded 
conformation. Unlike EcDHFR and MpDHFR, SeDHFR has no methionine residues 
located in the flexible M20 loop, although Met42 and Met92 are conserved in all three 
DHFR variants. Met42 and Met92 show significant chemical shift perturbations in 
EcDHFR and SeDHFR but not in MpDHFR. Methionine probes even when located 
distal to the active site therefore prove to be effective in mapping conformational 
behaviour.  
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Figure 3.23: Two overlaid 1H-15N HSQC spectra of 15N labelled SeDHFR in both the Michaelis (blue) 
and product complexes (red). 
 
[methyl-13C]-methionine labelling was found to be superior over [indole-δ1-13C] 
tryptophan labelling as a diagnostic tool for studying conformational behaviour in 
DHFR variants. Trp22 in all four DHFRs studied is found to form hydrogen bonds to 
bound folates in the active site, and as such is particularly susceptible to ligand binding 
effects.150 This explains the small chemical shift perturbation observed with respect to 
this residue in TmDHFR and MpDHFR between each of the measured complexes. 
EcDHFR exhibits large chemical shift perturbations between the apo and Michaelis 
complex but no significant differences between the apo and product complexes. 
SeDHFR, on the other hand, shows no significant chemical shift perturbations at Trp22 
for any of the measured complexes, highlighting how ligand-binding effects could 
mitigate chemical shift differences that would otherwise arise from changes in 
conformational behaviour. No evidence of conformational heterogeneity is also 
observed in apo spectra of EcDHFR, MpDHFR and SeDHFR in the [indole-δ1-13C] 
tryptophan labelled spectra like in the [methyl-13C]-methionine labelled spectra. 
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Although [indole-δ1-13C] tryptophan labelled spectra produced no chemical shift 
perturbations between the Michaelis and product complexes it is still evident that 
conformational behaviour can be tracked through tryptophan labelling as spectra 
relating to EcDHFR testifies. This is likely due to the increased number of tryptophan 
residues present in EcDHFR.  
 
3.6 Summary and Conclusions 
 
Although [methyl-13C]-methionine labelling and [indole-δ1-13C] tryptophan labelling 
were used with different protein samples they could be performed in the same protein. 
Spectra relating to EcDHFR and SeDHFR provided clear evidence of large-scale 
conformational changes following the chemical step, which had not been previously 
observed in any other DHFRs. The occluded conformation is stabilised by the Ser148-
Asn23 interaction in EcDHFR, in MpDHFR Ser148 is replaced by Pro150, and it has 
previously been published that loop motions must not be critical for efficient catalysis 
in MpDHFR as it remains in a closed conformation during catalysis.76 It is thought that 
the occluded conformation lowers the binding affinity for NADP+ as the switch to the 
occluded conformation occurs immediately after hydride transfer in EcDHFR, possibly 
mitigating any product inhibition effects.76,158 At close to physiological conditions 
MpDHFR and EcDHFR have similar single turnover rates and it has been concluded 
that the ability to switch to the occluded conformation does not impact significantly on 
hydride transfer. It has also been shown that increased distance between reactants in the 
occluded conformation would effectively make hydride transfer not possible.76,139  
 
Although assignment of specific residues in TmDHFR and SeDHFR was not possible it 
presented no impediment to our method. Theories that TmDHFR remains in a fixed, 
open conformation during catalysis was based upon two crystal structures, neither of 
which effectively modelled either the Michaelis or product complexes.89 Through side 
chain labelling described in this thesis the first direct evidence that TmDHFR does 
indeed remain in a fixed, open conformation during catalysis has been presented. The 
simplicity and low cost of the labelling strategies meant methionine or tryptophan 
labelled DHFR variants could be made and spectra rapidly recorded and interpreted. 
Again the lack of assignment data was no impediment, clear chemical shift 
perturbations between the Michaelis and occluded complexes indicating a definitive 
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change in conformational behaviour. Like in the product complex of EcDHFR evidence 
of an occluded conformation in SeDHFR has been observed. In SeDHFR however, 
equimolar concentrations of two conformations is observed, one of which is proposed to 
be the Michaelis complex.  
 
Traditional NMR approaches are significantly more expensive than the side-chain 
labelled experiments detailed here. Evidence of conformational behaviour if observed 
could be expanded into crystallography or more detailed NMR study if interest 
warrants. The cost of  [methyl-13C]-methionine labelling and [indole-δ1-13C] tryptophan 
is ~£11 and ~£96 per litre of culture made respectfully, where as doubly labelled (13C 
and 15N) or triply labelled (2H, 13C and 15N) which is necessary for triple resonance 
assignment costs ~£262 or ~£622 per litre of culture respectively. The spectra produced 
are also much simpler than that produced by traditional methods and often allows for 
simple, intuitive interpretation of the data. A full 1H-13C HSQC is also recorded over a 
spectral window of ~70 ppm, opposed to a window of 10-14 ppm in side chain 
experiments, drastically decreasing NMR acquisition time. In the case of  [methyl-13C]-
methionine labelled spectra the three equivalent protons on the methyl group also 
increase the sensitivity of the NMR experiment, perfect for studying systems were T2 
relaxation is poor.  
 
Through CPMG 15N relaxation experiments EcDHFR has been shown to sample 
conformational states belonging to the preceding and following complex in its catalytic 
cycle. It would be of interest to expand on the methodology described here and observe 
whether sidechain labelling would be sufficient for CPMG experiments to be performed 
within DHFR variants. 
 
 
 
 
 
 
 
 
Hydride Transfer and Catalysis by Salmonella enterica DHFR 
 91 
 
 
4 
 
Hydride Transfer and 
Catalysis by 
Salmonella enterica 
DHFR 
 							
Hydride Transfer and Catalysis by Salmonella enterica DHFR 
 92 
4.1 Introduction 
 
Enzymes utilise a multitude of motions on various timescales to efficiently catalyse 
reactions. Although the role of slower protein motions are somewhat established, the 
influence of fast femto-pico second motions on the chemical step of catalysis is still 
hotly debated.53 A number of reports have proposed the coupling of fast femto-pico 
second dynamics to the chemical step of catalysis. These motions have been proposed 
to be long ranging, involving amino acid residues distal to the active site.31,48,49,79,159–165  
 
In the last 15 years the use of heavy isotope labelling to probe the influence of such fast 
motions acting upon the chemical step of catalysis has been developed. Heavy isotope 
labelling is achieved by expressing the enzyme in minimal media containing 2H, 13C & 
15N labelled feedstock.79 It is considered that heavy isotope labelling does not influence 
the electrostatic properties of the enzyme; instead the vibrations between bonds are 
slowed. Therefore differences in rate constants between heavy and natural abundance 
enzymes are considered to originate from a slowing of protein motions as a result of 
mass induced effects. The study of enzyme KIE on the chemical step of catalysis allows 
for an insight into how or if dynamic coupling influences the chemical step of 
catalysis.48,49,53 In this thesis the term dynamics is used to refer to fast (femto-pico 
second), non-stochastic motions. 
 
A number of DHFR variants that live under a wide temperature range have been studied 
with respect to protein dynamics and its influence on catalysis including; EcDHFR 
(mesophile),107,113–115,166,167 MpDHFR (psychrophilic),47 BsDHFR (Thermophile)120 and 
TmDHFR (hyper-thermophile).53,168 The study of multiple DHFRs sourced from 
various physiological temperatures allows for a broader insight into the role dynamic 
coupling plays in catalysis. SeDHFR, like EcDHFR originates from a mesophillic 
bacterium and as such presents an opportunity to further investigate the relationship 
between dynamic coupling and catalysis in DHFRs and see if previous observations 
between the relationship of dynamics and catalysis holds true. Furthermore, SeDHFR is 
of interest, as like EcDHFR, it is believed to adopt an occluded like conformation 
following the chemical step. 
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By the study of single-turnover primary KIE and enzyme KIE and comparison of such 
results to other previously recorded DHFR homologues the relationship between 
dynamic coupling and catalysis in SeDHFR will be reported on in this chapter.  
 
4.2 Expression and Purification of 13C & 15N SeDHFR 
 
The gene encoding for SeDHFR (UniProt I.D. P12833) was purchased from GenScript 
in a pET-11b vector and transformed into One Shot™ BL21 Star™ (DE3) chemically 
competent cells. In order to grow heavy isotope (13C and 15N) labelled SeDHFR, protein 
was recombinantly overproduced in minimal media (M9) containing 13C glucose and 
15N ammonium chloride, as described in section 2.3.2. Natural abundance SeDHFR was 
expressed in LB media. 
 
Purification of SeDHFR largely followed previously published procedures for other 
DHFR variants with some adaptations to the method.153 Unlike EcDHFR and MpDHFR 
it was found that SeDHFR had an insufficient interaction with anion exchange resin (Q-
sepharose) at pH 7.0 causing the protein to elute immediately with multiple impurities. 
Adjusting the pH of the buffers to 8.0 resulted in the enzyme having a partial interaction 
with the column but the protein still eluted prior to the start the salt gradient (Figure 
4.1) (section 2.3.3.2). The fractions containing SeDHFR were concentrated and further 
purified on a HiLoad Superdex G75 (GE Healthcare) size exclusion column and the 
protein eluted with an isocratic gradient (buffer C) (Figure 4.2) (section 2.3.3.3). The 
purity of the protein was evaluated with SDS-PAGE, which showed a band with a 
molecular weight of ~18000, coinciding with a molecular weight of 18032.6 calculated 
for SeDHFR (Figure 4.3).  
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Figure 4.1: Chromatogram of the elution trace (red) of SeDHFR from the Q-Sepharose column. The salt 
gradient (% NaCl) is in blue. SeDHFR eluted before the salt gradient (60-120 mL).  
 
 
Figure 4.2: Chromatogram of the elution trace (red) of SeDHFR from the HiLoad Superdex G75 (GE 
Healthcare). SeDHFR elutes between 210-230 mL. 
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Figure 4.3: SDS-polyacrylamide gel showing; 1) Cell Lysate 2) Combined fractions from Q-Sepharose 
column 3) After size exclusion chromatography (BSD75). MW of SeDHFR = 18,032. 
 
Mass spectrometry (ESI-MS) was used to measure the mass difference between heavy 
labelled SeDHFR and that of natural abundance SeDHFR. The calculated mass of the 
natural abundance enzyme was 18032.6. The mass spectrometry result was in 
agreement with this as the de-convoluted spectrum gave a mass of 18036.2 ± 1.6 
(Figure 4.4). The mass of mono-isotopic SeDHFR was calculated to be 18012.00 and 
the weight of 13C, 15N labelled SeDHFR to be 19044.00. A mass spectrum of the heavy 
enzyme yielded a mass of 19031.6 ± 6.0, corresponding to a mass increase of ~5.5%, 
indicating >98.7 % of carbon and nitrogen atoms were successfully labelled (Figure 
4.5).  
 
 
Figure 4.4: Deconvoluted ESI mass spectrum of natural abundance SeDHFR (18036.2 ± 1.6). 
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Figure 4.5: Deconvoluted ESI mass spectrum SeDHFR labelled with 13C and 15N (19031.6 ± 6.0). 
 
4.3 Circular Dichroism analysis and Thermal Unfolding of SeDHFR 
 
Circular dichroism (CD) spectra were recorded for the both the natural abundance and 
the heavy labelled enzyme to confirm 13C and 15N heavy isotope labelling had not 
altered structural elements of the protein (Figure 4.6). CD spectra for both the light and 
heavy enzyme were almost superimposable, indicating that isotopic labelling does not 
have a detrimental effect on structure. Both traces are also characteristic of folded 
proteins, with a broad minima between 208 and 222 nm and a peak at 193 nm 
corresponding to the alpha helix.169 
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Figure 4.6: CD spectra of natural abundance (blue) and 13C and 15N labelled (red) SeDHFR, recorded at 
20 °C. 
 
Thermal melting temperatures (Tm) were also calculated for natural abundance and 
heavy labelled SeDHFR by measuring the change in mean residue ellipticity (MRE) at 
208 nm over a temperature range of 5 to 80 °C. For natural abundance SeDHFR a rapid 
loss in secondary structure was observed between 52 and 61 °C and the Tm was 
calculated to be 54.3 °C (Figure 4.7). This is similar to the value obtained for EcDHFR 
(Tm = ~51 °C).115 No significant differences, with respect to Tm, were observed between 
the natural abundance and heavy labelled SeDHFR (54.7 °C) thus indicating that 
isotope labelling did not impact the thermal stability of the enzyme. 
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Figure 4.7: MRE recorded at 208 nm over a temperature range of 5 to 85 °C for natural abundance 
SeDHFR.  
 
4.4 Steady State Kinetics of SeDHFR 
 
The steady-state rate of the reaction catalysed by SeDHFR was measured using UV-Vis 
spectroscopy, monitoring the decrease in absorbance at 340 nm, corresponding to the 
oxidation of the nicotinamide ring of NADPH. The rate of reaction can therefore be 
calculated from the change in absorption using the Beer-Lambert-Bouguer law 
(Equation 4.1) with an extinction coefficient (𝜀) of 11800 M-1 cm-1, which corresponds 
to the enzyme-substrate complex.129  
 𝐴 = 𝜀 × 𝑙 ×𝑐  
 
Equation 4.1: The Beer-Lambert-Bouguer law, A is the change in absorbance at a measured wavelength, 
ε equates to the molar absorptivity at a specific wavelength, l refers to the path length and c refers to the 
concentration of the substrate. 
 
 Steady state kinetics works on the principle that rate of formation of product is in 
equilibrium with the rate of formation of the enzyme-substrate complex. To accomplish 
this the concentration of reactants are used in vast excess with respect to the 
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concentration of enzyme. Each measurement was taken over a period of 60 seconds and 
was performed in triplicate with 3 different batches of enzyme, for a total of nine 
measurements.  
 
4.5 Effect of Temperature on Steady State Kinetics of SeDHFR 
 
The kinetics of SeDHFR have not previously been characterised. The measured kcat 
value for SeDHFR at pH 7.0 and at 20 °C (8.6 ± 0.3 s-1) is similar, although slightly 
slower than that measured for EcDHFR (12.6 ± 1.4 s-1)90 at the same temperature and 
pH. MpDHFR (14.8 ± 0.8 s-1)170 and BsDHFR (16.2 ± 2.8 s-1)145 are however, almost 
twice as fast under the same conditions. The kcat for SeDHFR is however ~72 fold faster 
than TmDHFR (0.2 ± 0.02 s-1)90 at pH 7.0 and 25 °C (Table 4.1, Figures 4.8 and 4.9). 
Like other DHFRs the steady state turnover rate increases exponentially with respect to 
temperature in accordance with expected Arrhenius behaviour. 
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Table 4.1: Temperature dependence of the catalytic turnover (kcat) on SeDHFR and the 
DHFR variants EcDHFR, MpDHFR, BsDHFR and TmDHFR at pH 7.0. 
Temperature  
(°C) 
SeDHFR 
kcat (s-1) 
EcDHFR[a] 
kcat (s-1) 
MpDHFR[b] 
kcat (s-1) 
BsDHFR[c] 
kcat (s-1) 
TmDHFR[a] 
kcat (s-1) 
5 2.2 ± 0.2 N/A 5.9 ± 0.2 N/A N/A 
10 3.2 ± 0.1 N/A 8.2 ± 0.4 7.0 ± 2.0 N/A 
15 6.2 ± 0.4 8.5 ± 1.2 10.8 ± 0.5 9.3 ± 2.2 N/A 
20 8.6 ± 0.3 12.6 ± 1.4 14.8 ± 0.8 16.2 ± 2.8 N/A 
25 14.4 ± 0.2 16.4 ± 3.6 18.7 ± 0.8 21.6 ± 1.6 0.20 ± 0.02 
30 21.0 ± 0.2 24.0 ± 3.0 25.3 ± 1.1 32.7 ± 1.4 0.35 ± 0.02 
35 28.1 ± 0.5 32.0 ± 5.0 32.5 ± 1.9 48.6 ± 6.8 0.47 ± 0.04 
40 38.4 ± 0.2 44.9 ± 6.1 39.6 ± 1.8 66.7 ± 3.9 0.61 ± 0.04 
45 N/A 53.9 ± 5.6 28.8 ± 0.8 87.3 ± 2.3 0.83 ± 0.07 
50 N/A N/A N/A 116.0 ± 5.0 1.17 ± 0.07 
55 N/A N/A N/A 145 ± 8 1.53 ± 0.09 
60 N/A N/A N/A 183 ± 8 2.00 ± 0.16 
65 N/A N/A N/A 236 ± 18 2.70 ± 0.14 
70 N/A N/A N/A 243 ± 12 3.40 ± 0.28 
75 N/A N/A N/A N/A 4.05 ± 0.39 
80 N/A N/A N/A N/A ~4.8* 
* Indicates extrapolated values, [a] data taken from reference,90 [b] data taken from 
reference,170 [c] data taken from reference.145 
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Figure 4.8: Effect of temperature (range of 5-40 °C shown only) on the steady state rate constant for five 
DHFR variants at pH 7.0. SeDHFR (red diamond), EcDHFR (blue square), MpDHFR (green triangle), 
BsDHFR (orange circle) and TmDHFR (black square). 
 
 
Figure 4.9: Arrhenius plot of the effect of temperature on the steady state rate of SeDHFR at pH 7.0. 
 
The activation energy (Ea) for the SeDHFR catalysed reaction is 61.6 +/- 0.6 kJ mol-1 
which is slightly higher than values reported for other bacterial DHFRs including 
BsDHFR and TmDHFR which are thermophilic (Table 4.2).90,145 Lower Ea values are 
usually synonymous with psychrophilic enzymes, as is the case with MpDHFR as there 
is less thermal energy available to overcome the activation barrier.84,171,172 Like 
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EcDHFR and BsDHFR, SeDHFR (27.44 ± 0.2 x108 s-1) has a much higher Arrhenius 
pre-factor than either TmDHFR or MpDHFR (Table 4.2).   
 
Table 4.2: Activation parameters for SeDHFR and the DHFR variants EcDHFR, 
MpDHFR, BsDHFR and TmDHFR at pH 7.0. 
 SeDHFR EcDHFR[a] MpDHFR[b] BsDHFR[c] TmDHFR[a] 
Ea [kJ mol-1] 61.6 ± 0.6 47.7 ± 0.8 39.9 ± 0.5 51.0 ± 3.5 51.9 ± 0.6 
AH [108 s-1] 27.44 ± 0.2 38.4 ± 1.3 1.84 ± 0.39 88.8 ± 0.5 0.86 ± 0.02 
[a] data taken from reference,90 [b] data taken from reference,170 [c] data taken from 
reference.145 
 
4.6 Effect of pH on Steady State Kinetics of SeDHFR 
 
The DHFR catalysed reaction not only transfers a hydride to the C6 position of DHF 
from the nicotinamide ring of NADPH but also the catalyses the protonation of the N5 
position of DHF.50,51 Altering the pH of the solution will change both the ionisation 
state of residues in the active site as well as the number of protons available in solution. 
The relationship between pH and steady state rate was characterised in SeDHFR over a 
pH range of 5 to 9 using MTEN buffer at 20 °C (Figure 4.10). At low pH the kcat is 
diminished (at pH 9.0, kcat = 2.94 ± 0.13 s-1), rising to a maximum of 12.05 ± 0.08 s-1 at 
pH 7.5. At higher pH values the kcat decreases to 5.60 ± 0.08 s-1 at pH 5.0.  
 
SeDHFR, like MpDHFR has a steady state pH dependency that forms a bell shaped 
curve.84 EcDHFR on the other hand does not exhibit a significant decrease in steady 
state rate at lower pH and has a sigmoidal curve.173 The mutant MpDHFR-P150S, that 
is postulated to allow MpDHFR to stabilise an occluded-like conformation was also 
found to have a sigmoidal relationship with respect to pH, similar to EcDHFR.76 
However, the mutant EcDHFR-S148P, where formation of the occluded conformation 
is destabilised, also exhibited a sigmoidal curve, however, the rate of kcat was reduced 
by ~80 % across the measured pH range compared to the wild type enzyme.76   
 
A bell shaped pH dependency is also observed in a triple mutant of EcDHFR wherein 
residues from human DHFR are inserted into the αC helix.97 A decrease in kcat at low 
pH values was attributed to poor dissociation of THF at lower pH values.97 These 
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changes with respect to pH dependency have been postulated to be a result of changes 
to different rate limiting steps.76 However, release of THF from the product complex in 
MpDHFR was found to be independent of pH.76 The decrease in rate at low pH values 
has been shown not to be a result of His24 in the active site being protonated in 
MpDHFR.84 It is also unlikely that the decrease is a result of MpDHFR or SeDHFR 
becoming denatured as both enzymes are able to withstand pH values of 5.0 for a period 
of at least 30 minutes without any significant decrease in steady state rate.84  
 
NMR studies reported in the previous chapter of this thesis propose that SeDHFR 
adopts a second conformation following the chemical step, like EcDHFR. The steady 
state rate (kcat) of TmDHFR also has a sigmoidal relationship with respect to pH.90 It is 
therefore unlikely that such relationships could be indicative of conformational 
behaviour.  
 
Figure 4.10: The effect of pH on the steady state rate constant in SeDHFR.  
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Table 4.3: pH dependency on kcat for the reaction catalysed by SeDHFR.  
pH SeDHFR kcat s-1 
5.0 5.60 ± 0.08 
5.5 5.79 ± 0.28 
6.0 6.29 ± 0.11 
6.5 7.72 ± 0.15 
7.0 9.63 ± 0.02 
7.5 12.05 ± 0.05 
8.0 11.49 ± 0.33 
8.5 6.96 ± 0.33 
9.0 2.94 ± 0.13 
 
4.7 Product inhibition in SeDHFR 
 
Formation of the occluded conformation following the chemical step has been 
postulated to be important for release of NADP+ from the active site.76,149 The mutant 
EcDHFR-S148P, where formation of the occluded conformation has been de-stabilised 
exhibited a massive decrease (~20 fold) in the IC50 value for inhibition by NADP+ in 
comparison to wild type EcDHFR (Table 4.4).76 Wild type MpDHFR has an IC50 value 
for NADP+ which is ~5 fold lower than wild type EcDHFR. Interestingly, the mutant 
MpDHFR-P150S, wherein formation of the occluded conformation is stabilised, 
exhibits an almost 2-fold increase with respect to IC50 value. This evidence strongly 
suggests that formation of the occluded conformation in EcDHFR mitigates product 
inhibition effects.76  
 
To this end, IC50 values for NADP+ have been measured in SeDHFR, which has been 
shown to adopt a second structural conformation like EcDHFR (Table 4.4 and Figure 
4.11). IC50 values for NADP+ have also been measured for TmDHFR, which is known 
to remain in a fixed open conformation during catalysis (Table 4.4). SeDHFR exhibited 
an IC50 value almost 2 fold higher than wild type EcDHFR and ~12 and ~6 fold higher 
than MpDHFR and TmDHFR, which are both known not to adopt an occluded 
conformation following the chemical step. This evidence corroborates with earlier 
reports that the ability to adopt an occluded conformation following the chemical step 
reduces product inhibition by NADP+.76 
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Table 4.4: IC50 values for NADP+ for a number of DHFR variants at pH 7.0 and 20 °C. 
Enzyme IC50 (µM) 
SeDHFR 2068 ± 300 
TmDHFR 343 ± 66 
EcDHFR[a] 820 ± 59 
EcDHFR-S148A[a] 40 ± 1 
MpDHFR[a] 170 ± 11 
MpDHFR-P150S[a] 321 ± 12 
[a] data taken from reference.76 
  
 
 
Figure 4.11: IC50 curve (µM) for NADP+ inhibition in SeDHFR.  
 
4.8 Hydride Transfer in SeDHFR 
 
Hydride transfer rates were measured under single turnover conditions. The reaction 
was excited at 292 nm and the emission measured with a cut-off of 400 nm. 
Fluorescence energy transfer is observed between a tryptophan residue in the active site 
(Trp22) to the nicotinamide ring of NADPH via a mechanism known as Förster 
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heavily utilised in the study of DHFR variants, facilitated by Trp22 being almost 
ubiquitous in the DHFR active site (Figure 4.12).174  
 
 
Figure 4.12: No crystal structure of SeDHFR exists. Shown is a cartoon representation of EcDHFR 
(1RX2),149 highlighted in blue is residue Trp22 that is conserved in nearly all DHFR variants including 
SeDHFR.174 Also highlighted is NADPH in cyan, FRET occurs between Trp22 and the nicotinamide ring 
of NADPH. 
 
Previously, some stopped flow measurements have been performed at pH 9 where the 
rate of hydride transfer becomes rate limiting. At such high pH values the kinetics will 
largely report on the rate of the chemical step and contributions from other processes 
such as conformational behaviour will be minimised.51 However, at elevated pH values 
the enzyme is significantly removed from its physiological pH and, as such, the tertiary 
structure of the enzyme, conformational behaviour and protonation states of ionisable 
residues are all affected.111,175 Hydride transfer in SeDHFR was therefore studied at pH 
7.0 over a temperature range of 5-40 °C (Figure 4.13 and Table 4.5).   
 
SeDHFR exhibited a pre-steady state rate constant of 57 ± 0.6 s-1 at 20 °C and at pH 7.0, 
which is approximately 5-fold faster than the value of kcat under similar conditions. The 
rate constant (kH) increased exponentially with temperature corresponding to expected 
Arrhenius behaviour (Figure 4.14). SeDHFR exhibited ~2.5 fold lower single turnover 
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rate constant than its mesophillic counterpart EcDHFR (159 ± 7.9 s-1 at 20 °C) and is 
also slower than MpDHFR and BsDHFR. SeDHFR, like all other measured DHFRs is 
still significantly faster (kH) than the hyper-thermophile TmDHFR.  
 
 
Figure 4.13: Temperature dependence of the single turnover rate constant for hydride (blue triangles) and 
deuteride (red squares) transfer in SeDHFR at pH 7.0. 
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Table 4.5: Temperature dependency of hydride transfer in SeDHFR and previously 
mentioned DHFR variants at pH 7.0. 
Temperature 
(°C) 
SeDHFR 
kH (s-1) 
EcDHFR[a] 
kH (s-1) 
MpDHFR[b] 
kH (s-1) 
BsDHFR[c] 
kH (s-1) 
TmDHFR[a] 
kH (s-1) 
5 19.2 ± 0.1 81.9 ± 1.7 267.6 ± 14.4 N/A 0.04 ± 0.01 
10 25.5 ± 0.1 106.3 ± 3.1 327.2 ± 14.4 68.3 ± 8.3 0.06 ± 0.03 
15 36.0 ± 0.1 135.3 ± 5.6 420.3 ± 21.3 79.2 ± 3.7 0.09 ± 0.02 
20 57.0 ± 0.6 159.8 ± 7.9 484.4 ± 28.0 102.0 ± 5.0 0.12 ± 0.03 
25 93.8 ± 1.2 203.7 ± 7.4 526.8 ± 23.2 131.0 ± 2.0 0.17 ± 0.02 
30 140.8 ± 3.7 235.4 ± 13.8 570.5 ± 44.1 160.0 ± 8.0 0.24 ± 0.05 
35 187.2 ± 4.7 287.9 ± 12.0 N/A 184.0 ± 6.0 0.34 ± 0.06 
40 242.3 ± 13.4 N/A N/A 218.0 ± 7.0 0.49 ± 0.01 
45 N/A N/A N/A 249.0 ± 12.0 0.67 ± 0.02 
50 N/A N/A N/A 297.0 ± 10.0 0.93 ± 0.04 
55 N/A N/A N/A N/A 1.25 ± 0.06 
60 N/A N/A N/A N/A 1.65 ± 0.09 
67 N/A N/A N/A N/A 2.12 ± 0.16 
[a] data from ref,93 [b] data from ref,170 [c] data from reference.120  
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Figure 4.14: Arrhenius plots of hydride/deuteride transfer in SeDHFR at pH 7.0. Blue triangles represent 
hydride transfer and red squares denote deuteride transfer.   
 
The primary KIE for the reaction catalysed by SeDHFR was determined using 
enzymatically prepared NADPD (section 2.3.12). The KIE being calculated using 
Equation 4.1. At 5 °C the primary KIE is 2.40 ± 0.06 s-1 and falls slightly to 2.22 ± 
0.02 s-1 at 40 °C. With respect to temperature dependency of the primary KIE only a 
slight trend of decreasing KIE with increase of temperature can be observed (Table 4.6 
and Figure 4.15). 
 𝐾𝐼𝐸 = 𝑘!𝑘!  
 
Equation 4.1: Primary substrate KIE is calculated as the ratio between the rate constant with NADPH 
and the rate constant of NADPD. 
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Figure 4.15: Temperature dependency of the primary KIE for SeDHFR at pH 7.0. 
 
Table 4.6: Temperature dependency of hydride and deuteride transfer in SeDHFR 
and the resulting KIE at pH 7.0. 
Temperature (°C) kH kD KIE 
40 242.3 ± 13.4 109.34 ± 14.8 2.22 ± 0.02 
35 187.2 ± 4.7 99.9 ± 1.5 1.87 ± 0.08 
30 140.8 ± 3.7 65.6 ± 0.6 2.15 ± 0.07 
25 93.8 ± 1.2 39.8 ± 0.3 2.35 ± 0.02 
20 57.0 ± 0.6 22.4 ± 0.2 2.55 ± 0.01 
15 36.0 ± 0.1 15.3 ± 0.2 2.36 ± 0.02 
10 25.5 ± 0.1 12.2 ± 0.1 2.09 ± 0.05 
5 19.2 ± 0.1 8.0 ± 0.6 2.40 ± 0.06 
 
Primary KIEs have been measured for a number of DHFR variants. Interestingly the 
primary KIE in EcDHFR is independent of temperature at pH 9.0 where the chemical 
step becomes rate determining and therefore less influenced by other events that would 
increase kinetic complexity.32 At pH 7.0, however the primary KIE was determined to 
be temperature dependant; at 5 °C the primary KIE is 3.0 ± 0.2 and decreases to 2.2 ± 
0.2 at a temperature of 40 °C (Figure 4.16). This change in temperature dependency 
suggests different dynamics are at play at elevated pH values.126 At pH 7.0 the ratio of 
the Arrhenius pre-factors (AH/AD) for the EcDHFR catalysed reaction was measured to 
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be 0.12 ± 0.02, which is significantly lower than the semi-classical lower limit of 
0.71.34,126,176 It was concluded that tunnelling is therefore involved in the hydride 
transfer step and computational experiments concluded that the contribution from 
tunnelling effectively lowers the activation energy (Ea) of the reaction catalysed by 
EcDHFR.29,110,126,177  
 
 
Figure 4.16: Temperature dependency of the primary KIE for SeDHFR (red diamond), EcDHFR (blue 
square), MpDHFR (green triangle) and TmDHFR (black square) at pH 7.0. 
 
Like EcDHFR, the reaction catalysed by SeDHFR exhibits an Arrhenius pre-factor ratio 
(AH/AD) of 0.12 ± 0.02 for the primary KIE, which is also under the semi-classical limit 
of 0.71.176 SeDHFR also exhibits similar EaH/D values to EcDHFR and the ΔEa between 
the NADPH and NADPD catalysed reactions is very similar (ΔEa for EcDHFR = 7.60 ± 
0.92 kJ mol-1 and ΔEa for SeDHFR = 7.88 kJ mol-1). It therefore seems fair to apply 
similar conclusions about the influence of tunnelling on the reaction catalysed by 
EcDHFR to the reaction catalysed by SeDHFR.  
 
The role of fast protein motions, which occur on a femto-picosecond timescale and how 
they influence the chemical step of catalysis, is still hotly debated. A number of models 
that address the role of such motions have been proposed over the past two 
decades.43,178–181 Work by Klinman and co-workers proposes that such fast dynamics 
can increase the tunnelling probability via regulation of the potential energy barrier.179 
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DHFR has previously been reported to harbour such fast dynamics and compress the 
potential energy barrier, increasing the likelihood of tunnelling.182  
 
TmDHFR is currently the only known DHFR that forms a dimeric structure.89 
Interestingly below ~25 °C the primary KIE is strongly dependent on temperature, 
above ~25 °C the primary KIE shows no such strong dependancy.90 Such a breakpoint 
in temperature dependency of the KIE is also observed in a thermophilic alcohol 
dehydrogenase.30 It is considered that above the breakpoint, where the KIE is 
independent of temperature, the enzyme adopts an active site structure that helps 
facilitate hydride transfer. At lower temperatures the enzyme was postulated to 
increasingly rely on fast dynamics, which compress the potential energy barrier.183 For 
the monomeric DHFRs, EcDHFR and MpDHFR, the primary KIE becomes 
independent of temperature at elevated pH values, similar to the kinetics obtained for 
TmDHFR above 25 °C at pH 7.0.90 It has been postulated that under such conditions all 
three DHFR variants rely on the enzyme adopting a reaction ready configuration before 
the chemical step.126 
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Table 4.7: Temperature dependency of the primary KIE for hydride and deuteride 
transfer at pH 7.0 for SeDHFR, MpDHFR, EcDHFR and TmDHFR at pH 7.0. 
Temperature 
(°C) 
SeDHFR 
kH/ kD KIE 
EcDHFR[a] 
kH/ kD KIE 
MpDHFR[b] 
kH/ kD KIE 
TmDHFR[c] 
kH/ kD KIE 
5 2.40 ± 0.06 3.04 ± 0.22 2.25 ± 0.13 N/A 
6 N/A N/A N/A 6.67 ± 0.25 
10 2.09 ± 0.05 3.12 ± 0.32 2.08 ± 0.17 N/A 
11 N/A N/A N/A 6.19 ± 0.71 
15 2.36 ± 0.02 3.03 ± 0.28 1.96 ± 0.13 N/A 
16 N/A N/A N/A 5.44 ± 0.36 
20 2.55 ± 0.01 2.65 ± 0.22 1.91 ± 0.13 4.52 ± 0.20 
25 2.35 ± 0.02 2.71 ± 0.22 1.83 ± 0.10 4.02 ± 0.29 
30 2.15 ± 0.07 2.39 ± 0.16 1.76 ± 0.11 4.03 ± 0.16 
35 1.87 ± 0.08 2.29 ± 0.11 N/A 4.16 ± 0.26 
40 2.22 ± 0.02 N/A N/A 4.21 ± 0.27 
45 N/A N/A N/A 4.15 ± 0.12 
50 N/A N/A N/A 3.80 ± 0.23 
55 N/A N/A N/A 3.73 ± 0.24 
60 N/A N/A N/A 3.73 ± 0.26 
65 N/A N/A N/A 3.69 ± 0.29 
[a] data from ref.93 [b] data from ref.170 [c] data from ref.93 
 
Table 4.8: Activation energies (Ea) for the single turnover rate catalysed by SeDHFR 
and other reported DHFR variants. 
Enzyme EaH (kJ mol-1) EaD (kJ mol-1) ΔEa (kJ mol-1) 
SeDHFR 32.33 40.21 7.88 
EcDHFR[a] 29.42 ± 0.71 37.02 ± 0.58 7.60 ± 0.92 
MpDHFR[b] 21.55 ± 2.18 28.11 ± 2.55 6.56 ± 3.35 
TmDHFR(<25°C)[c] 49.95 ± 1.68  69.28 ± 3.69 19.32 ± 4.05 
TmDHFR(>25°C)[c] 53.55 ± 0.44 56.03 ± 0.84 2.49 ± 0.95 
[a] data from ref.93 [b] data from ref.170 [c] data from ref.93 
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Table 4.9: Arrhenius pre-factors (AH/D) for the single turnover rate catalysed by 
SeDHFR and other reported DHFR variants. 
Enzyme AH (s-1) AD (s-1) AH/ AD 
SeDHFR (3.29 ± 0.17) x 107 (3.27 ± 0.05) x 108 0.10 ± 0.08 
EcDHFR[a] (2.82 ± 0.05) x 107 (2.34 ± 0.03) x 108 0.12 ± 0.02 
MpDHFR[b] (3.17 ± 0.19) x 106 (2.44 ± 0.15) x 107 0.13 ± 0.09 
TmDHFR(<25°C)[c] (94.7 ± 0.36) x 107 (5.65 ± 0.35) x 1010 0.002 ± 0.001 
TmDHFR(>25°C)[c] (4.11 ± 0.03) x 107 (2.67 ± 0.04) x 108 1.54 ± 0.36 
[a] data from ref.93 [b] data from ref.170 [c] data from ref.93 
 
4.9 Enzyme KIE and Dynamics in SeDHFR 	
Heavy isotope labelling of enzymes has recently been employed as a tool to probe the 
relationship between fast dynamics and catalysis in enzymes.48,49,79,117,119,120 Heavy 
isotope labelling alters the vibrational properties of bonds, and protein motions on a 
multitude of timescales are affected, however, it is considered that the electrostatics 
remain largely unaffected.48,49 Enzyme KIEs are calculated using Equation 4.2. 
 𝑒𝑛𝑧𝑦𝑚𝑒 𝐾𝐼𝐸 = 𝑘!"𝑘!" 
 
Equation 4.2: The KIE is calculated as a ratio between the rate constants of the light (kLE) and heavy 
(kHE) enzymes. 
 
By measuring the rate of hydride transfer via stopped flow, the effect of heavy isotope 
labelling on the chemical step of catalysis in SeDHFR has been characterised. Hydride 
transfer was measured over a range of 5 to 40 °C for both natural abundance (light) and 
heavy SeDHFR (Figure 4.17 and Table 4.10). Between 5 and 35 °C the rate for 
hydride transfer increases exponentially for both natural abundance and heavy labelled 
SeDHFR. For natural abundance SeDHFR kH ranges from 28.0 ± 0.3 s-1 to 216.1 ± 17.2 
s-1 over the measured temperature range and for heavy SeDHFR kH ranges from 28.7 ± 
0.6 s-1 to 197.5 ± 12.0 s-1. The resulting enzyme KIE exhibited no significant 
temperature dependence increasing from 0.96 ± 0.01 at 5 °C to 0.99 ± 0.04 at 35 °C 
(Figure 4.19 and Table 4.11). This indicates that heavy isotope labelling of SeDHFR 
has no significant influence on the hydride transfer step of catalysis. 
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The effect of heavy isotope labelling was also measured on the rate of steady state 
turnover at pH 7.0 at 20 °C. Under these conditions the measured enzyme KIE on kcat 
was 1.06 ± 0.08, which is similar to the value reported for EcDHFR under similar 
conditions (kcatLE/ kcatHE = 1.04 ± 0.03). The enzyme KIE measured for EcDHFR 
increases from 1.01 ± 0.04 at 10 °C to 1.15 ± 0.02 at 40 °C. It is considered this 
temperature dependency of the enzyme KIE is a result of the conformational behaviour 
EcDHFR utilises for product release.79 On the other hand, the mutant EcDHFR-
N23PP/S148A which is considered to be conformationally restricted, exhibits an 
enzyme KIE of unity across the measured temperature range.119 It is therefore likely that 
the small enzyme KIE observed in SeDHFR is a result of conformational behaviour like 
that witnessed in EcDHFR. 		
	
Figure 4.17: Temperature dependence of the rate constant for hydride transfer in light SeDHFR (blue 
triangles) and heavy SeDHFR (red squares) at pH 7.0. 
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Figure 4.18: Arrhenius plots of hydride transfer in light SeDHFR (blue diamonds) and heavy SeDHFR 
(red diamonds) at pH 7.0. 
 
 
Figure 4.19: Temperature dependency of the enzyme KIE (kLE/kHE) at pH 7.0. 
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Table 4.10: Temperature dependence on the rate of hydride transfer in both light and 
heavy SeDHFR at pH 7.0. 
Temperature 
(°C) 
Light SeDHFR 
kH (s-1)  
Heavy SeDHFR 
kH (s-1) 
40 216.1 ± 17.2 197.5 ± 12.0 
35 176.1 ± 26.2 177.4 ± 26.5 
30 139.5 ± 3.1 142.9 ± 7.3 
25 92.7 ± 5.1 92.6 ± 5.3 
20 58.9 ± 0.8 59.1 ± 0.7 
15 39.8 ± 0.3 40.6 ± 0.4 
10 28.4 ± 0.3 28.7 ± 0.6 
5 21.0 ± 0.4 21.8 ± 0.2 
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Table 4.11: Temperature dependence of the enzyme KIE (kLE/kHE) in the DHFR 
variants SeDHFR, EcDHFR, MpDHFR, TmDHFR and BsDHFR at pH 7.0. 
Temperature 
(°C) 
SeDHFR 
KIE 
EcDHFR 
KIE[a] 
MpDHFR 
KIE[b] 
TmDHFR 
KIE[c] 
BsDHFR 
KIE[d] 
65 N/A N/A N/A 1.01 ± 0.01 N/A 
60 N/A N/A N/A 1.03 ± 0.01 N/A 
55 N/A N/A N/A 0.99 ± 0.01 N/A 
50 N/A N/A N/A 1.00 ± 0.01 N/A 
45 N/A N/A N/A 1.00 ± 0.01 1.10 ± 0.07  
40 1.09 ± 0.01 1.18 ± 0.09 N/A 0.99 ± 0.01 0.99 ± 0.05 
35 0.99 ± 0.04 1.07 ± 0.07 N/A 1.02 ± 0.01 1.10 ± 0.03 
30 0.98 ± 0.01 1.10 ± 0.04 1.46 ± 0.06 1.01 ± 0.01 1.11 ± 0.02 
25 1.00 ± 0.01 1.10 ± 0.03 1.42 ± 0.05 1.01 ± 0.01 1.21 ± 0.03 
20 1.00 ± 0.01 0.92 ± 0.04 1.26 ± 0.07 1.00 ± 0.01 1.26 ± 0.03 
15 0.98 ± 0.01 0.91 ± 0.03 1.09 ± 0.07 0.98 ± 0.01 1.25 ± 0.03 
10 0.99 ± 0.01 0.93 ± 0.01 1.05 ± 0.07 0.99 ± 0.01 1.30 ± 0.01 
5 0.96 ± 0.01 0.92 ± 0.04 1.11 ± 0.05 0.99 ± 0.01 1.24 ± 0.04 
[a] data taken from ref.79 [b] data taken from ref.47 [c] data taken from ref.121 		
Experiments that utilise isotopically labelled co-factors to yield a primary KIE, such as 
those described in the previous section have been used as evidence for the presence of 
tunnelling in enzymatic reactions. Such experiments have also been used as evidence to 
postulate fast dynamics on the femto–picosecond timescale manipulate the properties of 
the potential energy barrier to increase the tunnelling probability.178,180,181,184,185 In the 
past decade protein isotope labelling has been utilised as a probe to directly study the 
influence of protein dynamics.47,53,79,120,121  
 
Enzyme KIEs have been studied in a range of DHFR variants.53,79,120 Enzyme KIE in 
EcDHFR showed an increase from 0.92 ± 0.04 at 5 °C to 1.18 ± 0.09 at 40 °C, therefore 
showing a small temperature dependency (Figure 4.20).79 Computational simulations 
identified no significant change in the tunnelling probability for the heavy enzyme.79 
Small differences between the rate constants of the light and heavy enzyme are 
proposed to be a result of the heavier isotopologue being less responsive to fluctuations 
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in the environment. It has been proposed that the influence of any promoting motions in 
the reaction catalysed by EcDHFR would not have any significant impact on the overall 
rate of hydride transfer. In fact, it has been postulated that dynamic coupling to the 
reaction coordinate may be to blame for the heavier enzyme having a slower rate at 
lower temperatures compared to physiological temperatures. Allemann and co-workers 
therefore proposed protein-promoting motions, which actively decrease the width of the 
potential energy barrier do not play a significant role in catalysis by EcDHFR.79 
 
 
 
Figure 4.20: Temperature dependency of the enzyme KIE in a number of DHFR variants. SeDHFR (red 
diamond), EcDHFR (blue square), TmDHFR (black square), MpDHFR (green triangle) and BsDHFR 
(orange square) at pH 7.0. 
 
It has been shown that the EcDHFR-N23PP/S148A mutant no longer adopts the 
occluded conformation following the chemical step of catalysis and has a diminished 
rate constant for hydride transfer. Consequently it was also proposed that the mutated 
residues partook in long range promoting protein motions.98 Subsequent computational 
work proposed the reduction in the rate of kH was a result of diminished electrostatic 
pre-organisation.186 In terms of enzyme KIE the mutant exhibited a larger KIE  (1.37 ± 
0.03) than the wild type enzyme (1.10 ± 0.04).119 Computational experiments propose 
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that although motion is restricted on the µs-ms timescale there is increased motion on 
the pico-femto second timescale. It has therefore been proposed that increased 
dynamical coupling of fast protein motions to the reaction coordinate has a deleterious 
effect on the rate of hydride transfer.119  
 
TmDHFR is the only known dimeric DHFR. The structural loops, which in EcDHFR 
are mobile, are instead locked into the dimer interface and catalysis has to proceed 
through a fixed open conformation.83,88,89 TmDHFR exhibits drastically lower rate 
constants for both hydride transfer (kH) and catalytic turnover (kcat) than EcDHFR.88–90 
At pH 7.0 no significant difference in the rate of hydride transfer could be observed 
between light and heavy TmDHFR and a KIE of ~1 was yielded across the measured 
temperature range (5 – 65 °C) (Table 4.11 and Figure 4.20). The lack of any significant 
KIE gives strong evidence that protein dynamics do not couple to the reaction 
coordinate in TmDHFR.121 The inability to switch from an open conformation to a 
closed conformation following ligand binding means TmDHFR is unable to exclude 
solvent molecules from the active site like EcDHFR and this in turn prevents optimal 
electrostatic preorganisation.121 
 
BsDHFR is a thermophilic DHFR with a physiological temperature of ~60 °C and 
exhibits similar catalytic properties to EcDHFR.187,188 BsDHFR exhibits significant 
enzyme KIE at low temperatures (1.24 ± 0.04 at 5 °C) that decreases to unity as the 
temperature increases towards its physiological temperature (0.99 ± 0.05 at 40 °C). 
BsDHFR therefore exhibits much larger KIE values than EcDHFR. It has been 
proposed that the increased flexibility of BsDHFR leads to increased effects from 
protein motions.188 Computational simulations comparing RMSD values of the Cα 
confirmed BsDHFR is more flexible than EcDHFR on a pico-nanosecond timescale. 
The drastically increased enzyme KIE at low temperatures was therefore postulated to 
be a result of the increased mass of the heavy enzyme having an effect on the re-
crossing coefficient. In summary, it was postulated at lower temperatures light BsDHFR 
is better able to adopt a reaction ready conformation.188  
 
Reports on the enzyme KIE for MpDHFR showed an interesting temperature 
dependency. At 5 °C the KIE was 1.09 ± 0.04 which rose to 1.47 ± 0.04 at 30 °C. It was 
postulated that with rising temperature MpDHFR becomes more flexible and dynamic 
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coupling to the chemical coordinate means mass induced effects from the heavy isotope 
labelling have a deleterious effect on the re-crossing coefficient. Together with evidence 
from previously reported work it was proposed at close to physiological temperatures, 
effects from dynamic coupling to the chemical coordinate are minimised, resulting in 
Enzyme KIE that are close to unity.47  
 
SeDHFR exhibited an enzyme KIE that was close to unity at all measured temperatures, 
similar to the temperature dependency obtained for TmDHFR.121 This may mean that 
like TmDHFR, SeDHFR is more rigid than EcDHFR on a pico-nanosecond time 
domain which means mass induced effects on the re-crossing coefficient have less of an 
effect and thus no significant enzyme KIE is produced. 	
4.10 Summary and conclusions 	
In this chapter the recombinant overproduction and purification of SeDHFR has been 
detailed. Studying SeDHFR was of particular interest as it is from a mesophillic 
bacterium like EcDHFR and work described in the previous chapter indicated SeDHFR 
is likely to adopt an occluded conformation following the chemical step like EcDHFR.  
 
The occluded conformation in EcDHFR is believed to mitigate product inhibition 
effects. EcDHFR has an IC50 value for NADP+ almost ~5 fold higher than that observed 
for MpDHFR. Mutants which perturb the ability to adopt an occluded conformation in 
EcDHFR drastically lower the IC50 value for NADP+. SeDHFR exhibits an IC50 value 
for NADP+ almost ~2.5 time larger than EcDHFR and as such is not susceptible to 
product inhibition.76 This is likely the result of the enzyme adopting an occluded 
conformation following the chemical step, evidence for which was presented in the 
previous chapter.  
 
The steady state rate (kcat) for SeDHFR was measured to be 8 .6 ± 0.3 s-1 at 20 °C at pH 
7.0, slightly lower than the value measured for EcDHFR (12.6 ± 1.4 s-1) under the same 
pH and temperature. The steady-state rate (kcat) for SeDHFR was found to be greatest at 
a pH of 7.5 with a recorded value of 12.05 ± 0.08 s-1. Similar to MpDHFR and 
BsDHFR, SeDHFR also exhibits a bell shaped pH dependency of the steady state rate 
constant. EcDHFR and TmDHFR both have pH dependencies that are sigmoidal in 
nature, with no significant drop in steady state turnover at low pH values. The cause of 
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MpDHFR having lower rate constants at low pH values is still under discussion, 
however it has been postulated that a change in the steady-state rate limiting step at low 
pH values is likely the cause.76   
 
The primary KIE (kH/kD) in SeDHFR exhibits a similar trend to that observed for 
EcDHFR, producing near identical Arrhenius pre-factor ratios and similar activation 
energies.  
 
SeDHFR labelled with 13C and 15N was produced in order to measure the enzyme KIE. 
No significant differences were observed in CD spectra between the light and heavy 
enzyme, indicating labelling does not have a significant effect on stability or structure. 
The enzyme KIE was measured to be ~1 across the measured temperature range. This is 
in contrast to EcDHFR which exhibits a temperature dependant enzyme KIE that 
increases from 0.92 ± 0.04 at 7 °C to 1.18 ± 0.09 at 40 °C.79 TmDHFR, which is known 
to be conformationally restricted, exhibits a enzyme KIE that appears to be independent 
of temperature, maintaining a value of ~1 across the measured temperature range. It has 
been proposed this is evidence of a lack of dynamic coupling to the chemical step of 
catalysis in TmDHFR.121 SeDHFR also exhibits an enzyme KIE of ~1 across the 
measured temperature range and it is therefore likely dynamic coupling to the chemical 
step is minimised.   
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5.1 Introduction 
 
A number of DHFR variants have been studied with respect to the influence of fast 
dynamics coupling to the chemical step of catalysis.47,79,119–121 Over the past decade, 
enzyme KIEs have been utilised to explore the influence of fast protein dynamics on the 
chemical step of catalysis in DHFR. Evidence is growing that at close to physiological 
conditions, the coupling of dynamics to the chemical step of catalysis in DHFR is 
minimised. In fact such coupling of dynamics to the chemical step could actually be 
detrimental to catalysis.45,47,189,190 It is therefore of great interest to expand the study of 
the role of fast dynamics to other enzyme systems and examine whether the dynamic 
behaviour observed in DHFR is ubiquitous or scarce.  
 
Lactate dehydrogenase, like DHFR, catalyses a hydride transfer reaction from NADH 
and can be easily monitored by NADH absorbance at 340 nm. Furthermore, similar to 
what was proposed for DHFR, a network of residues that actively promote catalysis has 
been proposed to exist in human heart lactate dehydrogenase (HsLDH).161,191 This 
makes LDH an attractive enzyme for studying dynamic coupling to the chemical step of 
catalysis. 
 
5.2 Lactate dehydrogenase biochemistry 	
Through the glycolysis pathway, glucose is ultimately catabolised into 2 units of 
pyruvate in a process that yields 2 ATP and 2 NADH. Under aerobic conditions 
pyruvate is converted to acetyl-CoA and enters the citric acid (Krebs) cycle to yield 
more NADH and FADH2. These are regenerated in the electron transport chain (ECT), 
generating more units of ATP. However, under anaerobic conditions the ECT cannot 
operate so the cell requires an alternative method to regenerate NAD+. Lactate 
dehydrogenase (LDH) is ubiquitous to life and catalyses hydride transfer from the pro- 
R NADH to the C2 position of pyruvate (Figure 5.1), thereby regenerating NAD+ 
without the need for oxygen.9 Most LDH enzymes utilise a histidine residue in the 
active site as a proton donor, mutation of which results in enzyme inhibition.192 LDH is 
also able to catalyse the reverse reaction, although the equilibrium lies strongly in 
favour of the reduction of pyruvate. At high concentrations of lactate, LDH is 
susceptible to feedback inhibition and a decrease in the rate constant is observed. In 
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mammals, the liver takes up excess lactate where LDH converts it back to pyruvate as 
part of the Cori cycle.9  
 
  
Figure 5.1: Reaction catalysed by LDH. Pyruvate is reduced to L-lactate using NADH as a cofactor. 
 
Most LDH enzymes exist as either a homotetramer or a heterotetramer made up of 
different isoforms of LDH.193 Enzyme isoforms have different amino acid sequences 
but catalyse the same reaction with different kinetic properties.4 Three LDH isoforms 
are found to be present in humans; LDHA, LDHB and LDHC.194 LDHA favours the 
conversion of pyruvate to lactate and is commonly found in skeletal muscle, LDHB 
favours the reverse reaction and is found in aerobic tissue.195–197 LDHC is utilised by 
germ cells to produce energy during spermatogenesis and is consequently solely 
expressed in the testis.198,199 
 
5.3 Lactate dehydrogenase physical chemistry 
 
LDH from Bacillus stearothermophilus (BsLDH), exhibits two major structural 
conformations (open and closed) during the catalytic cycle as defined by the position of 
a key flexible loop (residues 99-110). The catalytic cycle for BsLDH has been proposed 
to go through a number of intermediates (Figure 5.2). BsLDH first binds NADH (NH) 
and pyruvate (Pyr) to form the ternary complex E:NADH:pyruvate before transitioning 
to a closed conformation in which the chemical step occurs. Conformational change 
precedes product release from the E:NAD+:lactate product complex.200 Loop closure has 
been proposed to be important for efficient catalysis as it excludes the active site from 
bulk solvent and brings a highly conserved arginine residue into contact with the 
carbonyl group of pyruvate, which has been proposed to stabilise the transition 
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state.201,202 Loop closure in BsLDH, which is required to activate the reaction was found 
to be the rate limiting step.202 
 
 
 
Figure 5.2: The proposed catalytic cycle of BsLDH (NH = NADH, Pyr = pyruvate, N+ = NAD+ and Lac 
= Lactate). A blue circle indicates the open conformation and a red circle indicates the closed 
conformation. 
 
A Recent computational study, however, has provided evidence that rabbit muscle LDH 
is able to catalyse the chemical step in an open conformation. According to calculations 
the free energy barrier for the reduction of pyruvate is approximately 2 kcal/ mol lower 
in the open conformation than in the closed conformation in this LDH variant. It was 
postulated that the closure of the flexible loop in rabbit muscle LDH is more crucial for 
catalysing the reverse reaction. It has further been hypothesized human heart LDH is 
more likely able to facilitate closure of the active site loop than skeletal muscle LDH 
due the relative positions of the reaction equilibriums.203 
 
The Schwartz group have presented evidence of a promoting vibration in human heart 
LDH.204 Through computational simulations, motions of a number of residues spread 
along a linear axis (Val31, Arg106, Gly32, Met33, Leu65 and Gln66) were proposed to 
couple to the reaction coordinate on a femtosecond timescale (Figure 5.3). It is thought 
that these residues act as a compressive force and move the pro-R hydride of NADH 
closer to the C2 carbon of pyruvate. It has been proposed such motions would diminish 
the activation barrier and further facilitate hydride transfer.204 
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Figure 5.3: Cartoon representation of Human heart LDH (1IOZ).205 The residues reported to be part of 
the promoting protein network are highlighted in blue and are Gln66, Leu65, Met33, Gly32, Val31 and 
Arg106 from left to right respectfully. NADH and oxamate are highlighted in red and green 
respectfully.206  
 
Recently Schramm and co-workers have expressed triply labelled (2H,13C and 15N) 
human heart LDH (HsLDH) and recorded the  enzyme KIE. As observed with DHFR 
systems, the heavy labelled HsLDH enzyme exhibited a slower hydride transfer rate 
constant than the natural abundance enzyme. It has been claimed this is evidence of fast 
dynamics acting upon the chemical step of catalysis in HsLDH to promote hydride 
transfer.163 Interestingly though, the enzyme KIE tends to unity as the pH nears 
physiological conditions (Figure 5.4). Such trends have also been observed in DHFR 
and it has been concluded that effects of dynamic coupling to the chemical step are 
minimised under physiological conditions.47  
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Figure 5.4: Enzyme KIE of human heart LDH against temperature. Data from reference.163 
 
The aim of this chapter is to further investigate the role of dynamic coupling in the 
chemical step of catalysis in lactate dehydrogenase (LDH). 
 
5.4 Lactate Dehydrogenase from Staphylococcus aureus 
 
One of the main goals of this chapter was to explore the influence of dynamic coupling 
upon the chemical step of catalysis, like the work done with DHFR enzymes.53 It has 
previously been found however that LDH enzymes exhibit hydride transfer rates that 
are too fast to be studied via the available stopped flow methodologies, making it 
difficult to measure effects acting upon the chemical step.207 Initial reports have stated 
that Staphylococcus aureus LDH (SaLDH) exhibits a kcat of 1.69 ± 0.03 min-1, 
significantly lower than steady state rates reported for other LDH enzymes.163,207,208 
Although the chemical step may be many orders of magnitude faster than the steady 
state rate, it was considered that SaLDH represented a good candidate for study, 
allowing for the study of the chemical step of catalysis in an LDH enzyme.  
 
Staphylococcus aureus expresses multiple isoforms of lactate dehydrogenase, called 
LDH-1 and LDH-2.209 The later is a constitutive LDH while LDH-1 is only produced 
under nitric oxide (NO) stress and has been shown to be important for virulence, 
making it a potential drug target.210 NO inhibits the respiratory chain, leading to a build 
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up of NADH. LDH-1 resets the redox balance by regenerating NAD+. In this thesis, L-
lactate dehydrogenase-1 (SaLDH) has been selected for study. 
 
SaLDH has 37 % sequence identity with human heart LDH (HsLDH), 42 % sequence 
identity to rabbit muscle LDH and 65 % sequence identity to LDH from Bacillus 
stearothermophilus (BsLDH). Like other LDH’s, SaLDH has a histidine residue 
(His179) in the active site that likely protonates the carbonyl of pyruvate.163 The crystal 
structure has been solved by x-ray crystallography.211 As with other LDH’s, pyruvate is 
bound deep within the active site (~10 Å) and NADH is held within a Rossmann 
binding fold. SaLDH, like many other LDH’s, exists as a tetramer (Figure 5.5).192,211,212  
 
 
 
Figure 5.5: Cartoon representation of a single monomer of SaLDH (3D4P)211 complexed with NAD+ 
(dark green) and pyruvate (light green).  Structural elements such as coils (cyan), helix’s (orange) and 
beta sheets (purple) are also highlighted, as well as the catalytically important His179 (red) residue. 
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5.5 Expression and purification of LDH from Staphylococcus aureus 	
The gene sequence for Lactate Dehydrogenase from Staphylococcus aureus was 
accessed from the American Type Culture Collection (ATCC) (ATCC®12600™) 
(UniProt I.D. H6UH59_STAAU) and a synthetic gene was ordered from Epoch Life 
Science in a pET-15b vector between Nde1 and BamH1 cloning sites. The gene was 
codon optimised for E.coli expression and a poly histidine (6*) tag and a Tobacco Etch 
Virus endopeptidase (TEV) cleavage site were encoded upstream for simplified 
purification of the corresponding protein. The vector was transformed into One Shot™ 
BL21 Star™ (DE3) chemically competent E.coli cells. An overnight colony was 
prepared in 10 mL LB media with selection antibiotic (ampicillin) and grown at 37 °C 
for 16 hours. This colony was used to inoculate 1000 mL of either LB or M9 media 
depending on whether isotope labelling was required. The cells were grown at 37 °C to 
O.D.600 0.6 at which point gene expression was induced with IPTG and the cells left to 
incubate at 20 °C for a further 16 hours.  
 
As recombinant SaLDH contained a poly histidine tag it was purified via Ni2+ nickel 
affinity chromatography. Pelleted cells were lysed via sonication in 50 mM potassium 
phosphate buffer at pH 8.0 containing 100 mM of NaCl and 20 mM of imidazole. The 
cell suspension was clarified via centrifuge and the supernatant loaded onto a pre-
equilibrated Ni2+ nickel affinity column. The column was washed with 50 mM 
potassium phosphate buffer at pH 8.0 containing 100 mM of NaCl and 100 mM of 
imidazole. SaLDH was eluted from the column in 50 mM potassium phosphate buffer at 
pH 8.0 containing 100 mM of NaCl and 250 mM of imidazole. Fractions containing 
SaLDH were incubated at 4 °C with TEV protease overnight, before being sequentially 
dialysed into 50 mM potassium phosphate buffer at pH 8.0 containing 100 mM of NaCl 
and 20 mM of imidazole. Again, the protein was loaded onto a pre-equilibrated Ni2+ 
nickel affinity column. SaLDH was eluted with the wash buffer, 50 mM potassium 
phosphate buffer at pH 8.0 containing 100 mM of NaCl and 20 mM of imidazole, TEV 
protease remaining bound to the column. The quality of purified enzyme was evaluated 
through SDS-PAGE (Figure 5.6). The monomer of SaLDH was calculated to have a 
molecular mass of 34583.46 from the primary sequence that aligns with the single 
purified bands in lanes 2 to 5. 
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Figure 5.6: SDS-PAGE of SaLDH purification. L = lysate, F = flow through and W = wash. Fraction 1 
was discarded; fractions 2-6 were combined for further use. 
 
5.6 Pre-steady state measurements  	
Similar to experiments described for DHFR, characterisation of the chemical step in 
SaLDH was attempted using the stopped-flow methodologies described in section 
2.3.14. As described in chapter 4, when measuring hydride transfer in DHFR, energy 
transfer (FRET) between Trp22 in the active site and the nicotinamide ring of NADPH 
allows the reaction to be monitored via FRET with an emission cut-off of 400 nm. Due 
to the lack of such a residue in the active site of SaLDH a decrease in absorbance at 340 
nm, corresponding to the chromophore of NADH was instead monitored. 
 
It has previously been noted in our group that single turnover rates for LDH can be very 
high: dogfish (Squalus acanthias) LDH exhibits a kH of >2000 s-1 at 5 °C.207 Most 
stopped flow instruments can only reliably measure rates of up to 600-800 s-1. Although 
continuous flow apparatus can measure faster rates, cost can become inhibitive when 
working with isotopically labelled enzymes. L-LDH from Staphylococcus aureus 
(SaLDH) was selected for this study as a previous report had noted a kcat of 
approximately 1.5 min-1 at 20 °C, which is exceptionally low for LDH enzymes and as 
such it was hoped the single turnover rate would be low enough to measure using our 
stopped flow equipment.208 Initial measurements however indicated hydride transfer in 
SaLDH is too fast to be studied via stopped flow methodologies.  
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In order to slow down the hydride transfer step and allow observations on the rate 
constant to be made, it was deemed necessary to use additives, even though these move 
a system away from physiological conditions. Firstly, 30 % methanol was added to the 
buffer system to allow rates at temperatures below 0 °C to be measured as these will be 
significantly slower. To ensure the addition of methanol was not impacting the 
properties of the enzyme the kcat was measured after 30 minutes incubation with 30 % 
methanol. No significant drop in the rate of kcat was observed after this incubation time, 
indicating that the addition of methanol does not impact either the stability or function 
of the enzyme on a timescale associated with the planned experiment. However, even 
pre-steady state measurements recorded at -25 °C produced no valuable data from 
which a rate constant could be derived. 
 
Another attempt to sufficiently slow the rate constant was to adjust the pH to 9 as this 
has previously been shown to reduce the single turnover rate in LDH variants.163 10 % 
glycerol was also added to buffers as this is known to increase the viscosity of the 
solution, slowing enzyme mobility.213 Even combinations of all three changes did not 
lower the single turnover rate to a measurable value. Further additives would only move 
the system further away from physiological conditions, making any results gained hard 
to draw worthwhile conclusions from.  
 
It has therefore been concluded that the single turnover rate in SaLDH is too fast to 
measure using our stopped flow instrument. Faster methods are therefore required to 
study this enzyme such as continuous flow spectroscopy or laser flash photolysis.  
 
5.7 pH dependency of steady state kinetics in SaLDH 	
The pH dependency of the reaction was measured in order to investigate steady state 
enzyme KIE at different pH values where different events in the catalytic cycle become 
rate limiting depending on the pH value. The steady state rate of the reaction catalysed 
by SaLDH was monitored in much the same way as DHFR, a decrease in absorbance at 
340 nm, due to depletion of NADH, was monitored over a period of 60 seconds. The 
previously reported value of kcat for SaLDH was 1.69 ± 0.03 at 20 °C for the reduction 
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of pyruvate and 1.75 ± 0.03 at 20 °C for reverse reaction. However these measurements 
were performed on impure enzyme samples and consequently are estimates.208  
 
The pH dependency of the steady state reaction was almost sigmoidal in nature. A 
maximum rate of 768 ± 9.8 s-1 was observed at a pH of 6.5 and a minimum of 162 ± 5 s-
1 at pH 9.5. At a pH of 5.5 the rate only dropped to 730 ± 6 s-1 (Figure 5.7 and Table 
5.1). In BsLDH the rate limiting step is attributed to motion of the active site loop at a 
pH of 7.0.200 The decrease in rate at high pH values in SaLDH is likely a consequence 
of a lack of protons in solution, diminishing the enzymes ability to efficiently protonate 
the carbonyl group of pyruvate. 
 
The pH dependency of the reaction catalysed with NADD was also measured over the 
same pH range to yield a primary KIE. As the reaction catalysed with NADD instead of 
NADH should have a minimal impact on conformational behaviour and ligand-binding 
effects, obtained primary KIE values will largely report on the chemical step. The pH 
dependency of the primary KIE exhibited a slight downward trend with a maximum 
value of 1.98 ± 0.01 at pH 5.5 decreasing to 1.45 ± 0.13 at pH 9.5 (Figure 5.8 and 
Table 5.2). This indicates that the chemical step in the reaction catalysed by SaLDH is 
partially rate limiting, especially at lower pH values. 
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Figure 5.7: pH dependency on the steady state rate constants for hydride (blue diamond) and deuteride 
(red square) transfer during catalysis by SaLDH at 20 °C. 
 
 
Figure 5.8: pH dependency on the steady state rate primary NADH/D KIE during catalysis by SaLDH at 
20 °C. 
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Table 5.1: pH dependency on the steady state rate constants for hydride (kcatH) and 
deuteride (kcatD) transfer during catalysis by SaLDH at 20 °C. 
pH kcatH s-1 kcatD s-1 
5.5 730 ± 6 369 ± 25 
6.0 749 ± 74 406 ± 42 
6.5 768 ± 9.8 436 ± 32 
7.0 748 ± 34 480 ± 39 
7.5 708 ± 43 438 ± 31 
8.0 650 ± 68 358 ± 69 
8.5 496 ± 21 336 ± 34 
9.0 258 ± 39 145 ± 19 
9.5 162 ± 5 112 ± 49 
 
Table 5.2: pH dependency on the steady state rate primary KIE during catalysis by 
SaLDH at 20 °C. 
pH KIE 
5.5 2.0 ± 0.1 
6.0 1.9 ± 0.1 
6.5 1.8 ± 0.1 
7.0 1.6 ± 0.1 
7.5 1.6 ± 0.2 
8.0 1.8 ± 0.1 
8.5 1.5 ± 0.1 
9.0 1.8 ± 0.2 
9.5 1.5 ± 0.1 
 
 
5.8 Examination of hydride transfer through steady state kinetics.  
 
In order to study the influence of the chemical step on catalysis in SaLDH it was 
deemed necessary to obtain primary NADH/D KIE measurements. The steady state rate 
constant in the reaction catalysed by SaLDH increased with temperature but did not 
have true Arrhenius behaviour, as observed by a non-linear Arrhenius plot (Figure 
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5.10). At 5 °C the primary KIE is 1.40 and at 30 °C is 1.39, meaning the KIE is largely 
independent of temperature.  
 
 
Figure 5.9: Temperature dependency on the steady state rate constants for hydride (blue diamond) and 
deuteride (red square) transfer during catalysis by SaLDH at pH7.0. 
 
 
Figure 5.10: Temperature dependency on the steady state rate constants for hydride (blue diamond) and 
deuteride (red square) transfer during catalysis by SaLDH at pH 7.0. 
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Figure 5.11: Temperature dependency on the steady state rate primary KIE during catalysis by SaLDH at 
pH 7.0. 
 
Table 5.3: Temperature dependency on the steady state rate constants for hydride (kcatH) 
and deuteride (kcatD) transfer during catalysis by SaLDH at pH 7.0. 
Temperature (°C) kcatH s-1 kcatD s-1 
5 174 ± 19 125 ± 6 
10 279 ± 44 203 ± 11 
15 459 ± 21 348 ± 26 
20 715 ± 39 508 ± 34 
25 871 ± 27 628 ± 8 
30 1089 ± 38 783 ± 41 
35 1411 ± 28.5 926 ± 19 
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Table 5.4: Temperature dependency on the steady state rate primary KIE during 
catalysis by SaLDH at pH 7.0. 
Temperature (°C) KIE 
5 1.40 
10 1.38 
15 1.32 
20 1.41 
25 1.39 
30 1.39 
35 1.52 
 
5.9 pH dependence of the steady state enzyme KIE 
 
13C and 15N labelled SaLDH was prepared in a similar manor to isotopically labelled 
DHFRs.79 Both the temperature (5-35 °C) and pH (5.0-9.5) dependency of the enzyme 
KIE has been measured under steady state conditions. 
 
With respect to pH dependency the KIE decreased from 1.58 at pH 6.0, to a minimum 
of 1.27 at pH 7.5 before increasing again to 1.51 at pH 8.5. From previous experiments 
it is evident that the chemical step is partially rate limiting at pH 7.0 in SaLDH. 
Although a lot of kinetic complexity will exist under steady state conditions at this pH it 
seems reasonable to assign some of the observed KIE to effects from the chemical step. 
Therefore the influence of fast dynamics in catalysis by SaLDH can loosely be 
discussed.  
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Figure 5.12: pH dependency on the steady state rate constants catalysed by light (blue diamond) and 
heavy (red square) SaLDH at 20 °C. 
 
 
 
Figure 5.13: pH dependency on the steady state rate enzyme KIE during catalysis by SaLDH at 20 °C. 
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Table 5.5: pH dependency on the steady state rate constant for natural abundance 
(kcatLE) and heavy enzyme (kcatHE) catalysis by SaLDH at 20 °C. 
pH kcatLE s-1 kcatHE s-1 
5.5 844 552 
6.0 846 534 
6.5 840 600 
7.0 746 562 
7.5 725 572 
8.0 635 471 
8.5 472 312 
9.0 267 204 
 
Table 5.6: pH dependency on the steady state enzyme KIE during catalysis by SaLDH 
at 20 °C. 
pH KIE 
5.5 1.52 
6.0 1.58 
6.5 1.40 
7.0 1.33 
7.5 1.27 
8.0 1.35 
8.5 1.51 
9.0 1.31 
 
In recent work Schramm and co-workers studied the pH dependency of the hydride 
transfer step in the catalysis by human heart LDH. They observed a decrease in enzyme 
KIE from 1.11 at pH 4.3 to 1.04 at pH 5.8. They concluded that the observed KIE was 
evidence of protein promoting vibrations acting on the chemical step.163 However no 
data has been reported for the enzyme KIE at higher pH values so an observation of the 
overall trend cannot be made. Interestingly though as the pH decreases to that of 
physiological conditions the KIE tends to unity. 
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Results from SaLDH show a similar trend, albeit under steady state conditions because 
as stated previously, the rate of hydride transfer in SaLDH could not be measured. The 
observed enzyme KIE is minimal under conditions close to physiological conditions in 
the reaction catalysed by SaLDH and raises as the pH either increases or decreases. This 
coupled with work by Schramm et.al. could be evidence that under physiological 
conditions the effects of dynamics coupling to the chemical step of catalysis in LDH are 
minimised. Multiple reports on DHFR variants show the enzyme KIE tends to unity at 
close to physiological temperatures.79,119–121,164,190   
 
5.10 Temperature dependence of the steady state enzyme KIE 
 
The kcat for the steady state reaction for both light and heavy (13C & 15N) SaLDH was 
measured over a temperature range of 5-35 °C. The enzyme KIE is minimal at 35 °C 
with a value of 1.08 ± 0.05 and increases with a decrease in temperature to a value of 
1.35 ± 0.18 at 5 °C (Figure 5.15 and Table 5.8).  
 
 
Figure 5.14: Temperature dependency on the steady state rate constants catalysed by light (blue 
diamond) and heavy (red square) SaLDH at pH 7.0. 
 
0 
200 
400 
600 
800 
1000 
1200 
1400 
1600 
0 5 10 15 20 25 30 35 40 
k c
at
 s-
1  
	
Temperature (°C ) 
Lactate Dehydrogenase 
 142 
 
Figure 5.15: Temperature dependency on the steady state rate enzyme KIE during catalysis by SaLDH at 
pH 7.0. 
 
Table 5.7: Temperature dependency on the steady state rate constant for natural 
abundance (kcatLE) and heavy enzyme (kcatHE) catalysis by SaLDH at pH 7.0. 
Temperature (°C) kcatLE s-1 kcatHE s-1 
35 1388 ± 44 1281 ± 62 
30 1149 ± 33 997 ± 38 
25 869 ± 36 547 ± 28 
20 760 ± 58 509 ± 88 
15 524 ± 35 303 ± 46 
10 303 ± 38 218 ± 45 
5 237 ± 51 172 ± 32 
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Table 5.8: Temperature dependency on the steady state enzyme KIE during catalysis by 
SaLDH at pH 7.0. 
Temperature (°C) KIE 
35 1.08 ± 0.05 
30 1.15 ± 0.09 
25 1.59 ± 0.18 
20 1.49 ± 0.16 
15 1.73 ± 0.16 
10 1.39 ± 0.24 
5 1.38 ± 0.18 
 
This is in contrast to EcDHFR where the enzyme KIE under steady state conditions 
increases from unity at 10 °C to 1.15 ± 1.15 at 40 °C. This increase in KIE in EcDHFR 
is believed to be a consequence of the conformational behaviour EcDHFR utilises for 
product release.79 The mutant, EcDHFR-N23PP/S148A is conformationally restricted 
and exhibits a temperature dependant steady state KIE.79,119 TmDHFR, which is also 
conformationally restricted, shows a similar temperature independence, exhibiting a 
KIE of ~1.3 across the measured range.121 BsDHFR exhibits a larger KIE of ~2.6 across 
the measured temperature range and it was concluded that this temperature 
independence of the steady state enzyme KIE shows that large scale conformational 
changes are not involved in catalysis. BsDHFR has been shown to be more flexible than 
EcDHFR and as such mass induced effects would be larger. Unlike EcDHFR, hydride 
transfer is also partly rate limiting in BsDHFR at pH 7.0.120,214  
 
The observed temperature dependence of the steady state KIE in SaLDH could be a 
result of one of two reasons, or a combination of the two. Firstly, work by Moliner et.al. 
has shown rabbit muscle LDH is able catalyse the reaction in an open conformation. 
Values calculated for the free energy barrier are very close for the reaction catalysed in 
both the closed and open conformations.203 With increasing temperature the system 
would gain thermal energy overcoming activation barriers. At higher temperatures it 
may become favourable for the enzyme to catalyse the reaction in an open 
conformation, resulting in conformational behaviour at higher temperatures becoming 
less important for efficient catalysis, explaining the observed decrease in the value of 
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KIE. This change in conformational behaviour at higher temperatures may also explain 
the observed non-Arrhenius behaviour.  
 
Secondly as the rate of hydride transfer has been shown to be at least partially rate 
limiting in SaLDH, effects of isotope labelling on this step may be observed in the 
steady state KIE. If this were the case it would align with earlier work carried out with 
DHFR, showing a minimisation of dynamic effects under close to physiological 
conditions.53,79,119–121,164 Work by Schramm et.al. also shows a minimisation of enzyme 
KIE at close to physiological pH.163 There is therefore weak circumstantial evidence to 
suggest that like DHFR enzymes, SaLDH may have adapted to minimise dynamic 
coupling acting upon the chemical step at close to physiological pH and temperature.  
 
5.11 Promiscuity in catalysis by SaLDH 
 
Staphylococcus aureus is a gram-positive bacterium that naturally colonizes human skin 
and respiratory tracts, often existing in a commensal relationship with the host. 
Methicillin resistant Staphylococcus aureus (MRSA), identified in the UK in 1962 is 
genetically different from the original strain, having evolved to be antibiotic 
resistant.215,216 Over the past few decades Staphylococcus aureus has exhibited 
increasing resistance to a vast number of antibiotics, resulting in medical complications. 
Staphylococcus aureus is able to form biofilms and survive under anaerobic conditions, 
which it is believed to utilize in order to survive antibiotics and overcome the hosts 
immune response.217,218 As such SaLDH from Staphylococcus aureus is a viable drug 
target.210 By testing the specificity of the enzyme for different substrates insights can be 
gained with respect to the nature of the active site. Ultimately, it is of interest to find 
differences between SaLDH and human LDH that can be exploited.219 It is established 
that LDH enzymes exhibit promiscuity with respect to the substrates they accept, being 
able to reduce a wide array of 2-ketocarboxylic acids.212,220 To investigate whether 
substrate promiscuity is similar to previously reported LDH enzymes a variety of 
substrates were measured with respect to kcat and KM values. 
 
The calculated KM for pyruvate was 253 ± 47.54 µM. SaLDH like previously studied 
LDH enzymes also exhibited substrate inhibition at higher concentrations of pyruvate 
(Figure 5.16), although the effect is minimal.  
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Figure 5.16: Graph of kcat (s-1) vs. concentration of pyruvate (µM). 
 
Four pyruvate analogues were tested with SaLDH at 20 °C and pH 7.0 and the kcat and 
KM measured (Figure 5.17 and Table 5.9). The worst substrate, as defined by its 
specificity constant (kcat/ KM) was found to be 2,3-butanedione, which lacked a 
carboxylic acid moiety. This is likely a consequence of SaLDH being unable to 
effectively bind the substrate, evident by the high Michaelis constant (KM = 200 ± 4 
mM) which is ~800 fold higher than for the natural substrate, pyruvate. The addition of 
a methyl group to the C3 position of pyruvate results in ~3.4 fold drop in the value of 
kcat and a ~7 fold increase in the Michaelis constant. Addition of a carboxylic acid group 
to the C3 position of pyruvate only results in a ~5 fold reduction with respect to kcat and 
a ~13 fold increase to the Michaelis constant. Only addition of a propanoic acid to the 
C3 position results in a significant decrease with respect to kcat (~250 fold reduction 
with respect to pyruvate). 
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Figure 5.17: Pyruvate analogues incubated with SaLDH, differences with respect to pyruvate are 
highlighted in red. From left to right, top to bottom; (A) Pyruvate, (B) 2-Ketobutyric acid, (C) 
Oxaloacetate, (D) 2-Ketoglutaric acid and (E) 2,3-Butanedione.   
 
Table 5.9: Kinetic constants for pyruvate analogues incubated with SaLDH at pH 7.0 
and 20 °C. 
Substrate KM (µM) kcat (s-1) kcat/ KM (s-1 M-1) 
(A) Pyruvate 253 ± 47 1122 ± 27 4.4 x106 
(B) 2-Ketobutyric 
acid 
1823 ± 722 327 ± 53  1.8 x105 
(C) Oxaloacetate 3452 ± 475 209 ± 14 6.1 x104 
(D) 2-Ketoglutaric 
acid 
8806 ± 2966 4.45 ± 0.45 505 
(E) 2,3-Butanedione 200618 ± 3968 3.54 ± 0.80 18 
 
5.12 Summary and conclusions 
 
In this chapter the expression and purification of LDH from Staphylococcus aureus 
(SaLDH) has been detailed. SaLDH was originally selected as a candidate for the study 
of fast dynamics acting upon the chemical step of catalysis by the study of enzyme KIE, 
expanding on work carried out with DHFR enzymes. Furthermore, SaLDH is of further 
interest as it is an essential protein that originates from a pathogenic organism and as 
such represents a drug target.  
 
Like in EcDHFR, a network of residues with motions on a fs-ps timescale have been 
proposed to actively promote hydride transfer in human heart LDH.204,221 Recently, 
through the study of enzyme KIE Schramm and co-workers have put forward 
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experimental evidence for the existence of such promoting motions acting on the 
chemical step in catalysis by human heart LDH.163 It was therefore desirable to apply 
the same heavy enzyme methodology to SaLDH to see if these results hold true for 
other members of the LDH family. 
 
Unfortunately attempts to study the chemical step in SaLDH were unsuccessful, due to 
the rate constant for hydride transfer being too high. Attempts to lower the single 
turnover rate constant by reductions in temperature, addition of glycerol and pH 
alteration all yielded no valuable kinetic information. It was deemed the rate of hydride 
transfer in SaLDH was too fast to be studied via the available stopped flow techniques. 
 
As pre-steady state kinetics could not be measured, steady state kinetics were 
investigated, with the understanding that the chemical step would likely not be rate 
limiting. The substrate KIE was measured with regards to NADH to asses the extent to 
which the chemical step was rate limiting under steady state conditions. A primary KIE 
(NADH/D), which decreased from 1.98 ± 0.01 at pH 5.5 to 1.45 ± 0.13 at pH 9.5, was 
observed and a primary KIE of ~1.38 was observed across the measured temperature 
range at pH 7.0. These results indicate that at low pH values the chemical step accounts 
for a larger proportion of the steady state rate constant. Dynamics acting on the 
chemical step can therefore loosely be studied through analysis of steady state enzyme 
KIE especially at lower pH values.  
 
Interestingly the pH dependency of the enzyme KIE on the steady state turnover 
mirrored results obtained by Schramm and co-workers in single turnover experiments 
with human heart LDH. The enzyme KIE for SaLDH under steady state conditions 
decreased from 1.58 at pH 6.0 to 1.27 at pH 7.5 before increasing to 1.51 at pH 8.5.  
Although under steady state conditions there will be increased kinetic complexity it is 
known from primary KIE data that the rate constant kcat, does in part report on the 
chemical step in SaLDH. The enzyme KIE under steady state conditions was found to 
only slightly decrease with temperature, indicating events such as conformational 
behaviour, which increase kinetic complexity might be minimised in SaLDH. Although 
results mentioned here are from steady state experiments and conclusions must be 
cautiously drawn, they align with work done with DHFR’s in the way the effect of 
dynamics seem to be minimised under or near physiological conditions.  
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Finally, Measurements with respect to substrate specificity show SaLDH is unable to 
tolerate larger substrates. As such, inhibitor design based upon pyruvate analogues may 
be greatly limited by substrate size. Consequently, design of an specific SaLDH 
inhibitor may be challenging.219,222  	
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Protein motions, which occur on various time domains, are known to be central for 
enzyme catalysis. Conformational behaviour has been shown to be important for 
efficient ligand binding and product release, and in some cases facilitating catalysis 
through the creation of an optimal environment. However, a number of DHFR variants, 
which follow similar catalytic cycles, have similar primary sequences and near super-
imposable tertiary structures exhibit diversity with respect to conformational behaviour. 
It is therefore of great interest to further probe the role of such conformational 
behaviour to understand its overall importance in catalysis. Further to this, the influence 
of dynamic coupling to the chemical step of catalysis is still under great debate. 
Although a number of papers now agree that dynamic coupling to the chemical step is 
minimised in DHFR catalysis there still remains controversy on the influence of such 
motions in other enzymatic systems. 
 
6.1 Probing of conformational behaviour in DHFR variants. 	
The initial aim of chapter 3 was to probe protein motions present in TmDHFR through 
an NMR based approach. Reports have given evidence that TmDHFR is a rigid enzyme 
considered to proceed through its catalytic cycle in a fixed, open conformation. It is 
therefore of interest to understand how an apparently rigid enzyme can efficiently 
proceed through its catalytic cycle. The initial approach relied on obtaining a fully 
assigned 1H-15N HSQC spectrum, which would act as a foundation for a number of 
NMR based studies. This however, proved not to be possible in the given timescale. As 
TmDHFR has a relatively high MW it was deemed necessary to deuterate the protein in 
order to improve relaxation issues. During purification, deuterium present in 
exchangeable positions is usually back-exchanged for protons in the purification buffer, 
necessary for the experiment to work. In TmDHFR however, the rigidity needed for its 
increased thermal stability prevents this process from happening, resulting in greatly 
diminished signal quality in residues that are not solvent exposed. All in all, it proved 
very challenging to assign a 1H-15N HSQC for TmDHFR due to fast T2 relaxation and 
poor tumbling in solution. This meant just over 30% of the backbone in TmDHFR 
could be assigned, which was deemed insufficient for further experiments to take place.  
 
As such, a new approach to probe conformational behaviour was needed. Selective 13C 
labelling of the methionine and tryptophan sidechains to probe conformational 
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behaviour in TmDHFR allowed for a simplified, cost effective and fast solution. 
Moreover, labelling of sidechains yielded spectra with increased cross-peak resolution 
and intensity due to the improved relaxation properties. 
 
In order to first validate our method, EcDHFR, which is known to adopt an occluded 
conformation following the chemical step was selectively labelled with [methyl-13C]-
methionine and [indole-δ1-13C] tryptophan. Significant chemical shift perturbations 
were observed between the Michaelis and product complexes, indicative of 
conformational change. MpDHFR, which is known to not adopt an occluded 
conformation following the chemical step showed no significant chemical shift 
perturbations between the Michaelis and product complexes. This in turn acted as a 
negative control for the methodology as it proved that the observed chemical shift 
perturbations were largely reporting on conformational behaviour and not ligand 
binding effects. TmDHFR, unlike EcDHFR and MpDHFR showed no significant 
changes in [methyl-13C]-methionine chemical shifts between the apo, Michaelis and 
product complexes. These results provided direct evidence for the first time that 
TmDHFR does indeed remain in a fixed, open like conformation throughout its 
catalytic cycle. 
 
Previously, evidence of formation of an occluded conformation had only been observed 
for EcDHFR. Conservation of a hydrogen-bonding network between Ser148 and Asn23 
has been shown as crucial for stabilising such a conformation in EcDHFR. Through 
amino acid sequence analysis, SeDHFR was shown to conserve the Ser148-Asn23 
interaction, and therefore theorised likely to adopt an occluded conformation following 
the chemical step. Like EcDHFR and MpDHFR the quality of spectra for [methyl-13C]-
methionine and [indole-δ1-13C] tryptophan labelled apo-SeDHFR was of low quality, 
indicative of conformational heterogeneity. Like EcDHFR and MpDHFR, [methyl-13C]-
methionine labelled SeDHFR exhibits three well defined cross peaks when in the 
Michaelis complex. However, six cross peaks are observed when SeDHFR is in the 
product complex, indicating the presence of two distinct conformational states. Half of 
the cross peaks in the product complex overlap with those present in the Michaelis 
complex and it was therefore proposed that in the product complex SeDHFR is in 
equilibrium between two species, one of which is likely to be the closed conformation 
and the other an occluded like state. To confirm this theory the mutant SeDHFR-S150A 
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was prepared, knocking out the hydrogen bonding network postulated to stabilise an 
occluded conformation. Like in the wild type enzyme, two species were also observed 
in [methyl-13C]-methionine labelled spectra for the SeDHFR-S150A mutant. There was, 
however, a drastic reduction in the population of the second species and the equilibrium 
shifted to the same species observed in the Michaelis complex. This evidence 
corroborated our theory that SeDHFR adopts an occluded like conformation following 
the chemical step. However, to provide further evidence, a 1H-15N HSQC of SeDHFR 
was recorded in both the Michaelis and product complexes. Significant chemical shift 
differences were observed between the two sets of spectra, as observed in [methyl-13C]-
methionine resonances. The evidence presented here suggests SeDHFR does indeed 
adopt an occluded like conformation following the chemical step. 
 
In comparison to traditional NMR based approaches that require triple isotope labelling 
of the protein this methodology is significantly cheaper. Moreover, the time taken to 
acquire spectra is lessened due in part to increased sensitivity of the experiment and 
reduced spectral widths being recorded. Moreover, the spectra are drastically simplified 
and almost intuitive with regards to interpretation, with only a handful of cross peaks 
being produced. This work has shown that this methodology is sufficient to diagnose 
conformational behaviour in four DHFR variants and could be readily expanded to 
other enzyme families. 
 
6.2 The role of dynamics in catalysis 
 
The contribution of dynamics to the chemical step of catalysis is still a hotly debated 
issue. Recently evidence has been growing that at close to physiological conditions the 
effect of dynamic coupling to the chemical step of catalysis is minimised in DHFR 
variants. However much controversy still remains on the contribution of tunnelling in 
other enzyme families. Systematically labelling proteins with heavy isotopes (2H, 13C 
and 15N) is believed to only alter bond vibrations. Electrostatic properties are believed 
to be largely unaffected. Comparison of rate constants for the hydride transfer step 
between a heavy labelled enzyme and a natural abundance (light) enzyme yields an 
enzyme KIE. A number of DHFR variants have been previously studied in this way 
including EcDHFR, MpDHFR, BsDHFR and TmDHFR. 
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The temperature dependence of the enzyme KIE for SeDHFR was ~1 across the 
measured temperature range. This is similar to the trend observed in TmDHFR, which 
also exhibits a enzyme KIE of ~1 across the measured temperature range. In TmDHFR 
this was proposed to provide evidence for a lack of dynamic coupling to the chemical 
step of catalysis. EcDHFR exhibits a temperature dependant enzyme KIE that verges to 
unity at close to physiological temperatures, as does MpDHFR. It is therefore likely that 
the effect of dynamic coupling to the chemical step is likewise minimised in SeDHFR.  
 
As evidence is growing that the effect of dynamic coupling to the chemical step is 
minimised in DHFR variants we looked to expand our study to other enzyme families. 
SaLDH was selected as it also catalysed a hydride transfer reaction that could be readily 
characterised using similar experiments to those used in our studies with DHFR. Similar 
to DHFR, a network of promoting motions have previously been proposed to actively 
promote catalysis in HsLDH. Furthermore, work by Schramm and co-workers has put 
forward experimental evidence supporting such a claim.  
 
Attempts to study the chemical step in SaLDH proved to be unfruitful. The rate constant 
for the chemical step proved too great to be studied via the available stopped flow 
methodologies. Investigation of steady state kinetics revealed a substrate KIEH/D that 
decreased from 1.98 ± 0.01 at pH 5.5 to 1.45 ± 0.13 at pH 9.5. With respect to 
temperature dependence, measured at pH 7.0 a value of ~1.38 for the primary KIEH/D 
was recorded over the measured range. This suggests that in part the steady state rate 
constant reports on the chemical step. As such, the effect of dynamic coupling to the 
chemical step could be tentatively studied trough enzyme KIE under steady state 
conditions. Although with any conclusions drawn we would have to be extremely 
cautious as under steady state there would be increased kinetic complexity that would 
perturb results. 
 
The steady state pH dependency of the enzyme KIE decreased from ~1.6 at pH 6.0 to 
~1.3 at pH 7.5, before increasing to ~1.5 at pH 8.5. Interestingly this was found to be a 
similar trend to that reported by Schramm and co-workers with human heart LDH under 
pre-steady state conditions. With respect to the temperature dependency of the enzyme 
KIE it was found to only slightly increase with temperature under steady state 
conditions. This suggests contributions from such things as conformational behaviour 
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may be minimised. Tentatively, this shows that at close to physiological pH values the 
contribution from dynamic coupling to the chemical step may be minimised, possibly 
aligning with results from DHFR variants. 
 
6.3 Summary 
 
In brief, we have provided further evidence that dynamic coupling to the chemical step 
is minimised in catalysis by DHFR and may also be minimised in catalysis by SaLDH. 
This thesis therefore provides further evidence that evolutionary pressure has minimised 
the influence of dynamic coupling to the chemical step of catalysis. We have also 
presented a simplified, cost-effective and intuitive approach to probe conformational 
behaviour in enzyme catalysis. This was utilised to provide evidence that TmDHFR 
does indeed remain in a fixed, open conformation during catalysis. The methodology 
was also used to confirm SeDHFR, like EcDHFR adopts a second structural 
conformation following the chemical step. 
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